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A b s t r a c t
The study o f a novel prolme-specific peptidase from bovine serum is presented The 
enzyme readily cleaves Z-Gly-Pro-MCA liberating the fluorophore MCA thus allowing 
quantification o f enzyme activity Unlike prolyl ohgopeptidase (PO) which also 
hydrolyses this fluorogemc substrate, this peptidase is completely insensitive to Z-Pro- 
Prolmal and has been designated Z-Pro-Prolmal Insensitive Z-Gly-Pro-MCA degrading 
Peptidase (ZIP)
The two peptidases were successfully separated from each other by phenyl sepharose 
hydrophobic interaction chromatography and the subsequent purification focused on the 
isolation o f ZIP from bovine serum In addition to phenyl sepharose, calcium phosphate 
cellulose and DEAE anion exchange chromatography were employed in the purification, 
with an overall enzyme yield o f 33% and a purification factor o f 4023 SDS PAGE and 
size-exclusion chromatography indicated a heterodimeric structure with a relative 
molecular mass o f 180kDa
The enzyme remained stable at temperatures less than 50X1 for up to an hour, while 
optimal activity was observed at 37°C ZIP was surprisingly stable over the pH range 
2 5-JO 0 Optimal activity was detected in the range pH 7 4-8 0 Isoelectric focusing 
revealed a p i  value o f5 68 and the enzyme appears to be 33% glycosylated
Inhibition by AEBSF suggests the peptidase may be a serine protease and ZIP possibly 
contains a cysteine residue near the active site a2M failed to inhibit activity suggesting 
an ohgopeptidase specificity HPLC analysis revealed a broad substrate specificity for  
proline-containmg peptides Kinetic analysis indicated that ZIP had a greater affinity for  
Z-Gly-Pro-MCA than PO with a Km o f 54pM deduced The ohgopeptidase showed 
complete insensitivity to a number o f PO-specific inhibitors, namely JTP-4819 and S- 
17092-1
ZIP exhibits similar biophysical characteristics to PO isolated from a number o f sources 
However the peptidases do appear to be distinct and ZIP may represent a novel prohne- 
specific serum peptidase, which may play a role in the degradation o f oligopeptides
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Mg Magnesium
VIII
M M  Michaelis-Menten
Mn Manganese
MOP Mitochondrial oligopeptidase
Na Sodium
NaCl Sodium chloride
NaOH Sodium hydroxide
ND Not determined
NEM N-ethyl maleimide
Ni Nickle
OH Hydroxy
P Pellet
Pn Substrate subsite located n positions from the scissile bond
on the N-terminal side
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pAb p-aminobenzoate
PAGE Polyacrylamide gel electrophoresis
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PBE Polybuffer exchanger
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PE Perkin Elmer
PEG Polyethylene glycol
pH log of the reciprocal of the hydrogen ion concentration
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pKa Negative log of the equilibrium constant for an acid
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PO Prolyl oligopeptidase
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Regression coefficient 
Acyl
Relative mobility 
Reverse phase 
Revolutions per minute 
Sulphur
First supernatant 
Second supernatant
Prolyl oligopeptidase family of serine proteases 
Sodium dodecyl sulphate (Lauryl sulphate)
Standard error
Size exclusion chromatography 
Thiol group
Enzyme subsite positioned n places from the active site 
the N-terminal side
Enzyme subsite positioned n places from the active site
the N-terminal side
Sulphate
Disulphide Bridges 
Succinyl-
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UV Ultraviolet
v/v Volume per volume
Ve Elution volume
V0 Void volume
w r t With respect to
Xaa Any amino acid
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ZnCl Zinc chloride
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1.0. Introduction
1 0 I n t r o d u c t io n  - O l ig o p e p t id  a s es
11 Background
The term oligopeptidase was once assigned to any peptide hydrolase, which appeared to 
act on oligopeptides yet showed no activity towards proteins However this vague 
terminology was soon disregarded on the discovery that many of these ‘ohgopeptidases’ 
were in fact exopeptidases whose inactivity towards proteins was due to a low molar 
concentration of susceptible terminal groups available as substrate (Barrett and Rawlings, 
1992) As recommended by the Nomenclature Committee (1992), an oligopeptidase is 
now defined as an endo acting oligopeptide hydrolase and no longer includes the 
exopeptidases
The earliest recognition of an oligopeptidase as a distinct sub-group of the 
endopeptidases was in 1979, by Camargo et a l, with the discovery of two brain 
peptidases capable of hydrolysing the neuropeptide, bradykinm Further research led to 
the identification of the neurotensin-degrading ability of these ohgopeptidases in rabbit 
brain (Camargo et a l, 1983 and 1984) The enzymes then referred to as endo- 
oligopeptidase A and B are now widely recognised as thimet oligopeptidase and prolyl 
oligopeptidase respectively
Since the 1980’s, there has been a surge of research into the proteinases, but little 
attention was given initially to their substrate-size limitations and hence the existence of 
the ohgopeptidases as a distinct class of endopeptidases was not focused on This, 
coupled to the inconsistent naming of the same enzyme makes it difficult to identify the 
exact number of true ohgopeptidases However, the recent classification, whether by 
catalytic type, reaction catalysed or evolutionary relationship (Barrett, 1994), and the 
trivial naming of the ohgopeptidases, has made it somewhat easier to quantify, recognise 
and research them
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12  Characteristics
The ohgopeptidases are a distinct sub-set of the endopeptidases, although they are not 
true proteinases due to their inability to hydrolyse peptide bonds within proteins They 
are confined to the degradation of oligopeptides or small polypeptide substrates, the size 
of which varies for individual enzymes within the class This strict substrate specificity 
is probably determined by their molecular structures though little structural information 
has been obtained and so the exact mechanism of action is not yet fully understood The 
ohgopeptidases are known to have few naturally occurring inhibitors Plasma is rich with 
inhibitors of various proteinases including ot2-macroglobulin (ot2M), which inhibits the 
majority of endopeptidases, irrespective of catalytic class (Barrett and Rawlings, 1992) 
Due to the large size of 012M, ohgopeptidases fail to cleave in the bait region, presumably 
for the same reason that they cannot hydrolyse proteins It is suggested that the 
endopeptidases cleave a peptide bond in a sensitive region of the macroglobulin, and that 
this results in a conformational change in the (X2M  molecule that traps the enzyme 
irreversibly Access of substrates to the active site of the enzyme becomes stencally 
hindered, causing inhibition that is most pronounced with large substrate molecules 
(Barrett and Starkey, 1993)
The precise biological functions of ohgopeptidases are still unknown yet for some of the 
enzymes possible roles have been elucidated They are thought to perform important, 
specialized biological functions including the modification or destruction of peptide 
messenger molecules The fact that they lack natural inhibitors may also be of some 
biological significance
13 The Oligopeptidases
The exact number of ohgopeptidases is difficult to ascertain due to the many different 
names given to the same enzyme and the ever-emerging new enzymes TABLE 1 1 
highlights the most common ohgopeptidases studied and the ones which are going to be 
focused on in this review, while table 1 2 lists other hydrolases which have been 
identified as ohgopeptidases but have not been as extensively characterised
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Oligopeptidase Number Catalytic Type Alternative Names
Prolyl EC 3 4 21 26 Serine protease Prolyl endopeptidase
Oligopeptidase Proline endopeptidase 
Endo-oligopeptidase B 
Post-proline cleaving enzyme
Thimet EC 3 4 25 15 Metalloprotease Pz peptidase
Oligopeptidase (thiol activated) Collagenase-like peptidase 
Endo-oligopeptidase A 
Soluble metalloendopeptidase 
Endopeptidase EC 24 15 
Kinmase A 
EC 3 4 22 19
Neurolysin EC 3 4 24 16 Metalloprotease Oligopeptidase M
EC 3 4 99 31
Thimet Peptidase 11
Microsomal
metalloendopeptidase
Mitochondrial oligopeptidase
(MOP)
Nepnlysin EC 3 4 24 11 Metalloprotease Neutral endopeptidase
Enkephalinase
Membrane-
metalloendopeptidase A
Oligopeptidase B EC 3 4 21 83 Serine Protease Protease II
Table 11  The Predominant Oligopeptidases
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Oligopeptidase Number Catalytic Alternative Names
Type
Oligopeptidase A EC 3 4 24 70 Metalloprotease -
Oligopeptidase F Metalloprotease LEPI
Oligopeptidase PepF 
Alkaline endopeptidase
Oligopeptidase MepB - Metalloprotease
Oligopeptidase 0 Metalloprotease Neutral thermolysin-like 
oligopeptidase (NOP) 
Oligopeptidase PepO
Insulysin EC 3 4 24 56 Metalloprotease Insulinase
Insulin-degrading peptidase
Oligopeptidase PepB - Metalloprotease PepB
Pitrilysin EC 3 4 99 44 Metalloprotease Protease III 
Protease Pi
Protease IV - Unclassified
Saccharolysin EC 3 4 24 37 Metalloprotease Oligopeptidase YscD
Table 1 2 The Emerging Oligopeptidases
13 1 Prolyl Oligopeptidase
Prolyl oligopeptidase (EC 3 4 21 26) activity was first observed in 1971 in a study on 
human uterine homogenates and appeared to cause the release of leucylglycinamide from 
oxytocin (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2), indicative of cleavage at the 
carboxy side of the proline residue (Walter et a l, 1971) This enzyme was further 
purified and characterisation revealed a broader specificity than was initially suggested 
In fact this oxytocin-degrading enzyme was found to be a proline specific peptidase 
capable of hydrolysing the carboxy side of proline residues and was referred to as post- 
prohne cleaving enzyme (Koida and Walter, 1976, Walter, 1976) Since its initial 
discovery, PO has been isolated from various sources and named according to the 
bioactive peptide acting as substrate For example, kinmase B isolated from rabbit brain 
(Oliveira et a l, 1976) and TRH deamidase from rat brain (Rupnow et a l, 1979) are now 
known to be the same enzyme Prolyl oligopeptidase is now the generally accepted term 
for this proline specific peptidase, as recommended in 1992 (Nomenclature Committee)
1 3 1 1  Assay
Following the discovery of PO, oxytocin and argimne-vasopressin were initially 
employed as natural and radiolabelled substrates for the enzyme (Walter et a l, 1976) 
Koida and Walter (1976) reported the use of the Z-Gly-Pro-Leu-Gly as substrate, the 
nmhydrin assay being employed to detect the cleavage product Leu-Gly The 
development of spectrophotometnc and fluorimetric substrates in the late 1970’s, lead to 
the synthesis of a number of potential chromogens and fluorophores The basic structure 
of PO substrates focuses on N-blocked proline containing dipeptides linked to a molecule 
that is readily detected on cleavage The N-terminal blocking agents N- 
benzyloxycarbonyl- (Z-) and succinyl- (Sue-) are most commonly linked to Gly-Pro 
residues such is the case for Z-Gly-Pro-MCA The synthesis of this first fluorogenic 
substrate was described in 1979 by Yoshimoto et a l, who reported a Michaelis constant 
(K m ) of 0 02nM for rat tissue PO The fluorophore MCA (7-amino-4-methyl-coumarin) 
can readily be detected at excitation and emission wavelengths of 370nm and 440nm 
respectively (Yoshimoto et a l, 1979)
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Various reports of novel fluorogenic synthetic substrates have been published since, and 
the superior sensitivity of fluonmetric over spectrophotometric assays is well- 
documented (Willard et a l, 1988) Kmsatschek et al (1980) reported a KM value of 
14|iM for Z-Gly-Pro-2-NNAp, an alternative fluorogenic substrate Although PO assays 
incorporating 2-NNAp (P-naphthylamide) have been reported, MCA shows enhanced 
sensitivity over the naphthylamide derivative (Polgar, 1994) A ten-fold lower KM 
(1 4|iM) was determined by Noula et al (1997) using 7-amino-4-methyl-2-quinolme 
(Meq) as an alternative to MCA The enhanced affinity of PO was as a direct result of 
replacement of the P2 positioned Gly with a cysteine-benzyl residue An added 
advantage of this fluorogenic substrate is the reduction in solvent concentration required 
for solubilisation Spectrophotometric assays have also been described using Z-Gly-Pro- 
4-mtroanilide (Polgar, 1992d) and mtrophenylesters (Walter and Yoshimoto, 1978, 
Polgar, 1992d) although these are generally less sensitive than their fluorescent 
counterparts To date, Z-Gly-Pro-MCA has been the most widely used, commercially 
available substrate employed for the detection of PO activity (Rennex et a l, 1991, 
Goossens et a l , 1995, Cunningham and O’Connor, 1998) It should be noted however, 
that the identification of a Z-Pro-Prolmal insensitive Z-GIy-Pro-MCA degrading 
peptidase (ZIP) by Cunningham and O’Connor (1997a) questions the classification of Z- 
Gly-Pro-MCA as a specific PO substrate
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13 12 Purification
Prolyl oligopeptidase activity has been identified and subsequently purified from a wide 
range of mammalian and bacterial sources PO distribution studies in human and rabbit 
tissues (Orlowski et a l, 1979, Kato et a l, 1980) have revealed an ubiquitous distribution 
with consistently elevated levels in the brain, offering a wide range of source tissues 
Initially, tissue samples are homogenised using mechanical and centrifugal forces and 
this is usually followed by an ammonium sulphate fractionation with up to 80% 
saturation (Yoshimoto et a l , 1981 and 1983, Monyama and Sasaki, 1983, Kalwant and 
Porter, 1991) Diethylaminoethyl (DEAE) resins at pH 7 0 are widely employed as the 
first chromatographic separation step in PO purification schemes and the concept of re- 
chromatographing on the same resin is commonly practiced Yoshimoto et al (1983) 
employed the anion exchange resin twice in the purification of bovine brain PO, while 
four distinct DEAE cellulose steps were reported by Rosen et al (1991) for the 
purification of PO from human erythrocytes, resulting in a 64,000-fold purification 
Separation based on relative molecular size is commonly performed using a variety of 
size exclusion chromatography columns, ranging from Sephadex G-150 (Monyama and 
Sasaki, 1983) to Sephacryl S-300 (Chevallier et a l, 1992) Many PO purification 
schemes published incorporate hydroxyapatite (Yoshimoto et a l , 1981, Kalwant and 
Porter, 1991, Rosen et a l, 1991) and phenyl sepharose hydrophobic interaction 
(Goossens et a l, 1995, Cunningham and O’Connor, 1998) chromatography resins 
Alternative purification methods include native polyacrylamide gel electrophoresis 
(Carvalho and Camargo, 1981) and multi-step fast protein liquid chromatography 
(Makinen et a l, 1994) A membrane-bound form of PO was purified 1400-fold by size 
exclusion, calcium phosphate cellulose and hydrophobic interactions chromatography 
with a yield of 23% (O’Leary et a l, 1996)
The effectiveness of these purification procedures is reflected in the overall purification 
factor achieved and the yield of biologically active peptidase PO punfication factors 
ranging from 30 to 64,000 have been reported using the aforementioned procedures, with 
an average yield of 10%
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13 13 Biochemical Characteristics
To date PO has been well characterised in terms of its biochemical and physiochemical 
properties It has been identified as a monomeric enzyme with a molecular weight 
ranging from 65 to 85kDa, the majority of reports indicating a molecular weight of 70 to 
75kDa (Kato et a l, 1980, Monyama and Sasaki, 1983, Yoshimoto et a l, 1987) 
Preliminary molecular weight determinations suggesting that PO was a dimer with native 
molecular weights ranging from 115 to 140kDa (Koida and Walter, 1976, Mizutam et a l, 
1984), have been disproved (Rennex et a l, 1991) Ammo acid sequences have been 
deduced from cDNA clones of prolyl oligopeptidase and further verify a monomeric 
structure Both porcine brain and human T-cell PO revealed a 710 ammo acid sequence 
and a deduced molecular weight of 80 75kDa (Rennex et a l, 1991, Shirasawa et a l,
1994) Bacterial PO has also been cloned and a molecular weight of 78 71kDa has been 
proposed for the 705 ammo acid residue sequenced (Yoshimoto et a l, 1992) In 1992, 
Chevallier et al verified this result and identified a 20 ammo acid N-termmal signaling 
peptide (also reported by Kanatani et a l, 1993), which when removed resulted in a 
molecular weight of 76 78kDa
In general, bacterial and mammalian PO have a neutral pH optimum with reported values 
between pH 6 5 and pH 8 3 depending on the source Isoelectric points of between 4 8 
and 4 9 indicate the acidic nature of mammalian PO (Koida and Walter, 1975, Yoshimoto 
et a l, 1983, Goossens et a l, 1995), while bacterial PO isoelectric points are generally 
higher Treponema denticola PO was reported to have a pi of 6 5 (Makinen et a l, 1994), 
while Yoshimoto et al (1980) reported a pi of 9 6 for PO isolated from Flavobacterium 
menmgosepticum and a value of 5 2 for Lyophyllum cinerascens PO in 1988 Both forms 
have an optimum temperature of 37°C to 40°C (Yoshimoto et a l, 1981, Kalwant and 
Porter, 1991, Makinen et a l, 1994), with some reports of thermostability at 45°C (Koida 
and Walter, 1976, Yoshimoto e ta l, 1981)
8
1 3 1 4  Distribution
PO distribution is predominantly cytosolic in nature, the majority of studies reporting the 
purification or characterisation of soluble PO from bovine, human, lamb, mouse, porcine, 
rabbit or rat cytosol Camargo et al (1984) were the first to report a particulate form of 
this endopeptidase, reporting 10% of the total rabbit brain PO activity to be associated 
with the membrane fraction Particulate forms of PO have also been reported in the brush 
border of kidney (Sudo and Tanabe, 1985) and in neuroblastoma cells (Checler et a l , s
1986) O’Leary and O’Connor (1995) were first to report the complete purification and 
characterisation of a membrane-bound form of PO The particulate bovine brain enzyme 
displayed similar characteristics to cytosolic PO, however the synaptosomal membrane 
localisation may be of potential physiological significance in relation to neuropeptide 
cleavage (O’Leary et a l, 1996)
As previously mentioned, PO is ubiquitously distributed throughout a variety of 
mammalian, plant and microbial sources, with high levels in the brain Localisation 
studies performed by Kato et a l, 1980 and Orlowski et a l, 1979, compared PO 
distribution in human and rabbit peripheral tissues respectively Highest levels of the 
peptidase in humans were observed in skeletal muscle, testes and kidney extracts while in 
rabbit peripheral tissues the small intestine, lung and spleen contributed to the highest PO 
activity Conversely in rabbit, skeletal muscle was the poorest source, followed by 
kidney and Camargo et al (1983) failed to detect the enzyme in rabbit spleen, lung or 
kidney The small intestine of rat exhibited poor PO levels, while activity in kidney and 
liver homogenates was substantial (Yoshimoto et a l, 1979) These studies imply 
considerable species to species variation in PO activity in mammalian peripheral tissues
Similar species variation is not observed in mammalian brain Consistently high PO 
levels have been identified in brain homogenates of bovine, human, lamb, mouse, rabbit 
and rat species examined (Blumberg et a l, 1980, Kato et a l, 1980, Yoshimoto et a l, 
1981, Dresdner et a l, 1982, Healy and Orlowski, 1992, Fukunan et a l, 1994) However, 
localisation studies have revealed considerable species variation in the regional 
distribution of PO in the brain For example, PO activity was highest in the frontal cortex
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of human brain (Kato et a l, 1980), in the endohinal cortex and hippocampus of rabbit 
brain (Orlowski et a l, 1979), but in the thalamus in bovine brain (Tate, 1981) This 
variation among specific regions within the brain may simply be species related (Kato et 
a l, 1980), however the consistently high activity observed in the brain as a whole, 
indicates a possible functional role of PO in the brain
1 3 1 5  Catalytic Classification
PO has been classified as a serine protease, initially based on its inhibition by the active- 
site directed reagents, DFP and to a lesser extent by PMSF (Kalwant and Porter, 1991, 
Stone et a l, 1992) Confirmation of its catalytic classification was achieved on 
identification of the active site by Rennex et al (1991) who successfully cloned PO from 
porcine brain Although PO is a serine protease, it differs from the established families 
of these enzymes in its substrate specificity, subcellular localisation and amino acid 
sequence Until recently serine proteases have been considered to consist of three 
groups, the trypsin, subtilisin and carboxypeptidase Y families (Neurath, 1989) The 
families have unrelated tertiary structures but possess similar catalytic sites and are 
believed to have evolved from a common origin (Polgar and Szabo, 1992)
When the deduced amino acid sequence of PO was reported, there was no apparent 
similarity between it and the other proteins in its class However in 1992, Polgar and 
Szabo (1992) detected a resemblance to DPP IV (EC 3 4 14 5), since both peptidases 
were proline specific and larger than classic serine proteases Rawlings et al (1991), 
while agreeing with Polgar and Szabo, claimed a clearer relationship between PO and 
acylaminoacyl-peptidase (EC 3 4 19 1) based on similar C-terminal residues It is now 
generally accepted that there is a fourth class of serine proteases, the prolyl 
oligopeptidase family, which includes, pig and F  memngosepticum PO, human and rat 
DPP IV, pig and rat acylaminoacyl-peptidase, among others (Barrett and Rawlings, 
1992)
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Within each family of serine proteases, the primary structures of the enzymes are 
homologous and the tertiary structures similar, while enzymes from different families are 
not homologous Similarly the ammo acids that surround the active site seryl residue are 
conserved in each family From ta b le  13 it is clear that the active-site sequence for PO 
showed no homology to those for the subtilism, trypsin or carboxypeptidase families 
confirming its classification as a new type o f serine protease (Rennex et a l, 1991) DPP 
IV and acylaminoacyl-peptidase sequences from different sources are also shown
Serine Protease Class Active site sequence 
Residues 552-558
Trypsin-like Gly-Asn-Ser-Gly-Gly-Pro
Subtilisin-like Gly-Thr-Ser-Met-Ala-Ser/Thr
Carboxypeptidase-like Gly-Glu-Ser-Tyr-Ala-Gly
Prolyl ohgopeptidase-like Gly-Xaa-Ser-Y aa-Gly-Gly
Examples of PO-like family
Pig PO Gly-Gly-Ser-Asp-Gly-Gly
F menmgosepticum PO Gly-Arg-Ser-Asp-Gly-Gly
Pig acylaminoacyl-peptidase Gly-Gly-Ser-His-Gly-Gly
Rat acylaminoacyl-peptidase Gly-Gly-Ser-His-Gly-Gly
Rat DPP IV Gly-Trp-Ser-Tyr-Gly-Gly
Human DPP IV Gly-Trp-Ser-T yr-Gly-Gly
Table 1 3 Amino Acid sequences Surrounding the Active Site Ser554 
Residues of Serine Protease Families
li
A second feature that distinguishes PO from the other families of serine proteases is the 
order of the catalytic triad The active site is believed to be located at the C-terminal end 
of the 710 ammo acid sequence Barrett and Rawlings (1992) highlighted the sequence 
homology between PO family members at Asp529, Ser554, His680 and Asp641 residues, 
three of which represent the catalytic tnad They concluded that Asp529 was located in a 
neutral, hydrophilic segment and was therefore most likely to be the catalytic aspartic 
acid In 1995, Goossens et a l , in a study of the secondary structure of PO, indicated that 
Asp641 was in fact the third member of the catalytic tnad Although the active sites of all 
serine protease in the SA, SB and SC clans (see Barrett et a l, 1998 for classification) 
contain a catalytic triad of Ser, His and Asp residues (Rennex, 1991), the order for PO 
(Ser554-His680-Asp641) appears to be unique in comparison to trypsin (His57-Asp102-Ser195) 
and subtilisin (Asp32-His64-Ser221) classes The linear arrangement of the active site 
residues of PO, differs from that of the established serine proteases and is in fact similar 
to the lipases and some carboxypeptidases (Polgar, 1992b) Goossens et al (1995) 
reported that the prolyl oligopeptidase is the first endopeptidase shown to adopt the a/pi
hydrolase fold structure, and the authors postulate that oligopeptidases are an 
evolutionary link between the exopeptidases and the endopeptidases
The prolyl oligopeptidase family (S9) is the most disparate of the serine peptidases 
(TABLE 14) Members include an endopeptidase that is confined to action on 
oligopeptides (EC 3 4 21 26), an exopeptidase that cleaves dipeptides from the N- 
terminal only when the terminal is free (EC 3 4 14 5) and an omega peptidase that 
preferentially cleaves N-terminal acetyl-aminoacyl residues from polypeptides (EC 
3 4 19 1) (Rawlings et al y 1991) The mixture of thiol-dependent and particulate and 
cytosolic peptidases further emphasises the diversity of the members of the S9 family of 
serine proteases
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Peptidase EC NO Peptidase Type Properties
Acylaminoacyl peptidase 3 4 19 1 Exopeptidase- Cytosolic, thiol dependent
Omega peptidase Cleaves N-formyl or vV-acetyl from the N-terminus of a
peptide
Dipeptidyl peptidase IV 3 4 14 5 Dipeptidase Particulate, not thiol dependent
Releases N-terminal dipeptides, preferential for prolyl bonds
Dipeptidyl peptidase IV-like - Dipeptidase Releases N-terminal dipeptides
protein
Dipeptidyl aminopeptidase A - Aminopeptidase Releases N-terminal dipeptides
Dipeptidyl aminopeptidase B - Aminopeptidase Releases N-terminal dipeptides
Prolyl oligopeptidase 3 4 21 26 Endopeptidase- Mainly cytosolic, thiol dependent
Oligopeptidase Cleaves prolyl and some alanyl bonds
Oligopeptidase B 3 4 21 83 Endopeptidase- Cytosolic
Ohgopeptidase Cleaves arginyl and lysyl bonds
Table 1 4 The Members of the Prolyl Oligopeptidase (S9) Family of Serine Proteases
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13 16  Mechanism o f Action
The catalytic triad amino acids each play an important role in the catalysis of PO The 
histidine acts as a general acid-base catalyst activating the nucleophilic group The 
hydroxyl group of the serine acts as a nucleophile in the attack on the peptide bond while 
the aspartic acid stabilizes charged tetrahedral intermediates formed in the reaction (Fink, 
1987, Rennex et al 1991) Although the mechanism of action of the serine proteases is 
still not completely understood, catalysis generally involves an acylation reaction in 
which the acyl (RCO-) moiety of the substrate is transferred to the enzyme’s serine 
group This represents the first half of the catalytic reaction The second stage involves a 
reversal of this step i e deacyl at ion, where the imidazole group of the histidine residue 
activates a water molecule by general-base catalysis ultimately leading to the formation 
of an acid product and enzyme (see Fink, 1987 for review of serine proteinase catalysis)
Polgar (1991) observed the remarkable sensitivity of PO to ionic strength and postulated 
the existence of two catalytically active forms while attempting to understand the 
catalytic mechanism of PO Usually the ionisation of the histidine residue in the active 
site of serine proteases governs the pH dependence of catalysis, exhibiting a pKa of 7 0 
However a second significant ionisation event in pH dependent kinetics was observed at 
pKa 5 0 (Polgar, 1991) Examination of the two PO forms revealed that the rate 
determining step of the low pH form followed general acid/base catalysis, while that of 
the high pH form was due to a physical step The rate of PO catalysis was unaffected by 
the nature of the substrate leaving group Consequently it was concluded that the rate- 
limiting catalysis of PO is governed by a physical rather than a chemical step (Polgar, 
1992c) In comparison, the rate-determining step in the catalysis of trypsin and subtilisin 
is a general acid/base catalysed chemical step, further substantiating the notion that PO is 
a member of a distinct family of serine proteases
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X-ray crystallography has helped to elucidate the crystal structure of PO (Fulop et a l, 
1998), a breakthrough which has revealed and confirmed many interesting structural 
properties of the enzyme The catalytic (peptidase) domain consists of residues 1-72 and 
428-710 As predicted by Goossens et a l , 1995, this region of the domain exhibits a 
characteristic a/p hydrolase fold A second (P-propeller) domain was also identified 
between residues 73 to 427, connected to the catalytic domain by hydrophobic forces Its 
structure is based on a seven-fold repeat of four-stranded antiparallel p-sheets, which are 
twisted and radially arranged around a central tunnel It was also evident that the 
catalytic triad is covered by the central tunnel of this unusual P-propeller Unlike other 
p-propellers, the first and last blades of the PO propeller are not closed The resultant 
partial opening provides access via the tunnel to the active site This domain controls the 
size-hmitation of PO substrates, by excluding large structured peptidases thus protecting 
large peptides and proteins from proteolysis within the cytosol The catalytic triad is 
hidden in the central cavity at the interface between the two domains The enzyme 
subsites, Si and S2, have been located in the peptidase domain, suggesting that the 
truncated catalytic domain alone preserves enzyme specificity (Fulop e ta l, 1998)
The P-propeller is partially opened and the presence of a narrow hole at its bottom could 
be responsible for the conformational change allowing the substrate gam access to the 
active site It is also possible that the active site entrance could be widened by the 
movement of flexible side chains located on the propeller and this is believed to be the 
physical rate-limiting catalysis step hypothesised by Polgar (1992c)
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13 17  Specificity
The ability of PO to hydrolyse a peptide is dictated by the presence of a particular residue 
(proline or alanine), the location of the residue and the length of the peptide Prolyl 
ohgopeptidase is assumed to have five binding subsites (Walter et a l , 1980) from S3 to 
S2’ (see FIGURE 1 1 for terminology) The smallest peptide cleaved is an N-blocked 
tripeptide or a tetrapeptide with residues in positions P3-P1’ As an ohgopeptidase, PO 
has a substrate-size limitation and is therefore unable to act on proteins or peptides longer 
than 25 amino acids in length (Koida and Walter, 1976, Walter et a l, 1980, Monyama et 
a l, 1988) This observation can be explained by the existence of the P-propeller domain 
described in section 13 16
Figure 11 Schematic Representation of an Enzyme-substrate Complex 
Residues of the substrate and enzyme subsites are numbered according to their distance 
from the scissile bond and their location on the N- or C-terminal side of the cleavage site 
(Berger and Schechter, 1970, Nomenclature Committee, 1992)
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PO is a proline specific peptidase, cleaving peptides with a proline in the Pi position 
Cleavage will not occur if a free a-amine exists in the N-terminal sequence (P3 position) 
or in the Pi’ position Pro-Pro bonds are not hydrolysed (where a proline also occupies 
the Pi’ site) nor are peptides with a proline residue at the P2 site N-terminally blocked 
peptides are readily hydrolysed as long as the above criteria are observed Nomura 
(1986) investigated the importance of the residue in the substrate Pi position and the 
corresponding effect on the sub site of the enzyme (Si) A range of substrates was
examined and it was observed that proline, alanine and N-methylalanme in the Pi
position yielded acceptable rates of bacterial PO catalysis This had been previously 
reported for mammalian PO, where Walter et al (1980) showed that the Pi proline could 
be substituted for an alanine residue Although alanine and N-methyl derivatives of 
alanine and glycine are possible Pi residues, the rate of hydrolysis is much slower, 
Nomura (1986) reporting this rate as only 16% the rate of the Pro bond cleavage It is 
generally accepted that the Si subunit of prolyl oligopeptidase is designed to specifically 
fit proline residues ( f ig u r e  1 2 ) but can tolerate residues carrying substituent groups, 
provided they do not exceed the size of proline’s pyrrolidine (Walter et a l, 1980,
Nomura, 1986, Makinen e ta l, 1994, Kreig and Wolf, 1995)
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Figure 1.2. A Schematic M odel of the A ctive Site of PO
The Si subsite is presumed to accommodate those residues with size and shape similar to
proline (Nomura, 1986)
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There is a preference for hydrophobic residues at the C-terminal of the scissile bond (Pi’) 
with lower specificities for acidic and basic residues (Koida and Walter, 1976, Krieg and 
Wolf, 1995) This explains why PO exhibits such a high specificity for the hydrophobic 
MCA employed in fluorogemc substrate synthesis (Yoshimoto et a l, 1979) Substrates 
incorporating phosphorylated serine residues in place of serine in the Pi’ position were 
shown to induce an increase in the rate of hydrolysis Similarly substitution of aspartic 
acid with an asparagine residue in this position also increased the rate of catalysis 
(Momand and Clarke, 1987)
Prolyl oligopeptidase has a broad specificity for proline-containmg oligopeptides and its 
ability to cleave a number of bioactive peptides in vitro is well documented The first 
report of such cleavage was in 1976 when the enzyme was initially identified as an 
oxytocin-degrading peptidase in human uterus (Walter et a l, 1976) Since then, many 
bioactive peptides were utilised as substrates including arginme-vasopressin, TRH and 
bradykinm TABLE 1 5 summarises the peptides reported to have been hydrolysed by PO 
and the identified cleavage sites Despite the volume of reports claiming PO hydrolysis 
in vitro, the precise role of the peptidase in vivo is still unclear, although research on 
specific inhibitors has helped in the elucidation of the role of PO in peptide turnover
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Peptide AA Sequence and Cleavage Site Reference
Angiotensin I 11 Asp-Arg-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu Monyama e ta l , 1988
Angiotensin II 8 Asp-Arg-Val-Tyr-Ile-His-Pro-Phe Monyama e ta l , 1988
Angiotensin III 7 Arg-V al-Ty r-Ile-His-Pro-Phe Monyama et a l, 1988
Arg-vasopressin 9 Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 Walter e ta l, 1976
Bradykinin 9 Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg Tate, 1981
LHRH 10 Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 Wilk eta l 9 1979
Melanotropin 13 Ser-The-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 Tate, 1981
Neurotensin 13 Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu Camargo e ta l, 1984
Oxytocin 9 Cys-Tyr-Ile-Gln-Asn-Lys-Pro-Leu-Gly-NH2 Walters a/, 1976
Substance P 11 Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met O’Leary e ta l , 1996
TRH 3 Pyr-His-Pro-NH2 O’Leary et a l , 1996
Tuftsin 4 The-Lys-Pro-Arg Tate, 1981
Vasopressin 8 Cy s-T yr-Phe-Gln-Asn-Pro-Arg-Gly O’Leary e ta l , 1996
Table 1 5 Bioactive Peptides Hydrolysed by PO
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1 3 1 8  Inhibitors
Specific inhibitors are typically substrate analogues that possess a higher affinity for the
active site thus binding reversibly or irreversibly to a region in the catalytic domain and 
preventing enzyme action Active site-directed inhibitors such as DFP and PMSF, 
exploit the primary sequence of a protein, however it is substrate analogue inhibitors, 
which play a role in identifying the physiological role of a peptidase Therefore a 
particular emphasis on the development of inhibitors that effectively inactivate prolyl 
oligopeptidase in vivo and can readily traverse the blood brain barrier has developed
The most suitable inhibitors were found to be ones in which the chain length 
corresponded to the three enzyme subsites, Si, S2 and S 3 In 1983, Wilk and Orlowski, 
reported the synthesis of a novel transition state aldehyde inhibitor, Z-Pro-Prolinal, which 
was shown to be remarkably potent against rabbit brain PO with an inhibition constant 
(K,) of 14nM In vivo studies on the same inhibitor illustrated an 85% decrease in PO 
activity in various mouse tissues following mtraperitoneal injection of 1 25mg/kg Z-Pro- 
Prolinal (Friedman et a l, 1984) Further work on Z-Pro-Prolinal inhibition revealed that 
it was a competitive, slow-tight binding inhibitor which presumably binds to the Si 
subsite forming a hemiacetal with the active serine of the enzyme (Wilk and Orlowski, 
1983, Bakker et a l, 1990)
Since the initial research on Z-Pro-Prolinal, the synthesis of a large number of potential 
analogues has been reported Yokosawa et al (1984) substituted the (Pi) proline with a 
number of ammo acid residues, of which valine proved to be the most potent (K, 2 4nM) 
Other alterations include the conversion of prolinal to thioprohnal or thiazolidine and the 
substitution of proline with thioprohne The resultant inhibitors, Z-thioprolyl-thioprolmal 
and Z-thioprolyl-thiazolidine yielded K, values of 0 OlnM and 0 36nM respectively 
(Tsuru et a l, 1988) The reported K, for the latter inhibitor is comparable to that of Z- 
Pro-Prohnal yet the aldehyde group has been removed Previous studies showed the 
importance of the aldehyde group, believed to be responsible for the potency of Z-Pro- 
Prolinal (Friedman et a l, 1984) Z-Pro-Prolmol and Z-Pro-Prolinal dimethylacetate did 
not exhibit the superior potency of Z-Pro-Prolinal, presumably due to the loss of the
i
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aldehyde prolinal group Having said this, Z-Pro-Prolinal dimethylacetate can be 
converted to the aldehyde in the stomach and hence was investigated for its in vivo 
potency (Goossens et a l, 1997)
Many other potent inhibitors which are variants of the N-b locked dipeptide chain have 
been developed (TABLE 1 5 lists some examples) The demonstration that nitriles could 
inhibit PO lead to the synthesis of the Fmoc derivatives by Li et al (1996) In addition to 
their potency (K, of 5nM each), these inhibitors were also shown to be cell permeable, 
stable and capable of penetrating the blood-brain barrier Similarly Y-29794, a potent, 
competitive PO inhibitor was found to easily traverse this barrier (Nakajima et a l, 1992) 
and Kato et al (1997) illustrated the prevention of amyloid-like deposits in the 
hippocampus of the mouse by oral administration of Y-29794 Z-Pro-3- 
fluoropyrrohdine, a derivative of Z-Pro-Prolinal, successfully inhibited PO activity in 
vivo Goossens et al (1997) reported a profound PO inhibition in the thymus, brain and 
testes of rats and claimed Z-Pro-3-fluoropyrrohdine showed no acute cell toxicity The 
potent PO inhibitors, JTP-4819, a pyrrohdmecar-boxamide derivative and S-17092-1, a 
perhydroindol carboxylic derivative have been devised for the treatment of Alzheimer’s 
disease (AD) JTP-4819 reduces memory impairment by restoring TRH content, which 
occurs on inhibition of PO, known to hydrolyse TRH (Shinoda et a l, 1996) Similarly S- 
17092-1 (Barelli et a l, 1999), illustrates cell penetration while effectively inhibiting PO 
in vivo with a K, of InM
Many inhibitors of bacterial origin also exhibit potent inhibition of prolyl oligopeptidase 
activity both in vitro and in vivo (see t a b l e  1 6 ) Postatin, produced by Streptomyces 
viridochromogenes was first reported in 1991 (Aoyagi et a l) as a potent inhibitor 
exhibiting an IC50 value of 0 03|ig/mL Analogues containing postatins characteristic 
(S)-3-amino-2-oxovaleryl group increased IC50 values up to 5 8ng/mL (Tsuda et a l, 
1996) Kimura et al (1997a) reported the isolation of four bacterial PO inhibitors, 
propeptin, SNA-8073-B, staurosponne and enduracidin from actinomycetes, while 
quercetin and luteohn from caryophylli floes yielded IC50 values of 0 17 and 0 19ppm 
respectively (Lee et a l, 1998)
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INHIBITOR POTENCY Reference
Mammalian
Fmoc-Ala-Pro-CN Kj= 5nM Li e ta l , 1996
Fmoc-Pro-Pro-CN Kj = 5nM Li e ta l , 1996
JTP-4819 IC50 = 0 83nM Toide et a l, 1995
ONO-1603 IC50 = 57nM Toda et a l , 1989
S-17092-1 Kr=lnM Barelli et a l, 1999
SUAM-1221 Kt= 190|¿M Saito e ta l, 1991
Y-27924 IC50 = 0 95|oM Nakajimaeía/, 1992
Z-Indolinyl-Prolinal Ki = 2 4nM Bakkere/a/, 1991
Z-Pro-3 -fluoropyrrolidine K, = 0 8nM Goossens et a l, 1997
Z-Pro-Prolinal IC50 = 0 74nM Wilk and Orlowski, 1983
Bacterial
Eurystatin A IC50 = 0 004|ig/mL Toda e ta l , 1992
Eurystatin B IC50 = 0 002^ ig/niL Toda e ta l , 1992
Postatin IC50 = 0 03|ag/mL Aoyagi e ta l, 1991
Propeptin K, = 0 7|nM Kimuraeía/, 1997b
SNA-8073-B K, =8nM Kimura e ta l , 1997a
Staurosponne Kj = 0 7jjM Kimurae/a/, 1990
TABLE 1 6 PO Specific Inhibitors
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13 19 Physiological Importance
Based on prolyl oligopeptidase’s ability to hydrolyse a variety of prohne-containmg 
bioactive peptides and its ubiquitous distribution in tissues including the brain, it is 
believed that the enzyme must contribute to a number of biologically important functions 
(Makinen et a l, 1994) Although much in vitro research has been carried out, the 
findings must also be correlated to in vivo studies To date, in vivo investigations carried 
out either compare enzyme activity levels in normal versus disease state environments 
(Maes et a l, 1995) or determine physiological patterns based on PO inhibition (Shinoda 
e ta l, 1996)
Maes et al (1994) has performed extensive research with regard to comparative activity 
studies Lower serum PO levels were observed in patients suffering from major 
depression in comparison to control patients It was initially thought that the putative 
involvement of PO activity in the pathogenesis of major depression revolved around its 
role in the degradation of neuropeptides and hormones, however it is now known to be 
due to other factors A number of studies have suggested that PO may be involved in 
modification of T-cell function (Aoyagi et a l , 1989) and in the pathogenetic mechanisms 
of inflammatory and autoimmune responses (Shoji et a l, 1989) Depression is often 
accompanied by a number of these pathophysiological characteristics
Further research by Maes et al (1995) reported increased activity in the plasma of manic 
and schizophrenic patients compared with normal volunteers Higher serum PO levels 
were also measured in patients with post-traumatic related (Maes et a l, 1999a) and 
physiological (Maes et a l, 1998) stress 58 3% of alcohol-dependent patients showed a 
decrease in serum PO levels (Maes et a l, 1999b) It was concluded that lower PO 
activity could contribute to the pathophysiology of major depression and alcohol 
dependence, while increased activity may be related to various stress conditions and 
psychotic conditions such as mama and schizophrenia
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In contrast, abnormally low prolyl oligopeptidase activities have also been observed in 
neurodegenerative disorders Comparison of enzyme levels in brain tissues from normal 
and various neurodegenerating disease cases was performed by Mantle et al (1996)
r
Data suggested a 65-70% reduction in PO activity in tissues from Parkinson’s, 
Hungtington’s and Alzheimer’s diseases and in Lewy body dementia It was assumed 
that this reduction in activity was characteristic of a generalised process of 
neurodegeneration (Mantle et a l, 1996) Yoshida et al (1996) observed similar reduced 
levels of serum PO activity in patients suffering from senile dementia of the Alzheimer 
type and even lower activities in vascular dementia cases Yoshida suggested that the 
brain of the dementia patients was affected by the metabolism of skeletal muscle, which 
subsequently caused a lowering of PO levels Conflicting data was observed in 
measurements of PO levels in AD brains Aoyagi et al (1990) reported enhanced 
peptidase activity while Ichai et al (1994), contradicted this data, claiming a substantial 
reduction of PO in the AD brain Lower than normal activity in AD brains was also 
reported in 1998 by Terwel et al
In addition to comparative activity studies, the effect of various inhibitors has been 
employed to aid in the elucidation of a possible physiological role of PO In vitro, 
substrates such as TRH, substance P and arginine vasopressin (AVP) are known to exert 
neuroprotective effects For example, AVP and TRH are known to improve the 
performance of animals in memory and learning tasks (De Wied, 1984, Griffiths, 1987) 
Therefore degradation of these peptides by peptidase activity is unfavourable and the 
inhibition of PO is targeted in an attempt to enhance neuroprotective effects Oral 
administration of Z-Pro-Prolmal successfully caused inhibition of the PO activity in rat 
brain and hence caused a significant increase in AVP levels in the brain (Miura et a l, 
1995) Similarly JTP-4819 enhanced memory processes in aged rats (Toide et a l, 1995) 
and reversed an age-related decrease of substance P and TRH levels (Shinoda et a l,
1995)
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A second attribute of JTP-4819, is its apparent role in AD The deposition of amyloid in 
senile plaques in the brain is now widely accepted as the hallmark of AD, the major 
component being a 42 residue protein referred to as the amyloid p-protein (A(3) (Ishiura,
1991) A number of peptidases have been implicated in the production of A0 from its 
precursor APP (amyloid precursor protein) Ishiura et al (1990) identified prolyl 
oligopeptidase as a possible y-secretase, cleaving APP between residues Ala713 and Thr714 
therefore contributing to the generation of AP (Checler et a l, 1995a) Based on this, a 
number of studies have investigated the use of potent PO inhibitors, such as JTP-4819 
and S-17092-1 in preventing Ap production Induced AP formation in a neuronal cell 
line was retarded upon addition of JTP-4819 (Shinoda et a l, 1997) further implicating 
PO in the pathogenesis of Alzheimer’s disease Despite these studies there are a few 
factors which question the ability of PO to degrade the APP and hence be involved in AP 
formation As previously discussed, PO is an oligopeptidase capable of cleaving peptides 
no greater than 25 ammo acids in length, yet APP is composed of over 700 residues 
However, as discussed in section 4 8 10 it may be possible that APP is first cleaved by a 
P-secretase which produces an APP fragment short enough for PO to hydrolyse
In summary, prolyl oligopeptidase is a large cytosolic enzyme that belongs to a new class 
of serine proteases (S9) The presence of an unusual P-propeller sheet regulates 
proteolysis by limiting substrate size Although an exact function cannot be deduced, PO 
is believed to be a regulatory peptidase involved in the degradation of prohne-contaimng 
neuropeptides and hormones It has been implicated in the pathogenesis of a number of 
neurodegenerative disorders, nevertheless the degree of involvement is not yet 
completely understood
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13 2 Thimet Oligopeptidase
Thimet oligopeptidase (EC 3 4 24 15) is a thiol-dependent metalloprotease, which is 
widely distnbuted in animals and plants The history of thimet oligopeptidase (TOP) 
began in the 1960’s with the design of the chromogemc substrate 
phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (Pz-peptide) by Wunsch and 
Heidnch (1963) and the presence of an enzyme in mammalian tissues capable of cleaving 
this substrate at the Leu-Gly bond Initially, it was believed that this enzyme was 
mammalian collagenase, however it was soon shown that animal collagenase and Pz 
peptidase activity were separable by gel filtration and that the peptidase had no activity 
towards native collagen (Harper et a l , 1970, Harris et a l , 1972) The enzyme then 
became known as collagen-like peptidase (EC 3 4 99 31)
Camargo et al (1973) discovered a bradykimn enzyme from rabbit brain, endo- 
ohgopeptidase A, which exhibited a clear thiol dependence It was believed to be a 
cysteine-type peptidase and was assigned EC 3 4 22 19 (Gomes et a l, 1993) Meanwhile 
soluble metalloendopeptidase (endopeptidase 24 15) was being independently researched 
(Orlowski et a l, 1983) Despite similarities between this metalloendopeptidase and 
endo-oligopeptidase A (substrate specificity and thiol dependence), it was assigned EC 
3 4 24 15 not EC 3 4 22 19 In 1989, Barrett and Tisljar et a l, independently suggested 
that all of these activities were in fact due to a single enzyme, which combined thiol and 
metal dependencies The enzyme became known as thimet oligopeptidase, EC 3 4 24 15, 
to account for this dual nature and also the unusual substrate-size dependence of the 
enzyme (Nomenclature Committee, 1992)
13 2 1 Assay
Pz-peptide was the first substrate used to identify thimet oligopeptidase activity (Wunsch 
and Heidrich 1963) This compound has the advantage that the chromophonc split 
product, Pz-Pro-Leu, is water insoluble and can be easily extracted into ethyl acetate and 
quantified spectrophotometncally This onginal assay was constantly modified and was 
popular until Juliano et al (1990) developed two quenched fluorescence substrates,
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namely, Dnp(2,4-dinitrophenyl)-Pro-Leu-Gly-Pro-Trp-D-Lys (QF01) and 7- 
methoxycoumarin-3-carboxylyl (Mcc)-Pro-Leu-Gly-Pro-D-Lys(Dnp) (QF02) The 
fluorescent product formed on cleavage excites at 345nm and emits at 405nm (Tisljar et 
a l, 1990) These compounds allow continuous monitoring of product formation (a major 
drawback with Pz-peptide) Continuous assays using substrates such as Suc-Gly-Pro- 
Leu-Gly-Pro-MCA and the aforementioned Dnp-Pro-Leu-Gly-Pro-Trp-D-Lys and Mcc- 
Pro-Leu-Gly-Pro-D-Lys(Dnp) are the most popular TOP assays due to the sensitivity of 
fluonmetric over spectrophotometnc assays
An alternative discontinuous assay substrate to Pz-peptide is Bz-Gly-Ala-Ala-Phe-p- 
aminobenzoate (pAb) designed by Orlowski et al (1983) TOP readily cleaves the Gly- 
Ala bond, followed by cleavage of Phe-pAb by an added aminopeptidase The release of 
aminobenzoic acid can be quantified in a diazo-couphng procedure Although this assay 
is useful for purification purposes, it can produce complications in more specific assays 
due to the presence of the aminopeptidase (Barrett et a l, 1995) Naturally occurmg 
peptides e g bradykmin, neurotensin, dynorphin A(l-8) and dynorphin A(l-17) are often 
employed as TOP substrates It should be noted at this point that there are no specific 
assays for this thiol-dependent metalloprotease Neurolysin also cleaves dynorphin A(l- 
8) at the same bond as TOP, while serine proteases such as PO have been shown to 
cleave bradykmin and neurotensin (Tate, 1981, Camargo et a l, 1984) Therefore the 
addition of peptidase inhibitors such as PMSF, Pro-Ile and phosphoramidon will inhibit 
serine proteases, neurolysin and neprilysin respectively
13 2 2 Distribution
TOP is widely distributed across species, including invertebrate animals and plants In 
higher animals it is present in most tissues, where it is mainly in the soluble fraction of 
the cytoplasm, not associated with any particular organelle A minor fraction (5-20%) is 
reported to be membrane-bound (Acker et a l, 1987) Location is mainly intracellular, 
the peptidase rarely being secreted or presented on the plasma membrane (Barrett and 
Chen, 1998) TOP is highly active in testes, brain, pituitary and liver tissues Healy and 
Orlowski (1992) determined the immunocytochemical localisation of thimet
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oligopeptidase in rat brain and peripheral tissues using a polyclonal antibody raised in 
rabbits Quantitation of enzyme levels suggested the activity of TOP in the kidney and 
other peripheral tissues (except testes) was only 20% of that identified in the brain, 
proposing a role for TOP in neuropeptide metabolism The existence of a particulate 
form of TOP was confirmed since subcellular fractionation of brain homogenates showed 
that 20% activity was associated with the membrane fraction (Healy and Orlowski, 1992)
13 2 3 Purification
The relative abundance of thimet oligopeptidase in rat testis, brain and chicken liver, 
make these sources ideal for purification purposes The first reported purification of TOP 
was by Aswamkumar and Radhaknshnan in 1972 from rat granuloma tissue, with a 
purification factor of 250 achieved In 1975 the same researchers reported an improved 
purification of TOP from monkey kidney (2500-fold purification)
To date the enzyme has been purified to homogeneity or near homogeneity from a 
number of sources including rat testis (Orlowski et a l, 1989), rabbit brain (Carvalho and 
Camargo, 1981), rabbit heart (Tisljar et a l, 1989), chicken embryo (Morales and 
Woessner, 1977) and chicken liver (Barrett and Browne, 1990) Purification from 
erythrocytes is worthwhile as purification factors of 40,000 have been reported (Dando et 
a l, 1993) and contamination with plasma albumin is eliminated (Barrett et a l, 1995) 
Recombinant rat TOP has successfully been produced (Pierotti et a l, 1990) 
Chromatography resins commonly employed include size exclusion, phenyl sepharose, 
DEAE cellulose and hydroxyapatite, the latter two being of particular importance as they 
separate TOP from contaminating neurolysin (Checler et a l, 1995b) Due to the thiol 
dependence of TOP, DTT (0 ImM) is usually added to all running buffers and substrates 
(Morales and Woessner, 1977) Similarly addition of ZnCl (0 ImM) in buffers markedly 
stabilises the peptidase thus increasing yields (Barrett et a l, 1995)
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13 2 4 Biochemical Characteristics
Thimet oligopeptidase has been identified as a monomeric enzyme with molecular 
weights determined to range from 73kDa to 75kDa depending on the source (Carvalho 
and Camargo, 1981, Camargo et a l, 1983, Tisljar et a l, 1989) cDNA cloning produced 
a 687 ammo acid sequence for TOP, from which a molecular mass of 78 3kDa was 
calculated (McKie et a l , 1993) Isoelectric focusing by Carvalho and Camargo (1981) 
revealed an isoelectric point of 4 75 for TOP, which was verified two years later by the 
same researchers (Camargo et a l, 1983) TOP exhibited an optimum pH in the 7 5 to 8 5 
range (Morales and Woessner, 1977), with later reports of pH optima of 7 5 and 7 8 
(Camargo et al 1983, Barrett and Chen, 1998) TOP does not contain disulphide bonds 
and there is no indication of any glycosylation based on the ammo acid sequence (Barrett 
eta l, 1995)
13 2 5 Catalytic Classification and Mechanism Action
The effects of site-directed inhibitors readily excluded TOP from the serine and aspartic 
types of endopeptidases yet it appeared to have characteristics of both cysteine and 
metallo-proteases (Barrett and Brown, 1990) A time-dependent decrease in activity was 
observed on incubation with EDTA and 1,10-phenanthrohne, while zinc, manganese, 
calcium, cobalt and cadmium metal ions restored activity after EDTA treatment (Barrett 
and Brown, 1990) It was these observations on chicken liver Pz peptidase that led 
Barrett to believe that it was in fact a metalloendopeptidase with thiol dependence, hence 
the name thimet was proposed and accepted
Thereafter, TOP has been classified as a member of the M3 family, the largest and most 
complex family of metalloproteases (Barrett et a l, 1998a) All peptidases in the family 
(see TABLE 17) contain the His-Glu-Xaa-Xaa-His (HEXXH) motif and the mechanism 
of substrate binding and catalysis with respect to TOP has finally been elucidated 
(Cummins et a l, 1999) As expected the active site of the peptidase exhibited the 
HEXXH motif, a common feature of zinc metalloenzymes His473, Glu474 and His477 
were confirmed by site-directed mutagenesis to be the residues essential for binding and 
catalysis of thimet oligopeptidase (Cummins et a l, 1999)
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It had been previously proposed that one of the Glu or His residues in the motif was also 
the ligand of the metal ion However Chen et al (1998) disproved this theory by 
mutagenesis claiming that neither of these ammo acids close to the HEXXH motif were 
required for the binding of zinc Due to the fact that Glu497 is highly conserved in 
thermolysin and other metalloproteases it was then believed that this same residue was 
responsible for zinc binding in mammalian TOP Further characterisation by Cummins et 
al (1999) showed that a third putative metal ligand, presumed to coordinate directly to 
the active site zinc ion with the two histidine residues, was identified as Glu502 Activity 
towards synthetic and physiological substrates was substantially reduced on modification 
of any of the aforementioned residues, and the peptidase lost its ability to bind the active 
site directed inhibitor, A/-[l-(RS)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-paminobenzoate 
(Cpp-Ala-Ala-Phe-pAb), thus emphasising their importance in the catalysis of TOP
It is believed that TOP behaves in a similar manner to other metalloproteases eg 
carbonic anhydrase II (Lesburg et a l, 1997) The histidine directly coordinates the active 
site zinc ion whereas the glutamate facilitates the acid/base catalysis by weakly co­
ordinating to the zinc via a water molecule (Cummins et a l, 1999) There are no 
indications of post-translational modifications in the biosynthesis of TOP or of a 
proteolytically activatable proenzyme (Barrett and Chen, 1998) Despite the results of 
Healy and Orlowski (1992), there is no apparent hydrophobic segment in the structure of 
TOP which would serve as a membrane spanning domain, questioning the existence of a 
particulate form of the metalloprotease (Pierotti etal 990, Barrett and Chen, 1998)
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Peptidase EC Type Properties
Thimet oligopeptidase 3 4 25 15 Oligopeptidase Cytosolic, thiol dependent
Cleaves when hydrophobic AA in Pi and P3’ and Pro m P2’
Neurolysin 3 4 24 16 Oligopeptidase Cytosolic, little thiol dependence 
All substrates contain 17 or fewer AA
Saccharolysin 3 4 24 37 Oligopeptidase Won’t cleave peptides with free N-terminal, need 
hydrophobic AA in Pi and P3’ and Pro in P2’
Oligopeptidase MepB - Oligopeptidase As for TOP
Oligopeptidase F - Oligopeptidase Broad substrate specificity, cleaves peptides 7-23 AA long
Oligopeptidase PepB - Oligopeptidase Cleaves small basic peptides, exact rules yet to be 
elucidated
Oligopeptidase A 3 4 24 70 Oligopeptidase Hydrolyses N-blocked terminals containing at least four 
amino acids but not fewer than five AA
Peptidyl-dipeptidase Dcp 3 4 15 5 Dipeptidase Cleaves penultimate bond in a-N-blocked tnpeptidases, free 
tetra- and higher peptides
Mitochondrial intermediate 3 4 24 59 Endopeptidase Involved in 2-step processing of mitochondrial protein
peptidase precursors
Table 1.7 The Members of the Thimet Oligopeptidase (M3) family of Metalloproteases
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13 2 6 Specificity
The substrate size specificity of human TOP was investigated using oligomers of (Gly- 
Pro-Leu)n, where n = 2, 3, 4 and 5 (Knight et a l , 1995) Hydrolysis was most rapid with 
(GPL)3 and slowest with (GPL)5, indicating a preferentially binding of substrates 
composed of 9 residues, although the endopeptidase cleaves peptides that are between 6 
and 17 amino acid residues in length (Barrett and Chen, 1998) This sharply defined 
upper limit of substrate size, which is also evident for prolyl oligopeptidase is responsible 
for the classification of TOP as an oligopeptidase Unfortunately, the precise rules 
governing TOP specificity remain unclear but general observations in specificity have 
been widely reported Primarily TOP cleaves on the carboxyl side of hydrophobic ammo 
acids i e when the Pi position (FIGURE 1 1) is occupied by a hydrophobic residue (Dando 
et a l, 1993, Camargo et a l , 1997) Isoleucine and valine, although hydrophobic in 
nature do not promote hydrolysis m TOP presumably due to their branched chain R- 
groups (Dando et a l, 1993, Barrett et a l, 1995)
A second prerequisite observed is that the presence of a hydrophobic or bulky ammo acid 
in the P3J position and a proline residue at P2 greatly increase the affinity of the substrate 
(or inhibitor) towards TOP (Dando et a l, 1993) TOP has been shown to cleave a 
number of neuropeptides and hormones Dando et al (1993) extensively studied the 
specificity of human TOP, showing cleavage of oligopeptides like bradykimn, 
neurotensin, LHRH and dynorphin fragments T ab le  1 8 lists some of the reported 
naturally occurring peptide substrates of TOP It is clear from this table that the TOP 
hydrolysis site in a particular peptide is unpredictable, for example, TOP cleaves the Tyr- 
lie bond in angiotensin II, yet fails to cleave the same bond in angiotensin I where 
hydrolysis of Pro-Phe bond is observed Knight et al (1995), observed that with 
isoleucine-containmg peptides, TOP preferentially to cleaved these peptides near the C- 
terminal and this may explain why many of the scissile bond are three or four residues 
from the C-terminal (Barrett et a l , 1995) In summary, despite the considerable peptide 
research that has been done, an exact description of TOP’s substrate specificity has still 
not been formulated
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Peptide AA Sequence and Cleavage Sites (Bold font)
Angiotensin I 11 Asp-Arg-Arg-V al-T yr-Ile-His-Pro-Phe-His-Leu
Angiotensin II 8 Asp-Arg-V al-Ty r-Ile-His-Pro-Phe
Bradykinin 9 Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
Dynorphin A(l-6) 6 T yr-Gly-Gly-Phe-Leu-Arg
Dynorphin A(l-7) 7 T yr-Gly-Gly-Phe-Leu- Arg- Arg
Dynorphin A(l-8) 8 Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile
Dynorphin B 13 Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr
LHRH 10 Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-Ntb
Neurokinin A 10 His-Leu-Thr-Asn-Ser-Phe-Val-Gly-Leu-Met-NH2
Neurotensin 13 Pyr-Leu-T yr-Glu-Asn-Ly s-Pro-Arg-Arg-Pro-T yr-Ile-Leu
Substance P 11 Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-GIy-Leu-Met
Table 1 8 Bioactive Peptides Cleaved by TOP (Dando e ta l, 1993)
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13 2 7 Inhibitors
As a metalloprotease, TOP is sensitive to exposure to metal-chelating agents such as 
1,10-phenanthrolme and time dependently to EDTA (Barrett and Brown, 1990) Specific 
TOP inhibitors are rare, due its broad, unpredictable specificity In addition to this, 
neurolysin has an extremely similar specificity for TOP substrates and subsequently 
many inhibitors inactivate both metalloproteases Potent synthetic TOP inhibitors are 
generally analogues of the Orlowski substrate (Bz-Gly-Ala-Ala-Phe-pAb) in which the 
Bz-Gly group has been substituted with a Cpp group It is thought that the Cpp group 
binds to the zinc atom in the active site of the peptidase, with the 3-phenyl ring in the 
hydrophobic Si subsite (Knight and Barrett, 1991)
The most potent inhibitor of TOP was Cpp-Ala-Pro-Phe-pAb, which exhibited an 
inhibition constant of 1 3nM for human erythrocytes and 7 OnM for rat testis TOP 
(Dando et a l, 1993) K, values of 16nM and 40nM were obtained for the inhibition of 
human erythrocyte and rat recombinant TOP respectively using Cpp-Ala-Ala-Tyr-pAb 
(Barrett et a l, 1995) Knight and Barrett (1991) investigated the effect of the p- 
aminobenzoate group on TOP inhibition Substitution of the pAb group for a hydroxy 
(OH) group to produce Cpp-Ala-Ala-Phe-OH, yielded a Kj of 200nM, five-fold poorer 
than with pAb (Knight and Barrett, 1991) It was believed that it was the negative charge 
on the pAb group that conferred potency and this was confirmed when K, values 
drastically decreased to 7 6|iM on removal of the C-terminal negative charge (Knight and 
Barrett, 1991)
N-[2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbonyl]-L- 
phenylalanine (SA898), an inhibitor designed by Ukai et al (1996), was shown to be a 
competitive inhibitor of rat TOP IC50 and K, values of 23nM and 9 InM respectively 
were obtained The inhibitory effect of SA898 on neprilysin activity was almost 
negligible The most specific TOP inhibitor to date is Z-(L,D)Phe (P02-CH2)(L,D)Ala- 
Arg-Phe, which has a K, of 0 16nM for TOP and one three orders of magnitude less for 
neurolysin (Jiracek et a l, 1995) Activities of other zinc metalloproteases, such as 
neprilysin and angiotensin-converting enzyme were unaffected by this inhibitor
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Substitution of the Phe residue with a methionine, was reported to yield a highly potent 
TOP inhibitor with a K, of 70pM Jiracek et al (1995) concluded from these results that 
TOP has a preference for inhibitors containing basic residues such as arginine or lysine in 
the ¥2 position, while neurolysin prefers a proline in this position Exploitation of this 
finding should allow a strategy for the development of potent TOP specific inhibitors
Natural occumng thimet ohgopeptidase inhibitors are few and the enzyme is not 
inhibited by (X2M, thus confirming its ohgopeptidase specificity Dynorphin A(l-13) has 
been shown to be a potent naturally occumng inhibitor of TOP activity, with reported 
values of 11 2nM, 48nM and 26nM for human, rat and chicken TOP respectively (Dando 
e ta l, 1993)
13 29  Physiological Importance
Initially it was believed that TOP contributed to the metabolism of collagen based on its 
hydrolysis of Pz-peptide (Wunsch and Heidrich, 1963) However it is now readily 
accepted that thimet ohgopeptidase is not involved in connective tissue matrix resorption 
(Barrett et a l, 1995) In vitro studies have been shown TOP to hydrolyse many peptides 
eg enkephalin-containing peptides, LHRH, bradykinm and neurotensin (which posses 
important biological functions) Initial in vivo tests were not very accurate because the 
inhibitor used Cpp-Ala-Ala-Phe-pAb was also cleaved by neurolysin This second 
activity releases Cpp-Ala-Ala on cleavage which inhibits angiotensin-converting enzyme 
which indirectly supplied misleading results (Cardozo and Orlowski, 1993, Lew et a l,
1996) Pierotti et al (1991) suggested that TOP contributes to hormonal balance by 
degrading LHRH, explaining its ubiquitous distribution in the testes The location of 
TOP, inside the cells, implicates a possible intracellular function, possibly participating in 
the intracellular catabolism of oligopeptides (Barrett e ta l, 1995)
Like prolyl ohgopeptidase, TOP has been implicated in the pathogenesis of AD, based on 
its potential as a y-secretase and subsequent generation of Ap (McDermott et a l, 1992) 
The ability of this ohgopeptidase to cleave APP is unlikely, but as for PO, hydrolysis 
may occur following primary cleavage by P-secretase (FIGURE 4 7) However, a role of
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TOP in AD seems unlikely since Brown et al (1996) indicated that TOP was not a y- 
secretase, this was later verified by Chevallier et al (1997)
It was proposed that TOP in tandem with a multicatalytic proteinase is responsible for the 
cytoplasmic protein degradation pathway, producing small peptides (Orlowski, 1990) 
Indications that the enzyme may be involved in the in vivo metabolism of opioid peptides 
were also suggested by Orlowski et al (1988) TOP was found to the primary factor 
responsible for degradation of LHRH in brain and peripheral tissues, administration of 
Ccp-Ala-Ala-Phe-pAb increased the half-life of centrally and peripherally administered 
LHRH (Lasdun et a l, 1989) In summary, TOP appears to have an unregulated 
biological activity, be fully active on synthesis, and show no evidence of pro-peptide 
presence Although an exact physiological function cannot be defined, the majority of 
studies suggest a role in the metabolism of some peptide hormones and bioactive 
neuropeptides In order for such claims to be substantiated TOP would have to exhibit an 
extracellular presence However a readily identifiable secretory signal sequence and a 
hydrophobic spanning domain would be expected for an extracellularly acting peptidase, 
features which are not present on the deduced TOP protein sequence Crack et al (1999) 
has recently associated thimet oligopeptidase with the extracellular surface of the cell 
plasma membrane, which is consistent with a putative role in neuropeptide metabolism 
acting at the external cell surface
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1.3 3 Neurolysin
As previously discussed Wunsch and Heidrich (1963) discovered Pz-peptidase, an 
enzyme present in rat tissues capable of cleaving Pz-peptide A study by Tisljar and 
Barrett (1990) suggested that there were actually two forms of thimet ohgopetidase, the 
second a mitochondrial form (thimet peptidase II) which although similar to TOP was not 
identical Oligopeptidase M  is predominantly a mitochondrial peptidase found in the 
liver of pig and rat (Senzawa et a l , 1995) It is now accepted that neurolysin is an 
enzyme identical to oligopeptidase M  (Barrett et a l, 1995) and thimet peptidase II 
(Tisljar and Barrett, 1990) yet different to TOP, and is classified as a distinct 
metalloprotease (EC 3 4 24 16)
13 31 Assay
TOP substrates, such as Pz-peptide, QF01 and QF02, were initially used to detect 
neurolysin activity However due to a similar substrate specificity of TOP and neurolysin 
these peptides failed to distinguish the two peptidases Barelli and co-workers (1991) 
successfully distinguished the two peptidases using neurotensin as substrate Although 
TOP and neurolysin both hydrolyse this neuropeptide, the cleavage sites and hence 
cleavage products are distinct and so can be separated by HPLC analysis In general 
neurolysin cleaves neurotensin at the Pro10-Tyrn bond, while the Arg8-Arg9 bond is 
hydrolysed by TOP (Millican et a l, 1991) Analysis of neurotensin degradation by 
HPLC has the advantage of allowing the direct identification of the peptidase, but it is too 
laborious for repetitive biochemical assays Checler et al (1995b) descnbes a 
radiometric assay using tntiated neurotensin which can be applied for the identification of 
neurolysin and is superior over HPLC analysis in its speed and reproducibility
An alternative assay reported for the detection of neurolysin involves using the quenched 
fluonmetric substrate QF02 (Mcc-Pro-Leu-Gly-Pro-D-Lys-Dnp) and two inhibitors 
(Senzawa et a l, 1995) Since PO, TOP and neurolysin all cleave QF02, the inhibitors are 
required to selectively assay for neurolysin activity Addition of Z-thioprolyl- 
thiazolidine inhibits PO while inclusion of the antibody R646/P successfully inhibits TOP 
by 100% This assay can also be employed for the selective detection of thimet
37
oligopeptidase by incorporating a neurolysin inhibiting antibody, K118 (Senzawa et a l, 
1995) Vincent et al (1996) also report the use of QF02 (referred to as QFS) for the 
detection of neurolysin by including Pro-Ile, a potent neurolysin inhibitor Neurolysin 
activity can be estimated by comparison of fluorescence recorded in the absence and 
presence of Pro-Ile Although no specific fluorimetnc substrate is available for 
neurolysin detection, the inclusion of inhibitors into the assay mixture and HPLC analysis 
of neuropeptide degradation have enabled researchers to isolate and quantify the 
metalloprotease Unlike TOP, neurolysin does not exhibit a thiol dependence and so 
there is no need for DTT or 2-mercaptoethanol in assay solutions (Barrett et a l, 1995)
13 3 2 Distribution
High concentrations of neurolysin have been isolated from the cytosol and membrane 
fractions of a variety of organs, particularly brain (Vincent et a l, 1996) and kidney 
(Barelli et a l, 1993) Checler et al (1995) identified the liver as the most abundant 
source, while Senzawa et al (1995) found high activity in rat spleen (see TABLE 19) It 
is thought to be primarily localised in the mitochondrial fraction and to a lesser extent in 
the cytoplasm, while no activity has been detected in microsomes or lysosomes (Barrett 
et al, 1995) It was neurolysin’s mitochondrial localisation that eventually distinguished 
it from TOP activity (Tisljar and Barrett, 1990) More specifically neurolysin is localised 
on the inner membrane of the mitochondria (Rioli et a l, 1998) Woulfe and co-workers 
(1992) attempted to elucidate the function of neurolysin in neurotensin hydrolysis by 
localisation of the peptidase in the brain Immunoradioautography revealed an ubiquitous 
distribution of neurolysin throughout the midbrain, many of the regions previously 
associated with high concentrations of neurotensin or abundant neurotensin receptors 
(Woulfe e/ a/, 1992)
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Rat Tissue Neurolysin Activity (%)
Checler et a l, 1995
Neurolysin Activity (%)
Serizawa et a l, 1995
Liver 100 0 80 5
Kidney 95 8 38 0
Bladder 80 3 ND
Testis 66 8 45 0
Spleen 49 4 100 0
Brain 26 9 40 5
Lung 23 8 32 0
Heart 14 8 13 0
Table 1 9 Distribution of Neurolysin in Rat Organs
Activities are expressed as percentages of the highest activity determined (100%) ND 
means not determined Both authors used the fluonmetric substrate QF02, Checler et al 
employed the inhibitor Pro-Ile, while Serizawa et al used îmmunoinhibitors to select for 
neurolysin activity
13 3 3 Purification
The first report of neurolysin purification in 1986 employing neurotensin as substrate was 
carried out on rat brain by Checler et al (1986) Following Triton X-100 solubilisation, 
DEAE anion exchange was performed yielding 15% active neurolysin with a purification 
factor of 541 A similar protocol was performed by Vincent et al (1996) with the 
addition of a hydroxyapatite chromatography step Although only 95-fold purification 
was attained, the inclusion of the extra resin served to separate neurolysin from 
contaminating peptidases including TOP and PO It was claimed that a MonoQ column 
served the same purpose and successfully distinguished TOP and neurolysin activities in 
HeLa cells (Krause et a l, 1997) Barrett and Dando (1998) have raised a neurolysin 
monoclonal antibody available for academic purposes such as neurolysin purification
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13 3 4 Biochemical Characteristics
Neurolysin in general has not been well characterised, in comparison to peptidases such 
as PO and TOP Many early studies on its charactensation were attributed to TOP, since 
they were believed to be the same enzyme A molecular weight of 70-75kDA has been 
estimated by SDS PAGE (Checler et a l, 1986) and gel filtration chromatography on pig 
neurolysin revealed it to be a monomeric peptidase with a relative molecular mass of 
80 76kDa (Barrett et a l, 1995) Estimations of pi values all fall between pH 5 0 and 6 0 
(Checler et a l, 1986, Tisljar, 1993) On alignment of the amino acid sequences available 
for TOP and neurolysin, there appeared to be a 60% conservation between peptidases, 
which would explain the similar biochemical characteristics and specificities observed 
(Barrett e ta l , 1995)
1 3 3 5 Catalytic Classification and Mechanism o f Action
The classification of neurolysin as a member of the thimet ohgopeptidase family of 
metalloproteases (M3), is hardly surprising based on the similarities of the two enzymes 
Neurolysin unlike many members of the family has been identified as a zinc 
metalloprotease and like TOP contains the HEXXH motif Unlike TOP, neurolysin is not 
substantially activated by thiol agents such as DTT, however it is inhibited by the metal 
chelators EDTA and 1,10-phenanthroline (Tisljar, 1993) Both metallopeptidases contain 
13-16 cysteine residues Three of these residues are conserved in TOP but are absent 
from neurolysin It is believed that the absence of one of these residues, most likely 
Cys246 or Cys253 is responsible for neurolysin’s unique lack of thiol dependence (Barrett 
e ta l9 1995)
Amino acid sequences for neurolysin have been reported from pig and rat sources 
(Sugiura et a l, 1992, Dauch et a l, 1995) both studies independently deducing sequences 
of 704 amino acids Neurolysin appears to have 24 additional residues not present in 
TOP, which are situated at the N-terminus (Sugiura et a l, 1992) It is likely that these 
residues may contain a mitochondrial targeting sequence (Glick et a l, 1992) which 
evidently is not required by TOP Comparable to TOP the sequence for neurolysin
40
suggests no indication of a hydrophobic transmembrane region or glycosylation (Barrett 
e ta l9 1995)
13 3 6 Specificity
Neurolysin has been classified as an ohgopeptidase, hydrolysing peptides containing no 
greater than seventeen ammo acids The enzyme’s substrate specificity is common to 
TOP, both peptidases cleaving Pz-peptide, QF01, QF02 and a range of biologically active 
peptides Despite similar specificities, the oligopeptidases exhibit disparity in the bonds 
that they hydrolyse Neurolysin readily cleaves bradykimn and dynorphin A(l-8) at the 
same cleavage sites as TOP ( ta b le  18), however ta b le  110 illustrates the contrasting 
cleavage sites for TOP and neurolysin on a number of peptides It is evident that
11 12 12 13neurolysin hydrolyses dynorphin A(l-17) at the Lys -Leu or Leu -Lys bond, 
however there is no hydrolysis by TOP of this peptide, which actually inhibits its activity 
(Dando e ta l, 1993)
Peptide AA Sequence and Cleavage Sites
Dynorphin A(l-17)
Neurotensin
QF34
QF37
17 Tyr-Gly-Gly-Phe-Leu-Arg- Arg-Ile-Arg-Pro-Lys-
Leu-Lys-T rp-Asp-Asn-Gln 
13 Pyr-Leu-Tyr-Glu- km-Lys-Vro-Arg-Arg-Yro-Tyr-
Ile-Leu
9 Mca-Gly-Gly-Phe-£eM-,4r£-Arg-Ala-Lys(Dnp)
9 Mca-Gly-Gly-Phe-Ile-y4rg-^ 4r^ -Ala-Lys(Dnp)NH2
Table 1.10 Bioactive Peptides Cleaved by Neurolysin (Senzawa et a l, 1995) 
Bold font indicates neurolysin hydrolysis site, while italics show the TOP cleavage site
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13 3 7 Inhibitors
Inhibition of neurolysin by peptides known to potently inhibit TOP is not extraordinary 
due to their extremely similar specificities Barrett et al (1995) showed that although 
neurolysin is sensitive to Cpp-Ala-Ala-Tyr-pAb and its analogues, these inhibitors exert 
far less potency towards neurolysin than for TOP The most effective and specific 
neurolysin inhibitor is the dipeptide Pro-Ile, shown to inhibit bran neurolysin with an IC5o 
value of 90|aM (Dauch et a l, 1991) A second inhibitor of bacterial origin, referred to as 
phosphodiepryl 03 was shown to inhibit neurolysin yielding a of 0 9nM TOP was 
also sensitive to this compound (Kj 7 5nM), however it had no detrimental affect on 
nepnlysin, PO or angiotensin-converting enzyme activities (Checler et a l, 1995b) In 
1996, Jiracek et al reported the development of the first potent and selective inhibitor of 
neurolysin The need for a specific neurolysin inhibitor, to help elucidate its 
physiological role, was recognised and screening of phosphmic peptides was the 
approach taken Pro-L-Phev|/(P02CH2)Gly-Pro was prepared based on the previous 
discovery that neurolysin had a preference for a proline in the P2’ position (Jiracek et a l, 
1995) The phosphmic peptide displayed a K, value of 4nM for neurolysin and was 2000 
times less potent on TOP activity
13 3 8 Physiological Importance
As with the majority of oligopeptidases it is difficult to assign an exact physiological 
function to neurolysin Its hydrolysis of neuropeptides has led to the belief that it is 
involved in neuropeptide, particularly neurotensin, metabolism However the bulk of 
neurolysin in most tissues is detected in the mitochondria and cytosol, an unfavourable 
location to mediate the degradation of an extracellular peptide such as neurotensin 
(Barrett and Dando, 1998) Therefore Barrett and Dando propose that neurolysin serves a 
function in the hydrolysis of intermediates in the turnover of cellular proteins
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13 4 Nepnlysm
Neprilysin (EC 3 4 24 11) is a metallopeptidase, which in most cases is bound to the 
plasma membrane It was first discovered in 1974 (Kerr and Kenny, 1974a) in the brush 
border membrane of porcine kidney and was known as neutral endopeptidase (EC 24 11) 
Microvillar structures of the kidney and intestine are enriched with neprilysin although it 
has also been isolated from many other tissues (see section 1 3 4 3 ) Neprilysin isolated 
in the brain became known as enkephalinase due to its ability to hydrolyse the Gly3-Phe4 
amide bond of opioid enkephalins However the kidney neutral endopeptidase and 
enkephalinase were soon shown to have identical amino acid sequence (Malfroy et a l,
1987), and are now both recognised as neprilysin
13 41 Assay
As for thimet oligopeptidase, there are no substrates specific for the determination of 
neprilysin activity with many aminopeptidases and chymotrypsin-like enzymes causing 
interference The most widely practiced assay for neprilysin detection uses synthetic 
chromogemc peptides such as Glu-Ala-Ala-Phe-4-MeO-2-Na Cleavage of the Ala-Phe 
bond by neprilysin, followed by the addition of an aminopeptidase, liberates 4-MeO-2-Na 
which can be spectrophotometncally or fluorimetncally monitored (see Chingwin and 
Hersh, 1995 for method) In general chymotrypsin-like enzymes compete for the 
substrate and so phosphoramidon is included in the assay mixture Phosphoramidon is a 
specific neprilysin inhibitor, conducting the assay in its presence and absence, coupled to 
the construction of a standard curve of free 4-MeO-2-Na, allows for the quantitation of 
neprilysin activity More sensitive radiometric and fluorimetric assay methods are often 
applied for neprilysin detection These assays involve the measurement of [tyrosyl-3H]D- 
Ala-Gly hydrolysis and the release of internally quenched fluorimetric substrates 
respectively The most popular fluorogemc substrate used is Dansyl-D-Ala-Gly- 
Phe(N02)-Gly designed by Florentin et al (1983) which is readily cleaved at the Gly-Phe 
bond by neprilysin releasing the dansyl group flouophore (Chingwin and Hersh, 1995) 
[D-Ala2, Leu5]-enkephalin provides a convenient substrate for HPLC analysis (Turner, 
1998)
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13 4 2 Distribution
Nepnlysin is an integral glycoprotein located in the plasma membrane of tissues in many 
diverse species In mammals kidney microvilli are a particularly rich source (Kerr and , 
Kenny, 1974a, Malfroy et a l, 1987) of the oligopeptidase followed by the epithelial cells 
of the intestine, lymph nodes and placenta (Danielsen et a l, 1980) Brain is a common 
source (Wilk and Orlowski, 1979, Checler et a l, 1984, Checler et a l, 1986) however 
nepnlysin activity is several hundred times greater in the kidney (Hardy and Orlowski,
1992) Significant levels of enzyme are localised to muscle cells in the stomach, colon 
and small intestine while lower activities have been identified in the adrenal glands, testis 
and lung (Chingwen and Hersh, 1995)
1 3 4 3 Purification
Because nepnlysin is exclusively membrane bound, a detergent (eg Tnton X-100) 
treatment is usually required prior to column chromatography Alternatively the use of 
papain-solubilised nepnlysin has been reported which eliminates the need for detergent 
(Chingwen and Hersh, 1995) A range of purification protocols has been reported, using 
size exclusion (Kerr and Kenny, 1974), ion exchange (Relton et al, 1983), 
chromatofocusing and lectin affinity (Chingwen and Hersh, 1995) and hydrophobic 
interactions chromatography (Danielsen et al, 1980) techniques Purification of 
nepnlysin has been much facilitated by the introduction of immunadsorbent columns 
harnessing monoclonal antibodies (Danielsen et al, 1980) Punfication factors of 23,000 
have been reported coupled to enzyme yields of 30% using immunadsorbent 
chromatography (Relton et al, 1983)
1 3 4 4 Biochemical Characteristics
Nepnlysin is an integral membrane-bound zinc metalloprotease In most species it 
appears to exist as a monomer (Kerr and Kenny, 1974b, Gafford et al 1983, Checler et 
a l, 1986), although the existence of dimeric subunits has also been reported (Fulcher and 
Kenny, 1983) Estimated molecular weights vary from 88kDa to 95kDa for the 
monomeric enzyme, with brain forms showing slightly lower molecular weights This 
has been attnbuted to the fact that kidney nepnlysin is 15% glycosylated while the brain
44
enzyme contains only 13% carbohydrate (Relton et a l , 1983) An isoelectric point 
between pH 5 0 and 5 3 was reported for porcine kidney neprilysin (Fulcher and Kenny, 
1983), while Checler et al (1986) used two-dimensional SDS PAGE revealing a pi of 
5 9-6 0 Neprilysin displays a broad neutral pH optimum range varying between pH 6 0 
(Kerr and Kenny, 1974b) and pH 7 0 (Damelsen et a l, 1980)
13 4 5 Catalytic Classification and Mechanism of Action
Neprilysin is a member of the M A  clan of metalloproteases and is sub-classified in to the 
Ml3 family It is a zinc metalloprotease closely related to the bacterial enzyme 
thermolysin, although is over double its molecular weight (Barrett et a l, 1998b) A 
histidine and an aspartic acid have been identified as catalytically essential residues in 
neprilysin and the zinc ligands have also been experimentally determined (Le Moual et 
a l, 1993 and 1994) The ammo acid sequence of neprilysin has been elucidated from rat' 
and human sources (Malfroy et a l, 1987 and 1988 respectively) Neprilysin consists of 
742 amino acids, with the presence of a single transmembrane spanning domain located 
close to the N-terminal (residues 28-50) which is believed to anchor the protease to 
membranes (Malfroy et a l, 1987, Devault et a l, 1987) Residues 1-27 represent the 
intracellular domain while the extracellular region (containing the active site) consists of 
the remaining amino acids (52-742) The C-terminal domain of neprilysin contains the 
classic zinc metalloprotease motif HEXXH, also seen in TOP and neurolysin The three 
zinc ligands have been identified as His583, His587 and Glu646 (Turner, 1998)
13 4 6 Specificity
Although neprilysin can hydrolyse peptides up to forty ammo acids in length, it is still 
classified as an oligopeptidase as substrate-size limitations do occur and there appear to 
be a lack of natural inhibitors of the peptidase Catalysis of small oligopeptides is 
favoured In general neprilysin cleaves peptides on the amino side of hydrophobic 
residues, unlike TOP The primary prerequisite for efficient catalysis is a substrate 
containing a bulky hydrophobic residue in the Pi’ position (Turner, 1998) Ammo acids 
with aliphatic side chains such as leucine are preferred to aromatic containing residues
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e g phenylalanine (Connelly et a l, 1985) A consensus sequence for efficient nepnlysin 
activity Phe-Phe-Gly-Phe-Leu was proposed (Turner, 1998)
In vivo nepnlysin is limited in the peptides that it cleaves Substance P appears to be the 
most efficiently cleaved (Matsas et a l, 1984) and reports of bradykinm (Wilk and 
Orlowski, 1979) and neurotensin (Checler et a l, 1983 and 1984) hydrolysis have also 
been reported Nepnlysin once referred to as enkephalinase cleaves opioid enkephalins 
e g Leu- and Met-enkephalinase releasing intact enkephalin, a neurotransmitter involved 
in pain-related pathways See TABLE 111 for cleavage sites of bioactive peptides
Peptide AA Sequence and Cleavage Sites (-- Bold font)
1 Angiotensin I 11 Asp-Arg-Arg—Val-Tyr—Ile-His-Pro—Phe-His-Leu
1 Angiotensin II 8 Asp-Arg--Val-Tyr--Ile-His-Pro-Phe
2Bradykinin 9 Arg-Pro-Pro—Gly-Phe-Ser-Pro—Phe-Arg
3Cholecystokinin-8 8 Asp-T yr-Met-Gly—T rp-Met-Asp—Phe-NH2
e^u-enkephalin 5 T yr-Gly-Gly—Ph e-Leu
e^t-enkephalin 5 Tyr-Gly-Gly—Phe-Met
Neurotensin 13 Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro—Tyr—Ile-Leu
5 Substance P 11 Arg-Pro-Lys-Pro-Gln-Gln—Phe—Phe-Gly—Leu-Met
Table 111 Bioactive Peptides Cleaved by Neprilysin
1 Gafford et a l, 1983, 2 Wilk and Orlowski, 1979, 3 Turner, 1998, 4 Checler et a l, 1983,5 
Matsas e ta l, 1984
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13 4 7 Inhibitors
Neprilysin is inhibited by zinc-chelating reagents such as EDTA (IC50 30|xM) and 1,10- 
phenanthrohne (IC50 0 6mM) based on its absolute requirement for Zn2+ (Damelsen et a l, 
1980) Like TOP, neprilysin is also sensitive to the thiol reagents 2-mercaptoethanol and 
DTT (Fulcher and Kenny, 1983) Alternative neprilysin inhibitors include 
phosphoramidon, thiorphan and captopnl Phosphoramidon an inhibitor of, and isolated 
from, thermolysin has been reported to yield an IC50 value of lOnM for neprilysin 
(Damelsen et a l, 1980) Although not a specific inhibitor for neprilysin activity, use of 
concentrations in the |xM region readily inhibit neprilysin yet show no effect on other 
enzymes in the Ml 3 family, which require higher concentrations Thiorphan and 
captopnl are of similar structure and exhibit inhibition constants of 4nM (Roques et a l,
1995) and 4 7nM (Checler et a l, 1983) respectively for neprilysin activity Roques et al 
(1995), generated a schematic illustrating the selective inhibition of neprilysin by 
thiorphan (FIGURE 13) A number of neprilysin specific inhibitors have been 
synthesised (see Roques et a l, 1995) based on the general structure of zinc-peptidase 
inhibitors such as thiorphan
CH „ COO"2
Figure 1 3 Selective Interaction between Neprilysin and Thiorphan
(Roques et a l, 1995)
Thiorphan
■CH CH
Enz ym e
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13 4 8 Physiological Importance
The most conceivable physiological involvement of neprilysin is in pain and 
inflammation pathways (Turner, 1998) The generation of enkephalins (neurotransmitters 
known to relieve pain) emphasises this role and Wilkins (1993) demonstrated an increase 
in the amount of atnal natriuretic peptides in the circulation following administration of a 
neprilysin inhibitor It appears highly possible that neprilysin is involved in the 
metabolism of inflammatory peptides and highlights the potential of specific neprilysin 
inhibitors in contributing to pain relief
On cloning of the gene, Devault et al (1987) discovered an exact correlation between 
neprilysin and CALLA (common acute lymphoblastic leukemia antigen), a cell surface 
antigen Although the exact biological function of neprilysin in the immune system 
remains unclear, CALLA is expressed at various stages in lymphoblastic leukemia and 
hence can be employed as a marker for the disease (Anderson et a l, 1984) In addition 
the CALLA/neprilysin antigen is also expressed in normal bone marrow, spleen and liver 
cells suggesting a role in metabolising some peptides in normal lymphoid differentiation 
(Le Bien and McCormack, 1989) Neprilysin may also serve physiological functions in 
bone metabolism (Howell e ta l, 1993)
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1.3 5 Ohgopeptidase B
Pacaud and Richaud (1975) first described the isolation of ohgopeptidase B (EC 
3 4 21 83) a trypsin like peptidase then referred to as protease II from E coh Its inability 
to hydrolyse high molecular weight proteins and the preferential specificity for Basic 
ammo acids were the reason the peptidase was subsequently named ohgopeptidase B A 
number of different bacterial and plant forms of ohgopeptidase B have been isolated 
namely from, soybean seed (Nishikata, 1984), Rhodococcus erythropohs (Shannon et a l, 
1982), Trypanosoma brucei (Kornblatt et a l, 1992) and Trypanosoma cruzi (Santana et 
a l, 1992) Despite the wide distribution, physiochemical properties vary according to the 
source
13 51 Assay
Both a spectrophotometric and fluorimetnc assay have been described for ohgopeptidase 
B Benzoyl-Arg-P-naphthylamide (Bz-Arg-PNa) is readily hydroysed by E coh and T 
brucei oligopeptidases, releasing PNa which can be measured spectrophotometncally at 
550nm (Tsuru and Yoshimoto, 1994) A similar substrate incorporating MCA in place of 
PNa is employed for more sensitive fluorimetnc assays T brucei ohgopeptidase B can 
also be fluorimetncally quantified using Z-Phe-Arg-MCA (Caler et a l, 1998)
13 5 2 Distribution and Purification
Oligopeptidases B appear to be distributed widely in plant and prokaryotic cells The T 
cruzi form of the ohgopeptidase is expressed in all life cycles of T cruzi and is often 
purified from epimastigotes, a nch source of the protozoan parasite (Burleigh and 
Andrews, 1998) The enzyme has been purified from E coh , R  erythropohs, T brucei, 
Moraxella lacunanta and soybean seed (Pacaud and Richaud, 1975, Shannon et a l, 1982, 
Kornblatt et a l, 1992, Yoshimoto et a l, 1995, Nishikata, 1984 respectively) 
Ammonium sulphate fractionation, ion exchange chromatography and size exclusion 
chromatography have been described as successful purification tools (Tsuru and 
Yoshimoto 1994), purification factors from transformant cells ranging from 57 
(Yoshimoto et a l, 1995) to 90 (Kanatam et a l, 1991)
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13 5 3 Biochemical Characteristics
The biological properties of the ohgopeptidases B vary greatly depending on the source 
of the enzyme TABLE 1 12 summarises the characteristics of a number of 
ohgopeptidase B forms
S o u r c e M W
kDa
P i PH
OPTIMUM
T h er m a l
Sta b il ity
Su b u n it
[E  coh 81 8 52 80 45°C Monomer
2rrrT cruzi 120 4 8-5 0 ND ND Dimer
3 T brucei 80 5 1 82 ND Monomer
lacunata 80 43 65 35°C Monomer
5R erythropohs 82-90 5 1 7 0-7 2 37°C Monomer
6Soybean seed 59 ND 85 ND Monomer
Ta b l e  1 1 2 . Ph y sio c h e m ic a l  Pr o pe r t ie s  o f  o l ig o pept id a se s  B  fr o m  a  N u m b e r  
o f  So u r c e s
JKanatam et a l, 1991,2Burleigh and Andrews, 1998,3Komblatt et a l, 1992,4Yoshimoto 
e ta ly 1995,5Shannon e ta l, 1982, Nishikata, 1984
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13 5 4 Catalytic Classification and Mechanism o f Action
Oligopeptidases B catalyse the hydrolysis of peptides exclusively at the carboxyl side of 
basic amino acids such as lysine and arginine (Tsuru 1998) All oligopeptidases B are 
inhibited by the serine protease inhibitors, dnsopropyl fluorophosphate (DFP), tosyl-L- 
lysylchloromethane (TLCK) and leupeptin, justifying their serine protease classification 
Although E coh oligopeptidase B is very similar to trypsin (except for its oligopeptidase 
specificity), the oligopeptidases B do not belong to the SI family of trypsin peptidases 
In fact the oligopeptidases B show a high degree of homology with PO and have hence 
been classified as members of the S9 family of serine proteases The sequence of the 
E  coh peptidase shows a 24-25% homology with PO (Tsuru, 1998), while less similarity 
(18-22%) is noted between prolyl oligopeptidase and T cruzi oligopeptidase B (Burleigh 
e ta l, 1997)
These members of the S9 family also exhibit the Gly-Xaa-Ser-Xaa-Gly-Gly consensus 
sequence common to the family (Barrett and Rawlings, 1992), where Ser is the active- 
site serine Using radiolabeiled DFP, Ser532 was identified as the active site of E coh 
oligopeptidase B (Kanatam et a l , 1991) The remaining members of the catalytic triad 
were deduced to be Asp617 and His652 (Tsuru, 1998) In distinction from that found with 
most serine endopeptidases, oligopeptidase B appears to have a physical rather than 
chemical rate-limiting step (Polgar, 1997), as is the case for prolyl oligopeptidase 
(Polgar, 1992c) Although the crystal structures of oligopeptidases B have not been 
determined, these serine protease oligopeptidases may possess a similar catalytic 
mechanism to any one of the other a/p fold hydrolases within the S9 family, possibly PO
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13 5 5 Specificity and Physiological Importance
As the name suggests, oligopeptidases B readily cleave short peptides less than 6kDa and 
have a preference for basic amino acid residues in the Pi position Therefore, basic 
residues such as arginine and leucine are often incorporated into synthetic substrates, like 
Bz-Arg-PNa, Bz-Lys-PNa and Z-Phe-Arg-PNa There are no reports of neuropeptide 
cleavage by the oligopeptidases B and so biological substrates and functions remain 
unidentified A recent publication implicates T cruzi oligopeptidase B m host cell 
invasion events Caler et al (1998) showed that the removal of the oligopeptidase B 
gene reduced host cell invasion, an essential step in the development of infection by 
intracellular pathogens such as T cruzi This infers a physiological role for 
oligopeptidase B from T cruzi as a processing peptidase responsible for the signaling 
between pathogens and host cells
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13  6 Other OUgopeptidases
A number of other ohgopeptidases exist most of which have not been well characterised 
The majority are prokaryotic metalloproteases belonging to the M3 family, however a 
few have yet to be classified Table 1 13 names such ohgopeptidases and denotes an 
insight into their specificity and physiochemical characteristics
1 3  7 Z-Pro-Prohnal Insensitive Z-Gly-Pro-MCA Degrading Peptidase
Cunningham and O’Connor, (1997a) identified a novel prohne-specific peptidase from 
bovine serum related to the oligopeptidase PO This enzyme is detected on hydrolysis of 
the fluorogemc substrate, Z-Gly-Pro-MCA and differentiates itself from PO in its 
insensitivity towards Z-Pro-Prohnal and other specific PO inhibitors In addition, the two 
peptidases can be separated by ion exchange and hydrophobic interactions 
chromatography This second peptidase has been referred to as ZIP, based on it being a 
Z-Pro-Prohnal insensitive peptidase and may well exhibit oligopeptidase specificity The 
aim of this project was to purify ZIP from bovine serum and subsequently characterise to 
determine biophysical properties, effects of a range of functional reagents and inhibitors 
and to elucidate its substrate specificity
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Olig opeptidase M W  kDci Pro perties INHIBITORS Ph y sio lo g ic al  functions
n^sulysin Dimer pi 5 9 1,10-phenanthrohne, Degradation of insulin and damaged
EC 3 4 24 56 110 pH 7 0-8 5 EDTA proteins m cells
201igopeptidase MepB Monomer pi 5 6 1,10-phenanthrolme, Intracellular degradation of peptides
82 pH 7 1 DTT EDTA, DFP,
3 401igopeptidase A Monomer - Zn2+, Ni2+, Cu2+ Degradation of signal peptides
EC 3 4 24 70 77 EDTA
5Ohgopeptidase F Monomer pH 7 0-9 0 1,10-phenanthrohne Protein turnover in cheese making
90 Temp 40°C EDTA
601igopeptidase 0 Monomer pH 6 0-6 5 EDTA Cheese fermentation
71 5 Temp 30-38°C Cu2+, Zn2+ Degradation of casein derived peptides
pi 4 62
701igopeptidase PepB Monomer pi 4 9 - Possibly peptide transport
69 6
’Pitnlysm Monomer pH 7 4 EDTA, DTT, bacitracin Possibly turnover of abnormally folded
EC 3 4 24 55 105 pi 5 7 1,10-phenanthrohne proteins
9Protease IV Tetramer pH 7 2-7 6 DFP, PMSF, leupeptin, Degradation of signal peptides
268 antipain
10Saccharolysin Monomer pH 5 5-7 9 Cpp-Ala-Ala-Phe-pAb, Degradation of peptides resulting from
EC 3 4 24 37 81 8 EDTA, mercury non-vacuolar proteolysis
Continued overleaf
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O l ig o pe p t id  ase C l a n  Fa m il y T y p ic a l  S o u r c e Sp e c if ic it y  a n d  Su b s t r a t e s
^nsulysin MEM16 H sapiens, S cerevisiae, Cleaves amino side o f hydrophobic groups
EC 3 4 24 56 D melanogaster Substrates insulin, glycogen, insulin B chain, Ap
201igopeptidase MepB MX M3 S typhimunum, E coli, 
H influenzae
Cleaves N-termmal blocked peptides with at least 4 AA or 5 
AA if  unblocked Substrates Ala5, AcAla4
3401igopeptidase A MX M3 L lactis, M genitalium. Broad specificity for 7-23 residues
EC 3 4 24 70 M pneumoniae Substrates bradykimn, Mcc-Pro-Leu-Gly-Pro-D-Lys
501igopeptidase F MX M3 A fumigatus Similar specificity as TOP Substrates Pz peptide, collagen
6Ohgopeptidase 0 MAM13 L lactis lactis,
L lactis cremons
Cleaves hydrophobic residue in P i’, hydrolyses peptides o f 5-
30AA higher affinity for larger peptides
Substrates oxidised insulin B chain a-, p- or k- casein
701igopeptidase PepB MX M3 S agalaciae Hydrolyses small basic peptides, length and flexibility rather 
than AA are important Substrates bradykimn, neurotensin
^ltnlysin MEM16 E coli Cleaves peptides less than 7kDa
Substrates insulin B chain, insulin, substance P
9Protease IV U X U 7 C jejuni, E coli, 
H influenzae
Hydrolyses N-or C- blocked peptides with hydrophobic 
residues in Pj and Pi’ positions, minimum of 6  AA
10Saccharolysin 
EC 3 4 24 37
MX M3 S cerevisiae Hydrolyses N-terminally blocked peptides, hydrophobic 
residue in Pi and P3’, prolme in P2’ Substrates bradykimn
T a b l e  1 1 3  Su m m a r y  o f  O t h e r  O l ig o p e p t id a se s
o^th, 1998a, 2 Ibrahim-Granet and d’Enfert, 1998, 3 Conlin and Miller, 1995, 4 Miller, 1998a, 5Monnet, 1998, 6 Mierau and Kok, 
1998,7Pntchard, 1998,8 Roth, 1998b, 9Miller, 1998b, 10 d’Enfert and Ibrahim-Granet, 1998
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2.0. M a t er ia ls  a n d  M e t h o d s
2 1  M a t e r ia l s
Sigma Chemical Company (Poole, Dorset, England)
a2M
ß-Galactosidase
1, 10-phenanthroline
1, 7-phenanthroline
2-mercaptoethanol
4, 7-phenanthrohne
8-hydroxyquinoline
Acetic Acid
Acetone
ADH
AEBSF
Ala-MCA
Ammonium Persulphate
Angiotensin I, II & III
Antipain
APMSF
Aprotimn
Arg-MCA
Bacitracin
Benzamidine
Bisacrylamide 
Blotting Paper 
Blue Dextran 
Boric Acid
Bovine Serum Albumin 
Bradykinin
Brilliant Blue G Colloidal Stain
Cadmium Chloride
Cadmium Sulphate
Calcium Sulphate
CAPS Buffer
Carnitine
CDTA
Cellulose Type 50
Chymotrypsin
Cobalt Sulphate
Dithiothreitol
DTNB
EDTA
Egg Albumin
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EGTA
Glycine
HRP
IEF Standards 
Imidazole 
Insulin B Chain 
Iodine 
Iodoacetate 
Iodoacetic Acid 
Leupeptin 
LHRH
Magnesium Sulphate 
Manganese Sulphate 
MCA
Mercuric Sulphate 
Myosin 
Naphthol 
N-Ethylmaleimide 
Nickel Sulphate 
Ninhydnn 
Pepstatin A 
PMSF 
Ponceau S
Potassium Iodide
Potassium Phosphate (Dibasic)
Potassium Phosphate (Monobasic)
Pro-MCA
Puromycin
PVDF Membrane
SDS
Silver Stain High M W  Standard Kit
Silver Stain Kit
Sodium Chloride
Sodium Phosphate
Sodium Sulphate
Substance P
Sulphuric Acid
TEMED
TFA
Thioglycolic Acid 
Trifluoroacetic Acid 
Tns
Trypsin Inhibitor from Soybean
Trypsinogen
Zinc Sulphate
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BDH Chemicals Ltd (Poole, Dorset, England)
Acrylamide Dioxane
Ammonia Solution Fehhng’s Solution A
Biuret Reagent Fehling’s Solution B
Bromophenol Blue Glacial Acetic Acid
Calcium Chloride Glycerol
Citric Acid Hydrochlonc Acid
Climstix Methanol
Copper Sulphate Polyethylene Glycol 60
Dimethylformamide Urea
Dimethylsulphoxide
Bachem Feinchemikalein AG (Bubendorf, Switzerland)
(Arg8) Vasopressin Leu-MCA
(G1u2)-TRH Lys-Ala-Ala
(Phe2)-TRH Lys-Ala-MCA
A ß l  28 Lys-MCA
A ß l  48 Na-benzoyl-Arg-MCA
A ß 25  35 Neurotensin
Cyclo-(His-Pro) Pyr-His-Pro-MCA
Glu-Phe-MCA Pyr-His-Gly
Gly-Gly-Pro-Ala Z-Pro-Ala
Gly-Phe-Ala Z-Pro-Gly
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Gly-Pro-Ala Z-Pro-Leu-Gly
Gly-Pro-MCA Z-Pro-Pro
His-Pro Z-Pro-Prohnal dimethylacetate
Leu-Gly
Merck Chemical Company (Frankfurt, Germany)
Ammonium Sulphate Sodium Hydrogen Phosphate
Potassium Chloride Sodium Hydroxide
Novex (San Diego, California, USA)
Anode Buffer Precast IEF Gels
Cathode Buffer
Pharmacia Fine Chemical Company (Uppsala, Sweden)*
BioSep Sec 300 Polybuffer 74
DEAE-Sepharose Fast Flow Polybuffer Exchanger 94
Phenyl Sepharose CL-4B
Pfizer (Groton, CT, USA, Courtesy of Dr. S Faraci) 
Z-Indohnyl-Prolinal
Biorad Laboratories (Hercules, California, USA).
Biogel HT Hydroxylapatite
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Keypak Meats (Clonee Co Meath, Ireland):
Bovine Whole Blood
Pierce Chemical Company (Illinois, USA)
BCA Reagent
School of Biotechnology, Dublin City University
Ethanol
Mount Sinai School of Medicine (New York, Courtesy of Dr. S Wilk)
Fmoc-Ala-Pro-Nitnle Z-Pro-Prolinal
Fmoc-Pro-Pro-Nitnle
Central Pharmaceutical Research Institute (Japan , Courtesy of Dr K Toide)*
Institute of Microbial Chemistry (Tokyo, Japan, Courtesy of Dr M. Nagai)
Postatin
NUI Galway (Courtesy of Dr. G O’Cumn)
JTP-4819
Ala-Arg Leu-Gly
Ala-Gln Lys-Ile
Ala-Pro Lys-Tyr
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Arg-Ala Pro-Gly
Arg-Glu Pro-Leu
Asp-Lys Pro-Pro
Asp-Tyr Pyr-Ala
Glu-Lys Pyr-Gly
Glu-Val Pyr-Phe
Gly-Pro Pyr-Val
His-Pro Z-Pro
IMPC du CNRS, (Valbonne, France, Courtesy of Dr F Checler)*
S I70921 S I9825
Hans-Knoell Institute of Natural Product Research (Germany, Courtesy of Prof H 
Demuth)
Boc-Glu (NHB02)-Pyr Z-Phe-Ala-CMK
Ile-Pyrrohdide Z-Phe-Pro-Methylketone
Ile-Thiazohdide
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2 2 F l u o r e sc e n c e  Sp e c t r o m e t r y  u s in g  7-A m in o -4-M e t h y l -C o u m a r in  (M C A )
2 2 1 MCA Standard Curves
IOOjuM 7-Amino-4-Methyl-Coumann (MCA) stock solution was prepared containing 2%v/v 
dimethylsulphoxide (DMSO) in lOOmM potassium phosphate, pH 7 4 All lower 
concentrations required were obtained using lOOmM potassium phosphate, pH 7 4 containing 
2%v/v DMSO, as diluant and stored at 4°C in the dark (for a maximum of three months) 
Standard curves were prepared in the MCA concentration ranges 0-10juM and 0-2 5 (jlM  as 
follows
• lOO^ iL lOOmM potassium phosphate, pH 7 4
• 400^L appropriate MCA concentration
• lmL 1 5M acetic acid
Fluorescent intensities were measured using a Perkin Elmer LS-50 Luminescence 
Spectrophotometer at excitation and emission wavelengths of 370nm and 440nm respectively 
Emission slit widths were vaned according to the extent of the fluorimetrie intensities 
observed, while an excitation slit width of lOnm was maintained All solutions were assayed 
in triplicate and the mean fluorimetrie intensity calculated
2 2 2 Inner Filter Effect
The inner filter effect (filtering) of enzyme samples was determined by combining lOOjal of 
enzyme sample with 400(^ 1 MCA solution and lmL 1 5M acetic acid Filtering of crude serum 
samples was monitored in the presence and absence of 5x10 4M Z-Pro-Prohnal or 2 5 x 1 0 ^
JTP-4819 in 10%v/v methanol (MeOH) as appropriate These samples, prepared in triplicate, 
were fluorimetrically assayed as outlined in section 2 2 1
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2.3 Pr o t e in  D e t e r m in a t io n
2 3 1 Biuret Assay
The Biuret assay was used to qualitatively monitor the elution of protein from a number of 
chromatography columns Dialysis was performed when necessary using 2 4mm pore visking 
tubing with a cut off of 12,000-14,000 Da (subsequent references to dialysis also utilised this 
tubing) to remove any interferents or contaminants such as incompatible buffers Fractions 
were dialysed against lOOmM potassium phosphate, pH 7 4 overnight at 4°C and assayed on a 
96-well plate as follows
• 50|iL Post-column fraction
• 200(iL Biuret Reagent
• Incubated for 30min at 37°C
The Biuret assay was also used to quantify protein in post-column chromatography enzyme 
pools containing between 2mg and lOmg protein per mL High protein content samples were 
diluted in lOOmM potassium phosphate, pH 7 4 to achieve a concentration suitably 
determinable by the assay Bovine serum albumin (BSA) standards (O-lOmg/mL) were 
prepared and 50jiL of each was added in triplicate to 200jjL Biuret reagent in a 96-well 
microtitre plate Absorbances were determined at 570nm using a Tecan Spectra Plate Reader 
and a standard curve was constructed Enzyme pools were assayed in parallel and the 
concentration of protein estimated using the standard curve
2 3 2 Standard BCA Assay
Post-column chromatography enzyme samples containing less than 2mg/mL protein were 
quantified using the standard bicinchonmic acid (BCA) assay protocol based on the method 
described by Smith et a l , (1985) Samples were prepared as outlined in section 2 3 1 and 
BSA standards in the range Omg/mL to 1 4mg/mL were included 50fiL of sample or 
standard was assayed, in triplicate with 200|iL BCA reagent at 37°C for 30min Absorbance 
of each sample was recorded at 570nm
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The BCA reagent was also employed to follow the elution of protein from chromatography 
columns as described for the Biuret assay in section 2 3 1 using BCA reagent in place of 
Biuret reagent
2 3 3 Enhanced BCA Assay
The enhanced BCA assay was employed to determine protein concentrations in samples which 
could not be accurately quantified using the less sensitive standard BCA assay The protocol 
was performed as described in section 2 3 2 but at an incubation temperature of 60°C for 
30min Samples were first dialysed against lOOmM potassium phosphate, pH 7 4, and assayed 
in triplicate along with BSA standards in the range 0-100}ig/mL
2.4. Enzyme Assays
2 4 1 Substrate Preparation
Prolyl oligopeptidase (PO) and Z-Pro-Prohnal insensitive Z-Gly-Pro-MCA degrading peptidase 
(ZIP) activities were determined using 0 lmM Z-Gly-Pro-MCA as a fluonmetnc substrate, 
according to a modification of the original protocol of Yoshimoto et a l , (1979) lOmM Z- 
Gly-Pro-MCA stock substrate solution was prepared in 100%v/v DMSO lOOmM potassium 
phosphate, pH 7 4 at 37°C was slowly added to 300|iL DMSO and lOOjaL stock substrate to a 
final volume of lOmL Substrate used for the determination of PO activity had 0 015g 
dithiothreitol (DTT) included, while 0 2922g sodium chloride (NaCl) was added to the 
substrate on determination of ZIP activity This resulted in a ‘ZIP substrate5 composed of
0 lmM Z-Gly-Pro-MCA in 4%v/v DMSO containing 500mM NaCl and a ‘PO substrate’ 
consisting of 0 lmM Z-Gly-Pro-MCA in 4%v/v DMSO containing lOmM DTT
2 4 2 Z-Gly-Pro-MCA Degrading Activities Assay
Prior to assay, both substrate and enzyme sample were pre-incubated at 37°C to allow them to 
reach thermal equilibrium 400|iL 0 lmM substrate was added to IOOjxL enzyme sample in 
triplicate and incubated at 37°C for 60min Reactions were terminated by the addition of lmL
1 5M acetic acid into each tube Negative controls consisted of lOOjiL enzyme sample to
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which lmL 1 5M acetic acid was added prior to substrate addition and 37°C incubation 
Liberated MCA was measured fluonmetncally as described in section 2 2 1 Fluorimetric 
intensities observed for each sample were converted to picomoles MCA released per min per 
mL using the appropnate filtered MCA standard curve as generated in section 2 2 2 Enzyme 
units were thus defined as picomoles of MCA released per min at 37°C (section 6 2 )
2 4 3 Z-Pro-Prolinal Insensitive Z-Gly-Pro-MCA Degrading Activities Assay 
The activity of ZIP was determined as described in section 2 4 2 in situations where it was 
certain that it had been separated from other Z-Gly-Pro-MCA degrading peptidases 
However, ZIP activity in crude bovine serum had to be differentiated from PO activity and so 
the following modification of the Z-Gly-Pro-MCA assay was necessary 100|iL of enzyme 
sample was pre-incubated for 5 min at 37°C with 20(iL of 5x10 4M Z-Pro-Prolinal in 10%v/v 
MeOH prior to substrate addition Negative controls containing no Z-Pro-Prolinal but 
incorporating 20|iL 10%v/v MeOH were included and determinations were earned out in 
tnplicate MCA liberated from the substrate was determined fluonmetncally as desenbed in 
section 2 2 1 and fluonmetnc intensities were converted to enzyme units as outlined in section 
6 2 , where MCA standard curves used had 20|iL Z-Pro-Prolinal included Enzyme units were 
defined as picomoles MCA released per min at 37°C
2.4.4 Non-Quantitative Z-Gly-Pro-MCA Activities Assay
A non-quantitative fluonmetnc microtitre plate assay was employed to facilitate the rapid
identification of Z-Gly-Pro-MCA degrading activities in post-column chromatography
fractions 200[iL of 0 ImM Z-Gly-Pro-MCA in 4%v/v DMSO containing 500mM NaCl, at
37°C, was added to IOOjiL of sample in each well Post-phenyl sepharose fractions were
v  4assayed in the presence of 20|iL 5x10" M Z-Pro-Prolinal in 10%v/v MeOH and in its absence 
(where 20jiL lOOmM potassium phosphate, pH 7 4 containing 10%v/v MeOH was included in 
each well) The microtitre plate was incubated at 37°C for 30min MCA released was 
determined fluonmetncally as outlined in section 2 2 1 using the Perkin Elmer LS-50 
Luminescence Spectrophotometer plate reader attachment
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2 5 PU RIFICA TIO N  OF BO VIN E SERUM  Z IP
All purification procedures were earned out in a 4°C cold room unless otherwise stated 
2 5 1 Serum Preparation
Bovine whole blood was collected from a freshly slaughtered animal and transported to a 4°C 
cold room where the clot was allowed to shrink After 24hr, the remaining unclotted blood 
was decanted and centrifuged at 6000rpm for 60min at 4°C using a Beckman J2-MC centrifuge 
fitted with a JL-10 5 rotor The supernatant and loose cellular debns was decanted and re- 
centnfuged at 20,000rpm for 15min using a JL-20 rotor The serum (supernatant) was 
collected, pooled and stored in 20mL aliquots at -17°C
2 5 2 Phenyl Sepharose Hydrophobic Interaction Chromatography
A 30mL phenyl sepharose CL-4B hydrophobic interactions column (2 5cm x 7cm) was 
equilibrated with lOOmL of lOOmM potassium phosphate containing 200mM ammonium 
sulphate, pH 7 4 Crude serum was thawed at 37°C and solid ammonium sulphate 
((NH4)2S0 4) was added to give a final concentration of 200mM (NH^SC^ 20mL salted 
serum was applied to the equilibrated column followed by lOOmL wash of lOOmM potassium 
phosphate containing 200mM (NFL^SC  ^ The column was then washed with lOOmL lOOmM 
potassium phosphate containing 50mM ammonium sulphate, pH 7 4 Bound protein was 
eluted isocratically with lOOmL distilled water Equilibration was carried out at lmL/min, 
while loading, washing and elution steps were performed at 2mL/min 5mL fractions were 
collected throughout the purification step, which were assayed for ZIP following the microtitre 
plate assay protocol in section 2 4 4 Protein content in each fraction was determined 
spectrophotometncally using the Biuret assay as outlined in section 2 3 1 Fractions containing 
ZIP activity were combined to yield post-phenyl sepharose ZIP The phenyl sepharose resin 
was regenerated with lOOmL wash EtOH at 0 5mL/min, lOOmL distilled water wash at 
2mL/min followed by equilibration as described previously
6 6
2 5 3 Calcium Phosphate Cellulose Chromatography
The calcium phosphate gel was prepared at room temperature 1L of 500mM sodium 
hydrogen phosphate was added (at a rate of 6mL/min) to 1 5L of constantly stirred 500mM 
calcium chloride Following a 15min agitation, 1 5mL concentrated ammonia solution was 
added and stirred for a further 10mm The precipitated gel was allowed to settle and the 
supernatant decanted and discarded 1L of distilled water was added and stirring continued for 
5min Settling and decanting was performed and this procedure was repeated until the gel had 
been washed with 10L of distilled water The washed calcium phosphate gel was stored in 1L 
distilled water at 4°C lOg Sigma cellulose type 50 was soaked overnight in 200mL 500mM 
potassium phosphate containing 150mM potassium chloride, pH 6 8 The cellulose was 
washed eight times with distilled water and dried overnight at 70°C 2g washed and dned 
cellulose was dissolved in 20mL 20mM potassium phosphate, pH 7 5 and added to 24mL 
evenly suspended calcium phosphate gel This calcium phosphate cellulose was poured into a 
column (2 5cm x 3 0cm) and allowed to settle, yielding an 18ml packed resin
The column was equilibrated at lmL/min with lOmM potassium phosphate, pH 7 4 The post­
phenyl sepharose ZIP was applied to the column followed by a further lOOmL wash with 
lOmM potassium phosphate, pH 7 4 lOOmL 500mM potassium phosphate, pH 7 4 was 
applied to elute bound protein Loading, washing and elution steps were earned out at 
2mL/min and 5mL fractions were collected throughout the run The standard BCA assay was 
employed to determine protein in each fraction as desenbed in section 2 3 2 Fractions 
containing ZIP activity (microtitre plate assay outlined in section 2 4 4 )  were pooled yielding 
post-calcium phosphate cellulose ZIP
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2 5 4. Diethylaminoethyl Sepharose Anion Exchange Chromatography
lOOmL 50mM Tns/HCl, pH 8 0 was used to equilibrate a 30mL diethylaminoethyl (DEAE) 
sepharose anion exchange column (2 5cm x 6cm) at lmL/min The post-calcium phosphate 
cellulose ZIP sample was dialysed overnight against 5L of Tns/HCl, pH 8 0 at 4°C The pH of 
the dialysate was checked prior to application onto the DEAE resin The column was washed 
with lOOmL of equilibration buffer to remove unbound proteins ZIP was eluted with lOOmL 
Tns/HCl containing 200mM NaCl, pH 8 0 The entire procedure was performed at a flow-rate 
of lmL/min 5mL fractions were collected and assayed for ZIP activity using the microtitre 
plate procedure detailed in section 2 4 4 The column was regenerated with 2M NaCl at 
lmL/min Removal of Tns buffer by dialysis against lOOmM potassium phosphate, pH 7 4 was 
necessary prior to using the enhanced BCA assay (section 2 3 4 ) to determine protein content 
in collected fractions
Pooled post-DEAE fractions represented purified bovine ZIP, which was employed for all 
charactensation, assay development and localisation studies Dialysis was always performed at 
4°C overnight to remove Tns buffer or salt prior to enzyme assays The dialysis buffer 
employed depended on the application, however lOOmM potassium phosphate, pH 7 4 was 
most commonly used Therefore reference to purified ZIP indicates post-DEAE bovine ZIP 
which had been dialysed extensively against lOOmM potassium phosphate, pH 7 4 The 
punfied PO sample used in some of the assays had previously been punfied in our laboratory 
from bovine brain, using fractionation, chromatofocusing, S-200 size-exclusion and phenyl 
sepharose hydrophobic interactions chromatography (unpublished data) It was extensively 
dialysed against 1 OOmM potassium phosphate, pH 7 4 unless otherwise stated
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2 6 Purity Determination 
2 6 1 Polyacrylamide Gel Electrophoresis
A discontinuous sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) 
system based on the method of Laemmli, (1970) was employed to assess the effectiveness of 
the purification procedure and to estimate the relative molecular mass of ZIP (section 2 9 2 )  
Electrophoresis was also used to determine the subunit structure of ZIP and the molecular 
weight of these subunits
2 6 1 1  Sample Preparation .
Samples generated during the purification procedure, namely, crude serum, post-phenyl 
sepharose ZIP, post-calcium phosphate ZIP and post DEAE sepharose ZIP were 
electrophoresed using SDS PAGE Sample preparation involved an extensive dialysis (18hr) at 
4°C against 2L 62 5mM Tris/HCl, pH 6 8, with buffer changes at 3, 6 and 12hr Dialysed 
samples were diluted with an equal volume of solubilisation buffer which consisted of 62 5mM 
Tris/HCl, pH6 8, 20%v/v glycerol, 8%w/v SDS, 10%v/v 2-mercaptoethanol and 0 01%w/v 
bromophenol blue Silver stain high molecular weight standards were also prepared These 
standards consisted of Myosin (205,000Da), P-Galactosidase (116,000Da), Phosphorylase B 
(97,000Da), Fructose-6-phosphate kinase (84,000Da), BSA (66,000Da), Glutamic 
dehydrogenase (55,000Da), Ovalbumin (45,000Da) and Glyceraldehyde-3-phosphate 
dehydrogenase (36,000Da) Samples in solubilisation buffer and markers were denatured on 
immersion in a boiling water bath for 90sec and immediately stored on ice prior to application 
onto the gel
2 6 1 2  Preparation of SDS Gel
Table  2 1 lists the stock solutions required for the production of an SDS gel All solutions 
were prepared in ultra-pure water and from these a 10%v/v resolving gel with a 3 75%v/v 
stacking gel was poured (see TABLE 2 2 )  Gels were prepared in an ATTO vertical 
electrophoresis system (160mm x 160mm x 1mm) The system was filled with running buffer
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and 20(iL of the prepared samples and markers were loaded into the wells under the buffer 
Electrophoresis was earned out a constant current of 25mA per gel for approximately 3 5hr
2 6 1 3  Visualisation of Proteins
Polyacrylamide gels were stained based on the method of Heukeshoven and Dermck (1985) 
using a Sigma silver stain kit and by brilliant blue G colloidal stain kit from Sigma TABLES 2 3 
and 2 4 outline the stages performed An image of each stained gel was captured using an 
Olympus digital camera coupled to Olympus C-2  OW95E software
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Solution Composition
Acryl/bisacyrl solution 30%w/v acrylamide, 0 8%w/v bisacrylamide
Ammonium persulphate 1 5%w/v ammonium persulphate
Resolving gel buffer 3M Tns/HCl, pH 8 8
Running buffer 25mM Tris/HCl, 192mM glycine, 0 l%w/v SDS, pH 8 3
SDS 10%w/v SDS
Stacking gel buffer 500mM Tns/HCl, pH 6 8
T ab le  2 l  SDS PAGE B u ffe r  P rep ara tion
So l u t io n 10 % v/v  R e so l v in g  G el
Volume
3.75 % v /v  St a c k in g  G el
Volume
Acryl/bisacyrl solution lOmL 2 5mL
Ammonium persulphate 1 5mL lmL
Resolving gel buffer 3 75mL -
SDS 300|iL 200|iL
Stacking gel buffer - 5mL
TEMED 15|iL 15|iL
Ultra-pure water 14 45mL 11 3mL
T ab le  2.2. SDS PAGE G e l P rep ara tion
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St e p R e a g e n t Vo lu m e  T im e
Fixing 30%v/v ethanol in 
10%v/v glacial acetic acid
3 x 300mL 2 x lOmin 
1 x overnight
Rinsing Ultra-pure water 3 x 300mL 3 x 20min
Silver staining Silver nitrate (kit) 300mL 30min
Rinsing Ultra-pure water 300mL 10 sec
Developing Sodium carbonate 
formaldehyde (kit)
2 x 150mL 2 x 8min
Development stop l%v/v glacial acetic acid 300mL 5 min
Rinse Ultra-pure water 300mL lOmin
Table 2 3 Silver Staining Procedure
Step Reagent Volume Time
Fixing 30%v/v EtOH 
10%v/v glacial acetic acid
3 x 300mL
2 x lOmin 
1 x overnight
Rinsing Ultra-pure water 3 x 300mL 3 x 10mm
Staining 80%v/v brilliant blue 
20%v/v MeOH
300mL Overnight
Destaimng 10%v/v acetic acid 
25%v/v MeOH
300mL 60sec
Rinsing 25%v/v MeOH 3x300mL 2 x 1 Omin 
1 x overnight
Table 2 4 Brilliant Blue G Colloidal Staining Procedure
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2 6 2 The Activity of ZIP Using Fluorimetnc Substrates
A range of fluorimetnc substrates was assayed in the presence of punfied bovine serum ZIP to 
assess the enzymatic punty of the sample TABLE 2 5 lists the substrates used and the 
peptidases which they are most commonly used to detect Each substrate was prepared as a 
lOmM stock in 100%v/v MeOH lOOmM potassium phosphate, pH 7 4 was heated to 37°C 
and added to IOOjiL each stock substrate and 300jaL MeOH to a final volume of lOmL This 
yielded a final substrate concentration of 0 ImM in 4%v/v MeOH ZIP activity was also 
assayed in 0 ImM Z-Gly-Pro-MCA in 4%v/v MeOH, containing no NaCl, which acted as a 
control Punfied ZIP was incubated with each substrate according to section 2 4 2 and 
fluorescent intensities were recorded
2 6 3. Purity Assessment using Reverse Phase HPLC
Fluorimetnc substrates listed in TABLE 2 5 were again used to assess the punty of ZIP using 
HPLC analysis IOOjuL purified dialysed ZIP was incubated with 400jiL 0 ImM Z-Gly-Pro- 
MCA in 4%v/v MeOH containing 500mM NaCl at 37°C for lhr The reaction was terminated 
by the addition of 25jiL 5%v/v tnfluoroacetic acid (TFA) Blanks were included in which TFA 
was added pnor to substrate addition These samples were then analysed by lon-pair HPLC 
using a Vanan Star system coupled to a fluorescent detector A Techmcol Exsil 5 Cis 
analytical column (220mm x 4 6mm) and a Beckman Ultrasphere 4 6mm x 4 5mm guard 
column were employed The column was equilibrated at lmL/min with lOmL solution of 
79 9%v/v MeOH, 20%v/v distilled water containing 0 l%v/v TFA 20|iL of sample was 
applied to the column followed by a 10mm wash with equilibration buffer, at a flow rate of 
lmL/min Column eluant was constantly monitored at excitation and emission wavelengths of 
370nm and 440nm respectively with appropriate slit widths
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Substrate Cleaved by
Ala-MCA Alanine aminopeptidase
Arg-MCA Arginine aminopeptidase
Glu-Phe-MCA Chymotrypsin
Gly-Pro-MCA DPP IV
Leu-MCA Leucine aminopeptidase
Lys-Ala-MCA DPP II
Lys-MCA Aminopeptidase B
Na-benzoyl- Arg-MCA Papain
Pyr-His-Pro-MCA Pyroglutamyl aminopeptidase I
Pyr-MCA Pyroglutamyl aminopeptidase II
Pro-MCA Proline aminopeptidase
Z-Arg-MCA Trypsin
Papain
Soya-bean trypsin-like enzyme
Z-Gly-Pro-MCA Prolyl ohgopeptidase 
ZIP
Z-Phe-Arg-MCA Plasma kallikrein 
Cathepsin B 
Cathepsin L 
Papain
Ohgopeptidase B
Table 2 5 Fluorimetric Substrates Tested
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2 7 Assay Development
2 7 1 MCA excitation and emission wavelengths
The excitation and emission wavelengths for MCA were tested using the luminescence 
spectrophotometer scan functions lmL 5jaM MCA in 0 2%v/v MeOH was placed in a glass 
cuvette and a pre-scan was performed The excitation wavelength obtained from the pre-scan 
was set and an emission scan was performed from 400-600nm at 5nm increments Similarly an 
excitation scan was performed between 250nm and 420nm using the previously determined 
optimum emission wavelength Optimal wavelengths were taken to be those at which 
fluorescence was at a maximum
2 7.2. Substrate Solvent Determination
lOmM Z-Gly-Pro-MCA stock substrates were prepared in 100%v/v DMSO, 
dimethylformamide (DMF), dioxane (DXN), EtOH and MeOH These stock solutions were 
diluted with lOOmM potassium phosphate, pH 7 4 to a final concentration of 0 ImM Z-Gly- 
Pro-MCA in 4%v/v solvent containing 500mM NaCl as described in section 2 4 1 Purified 
bovine serum ZIP was assayed in triplicate with suitable negative controls to determine the 
effect of these substrate solvents on enzyme activity
2 7 3 Solvent Concentration Determination
A range of substrates was prepared in order to assess the optimum methanol concentration for 
use in the Z-Gly-Pro-MCA degrading activities assay 0 ImM Z-Gly-Pro-MCA solutions 
containing 500mM NaCl in 2%, 3%, 4%, 5% and 6%v/v MeOH were prepared in lOOmM 
potassium phosphate, pH 7 4 as described in section 2 4 1 Purified ZIP was assayed in 
triplicate using these substrates as outlined in section 2 4 2
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2 7 4. Linearity of Enzyme Assays with Respect to Time
300 i^L purified ZIP and 1 2mL of 0 ImM Z-Gly-Pro-MCA containing 500mM NaCl in 4%v/v 
MeOH were pre-incubated separately at 37°C for 15min to allow each to reach thermal 
equilibrium A blank consisting of lmL substrate and 300juL enzyme was used to auto-zero 
the fluonmeter Substrate and enzyme were combined in a pre-warmed cuvette and the 
fluorescence was continuously monitored for 60min at 37°C in an incubated cuvette holder 
Liberated MCA was measured at optimum excitation and emission wavelengths every 2sec and 
plots of fluorescent intensity versus time were prepared to determine the linearity of ZIP 
activity over time The expenment was also earned out using crude bovine serum in the 
presence and absence of Z-Pro-Prohnal 300jiL crude serum was pre-incubated for 5min at 
37°C with 20|iL 5x10 4M Z-Pro-Prohnal pnor to addition of substrate and continuous 
momtonng of liberated MCA Blanks were incorporated as before but 20 |iL of either inhibitor 
was included
2.7.5. Linearity of Enzyme Assays with Respect to Enzyme Concentration
A range of dilutions of purified ZIP was prepared in lOOmM potassium phosphate, pH 7 4 
Enzyme dilutions were assayed with 0 ImM Z-Gly-Pro-MCA containing 500mM NaCl in 
4%v/v MeOH as described in section 2 4 2 Plots of fluorescent intensities versus enzyme 
concentration were prepared
2.7 6 Optimum Assay Temperature
Punfied ZIP was assayed at 4°C, 20°C, 30°C, 32°C, 37°C, 39°C, 40°C, 50°C and 65°C by a
rmodification of the assay desenbed in section 2 4 2 Both the substrate and enzyme sample 
was pre-incubated at the appropnate temperature for 15min prior to the assay to ensure that 
thermal equihbnum had been reached
2 7 7 Effect of DTT on ZIP Activity
2mL aliquots of 0 ImM Z-Gly-Pro-MCA in 4%v/v MeOH containing 500mM NaCl were
prepared incorporating 0, 4, 8, 12 and 20mM dithiothreitol (DTT) Punfied, dialysed ZIP was 
assayed m tnplicate with this range of substrates as outlined in section 2 4 2
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2 7 8 Effect of NaCl on ZIP Activity
2mL aliquots of 0 lmM Z-Gly-Pro-MCA in 4%v/v MeOH were prepared incorporating 0, 200, 
300, 400, 500, 600, 700, 800, 900 and lOOOmM NaCl Purified, dialysed ZIP was assayed 
with this range of substrates in triplicate as outlined in section 2 4 2
2 7 9 Prolyl Oligopeptidase Inhibitor Studies
In order to assay for ZIP activity alone in crude samples, it was necessary to find an inhibitor 
that was capable of inhibiting PO activity, yet effect no inhibition of ZIP Z-Pro-Prohnal was 
the potent prolyl oligopeptidase inhibitor initially employed, however due to depletion of the 
supply, an alternative inhibitor was required
2 7 91 Z-Pro-Prohnal Studies
A range of Z-Pro-Prohnal concentrations (5x105 to 5x1015M) was prepared in 10%v/v MeOH 
20jiL inhibitor was added to 100|iL crude sample followed by the addition of 400jiL 0 lmM 
Z-Gly-Pro-MCA in 4%v/v MeOH contaimng 500mM NaCl Samples were incubated for lhr 
at 37°C and the reaction terminated by the addition of 1 5M acetic acid Suitable controls and 
blanks were also included The effect of pre-incubation was also studied by incubating 20|jL 
5 x 1 0 ^  Z-Pro-Prohnal with 100|oL crude sample for 0, 5, 10, 15, 20, 25 and 30min 
Following this pre-incubation, samples were assayed at 37°C as outlined in section 2 4 2
2 7 9 2 Alternative Inhibitors
TABLE 2 6 lists the other inhibitors whose potency towards PO was examined A stock 
concentration of each inhibitor was prepared in a minimum volume of an appropriate solvent 
(DXN, DMSO or MeOH) From these stock solutions, a range of dilutions was prepared 
using lOOmM potassium phosphate, pH 7 4 incorporating the appropriate solvent and 
maintaining its concentration Each inhibitor was tested to assess PO and ZIP sensitivity 
towards them The reaction was performed as outlined in section 2 4 3 , where 20(^ L each 
inhibitor concentration was added to IOOjiL serum and incubated with 0 lmM Z-Gly-Pro- 
MCA for 60min at 37°C Acetic acid was used to terminate the reaction and appropriate
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blanks and controls were incorporated The effect of pre-incubating serum with 2 5x10 4M 
JTP-4819 for 0, 5, 10, 15, 20, 25 and 30min prior to substrate addition was also examined
In h ib it o r St o c k  C o n c e n t r a t io n
M
Pr e p a r a t io n
Z-Pro-Prohnal Dimethylacetate 5x105 10%v/v DXN
Fmoc-Pro-Pro-CN 26x105 l%v/v DMSO
Fmoc-Ala-Pro-CN 5x10 4 1 %v/v DMSO
Z-Indolinyl-Prohnal lxlO-4 13%v/vDXN
Postatin lxlO"4 10%v/v DXN
JTP-4819 1x10 2 10%v/v MeOH
T a b le  2 6  P r e p a r a t io n  o f  A l t e r n a t i v e  I n h ib i t o r s
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2 7,10 Optimised ZIP Assay
Based on the results observed in the assay development experiments, the ZIP and PO activities 
assay was modified slightly Substrate was prepared as a lOmM Z-Gly-Pro-MCA stock 
solution as described in section 2 4 1 except that 100% MeOH was used in place of DMSO 
This stock was subsequently employed to prepare 0 ImM Z-Gly-Pro-MCA in 4%v/v MeOH by 
combination of 100|aL stock substrate solution and 300piL MeOH, made to a final volume of 
lOmL with lOOmM potassium phosphate, pH 7 4 at 37°C 500mM NaCl or lOmM DTT was 
incorporated as described in section 2 4 1 for the detection of ZIP and PO activities 
respectively These substrate solutions were then employed in the Z-Gly-Pro-MCA degrading 
activities assays described in sections 2 4 2 and 2 4 3 Subsequent MCA solutions were 
prepared as outlined in section 2 2 1 except that the solubilisation solvent was changed from 
DMSO to MeOH
Initially ZIP and PO activities in crude samples were differentiated by the inclusion of 5x10 4M 
Z-Pro-Prohnal (sections 2 4 3 and 2 4 4), however, as explained in section 2 7 9 ,  an 
alternative inhibitor was required and based on the results, JTP-4819 was selected as the 
substitute PO inhibitor Therefore, expenments to differentiate ZIP and PO activities in crude 
samples subsequent to the assay development section, incorporated 2 5 x 1 0 ^  JTP-4819 in 
place of 5x10 4M Z-Pro-Prolinal but were otherwise performed as described in section 2 4 3 
The linearity of the Z-Gly-Pro-MCA degrading activity assay with respect to time was 
reassessed as outlined in section 2 7 4  but including 20|iL 2 5 x 1 0 ^  JTP-4819 These 
modifications to the assay were applied throughout the charactensation protocols following
2 8  L o c a l i s a t i o n  S tu d ie s
2 8 1 Tissue Preparation
Liver, lung, spleen, kidney and brain samples were obtained from a freshly sacrificed bovine 
and transported to the laboratory on ice Each organ was divided into approximately 25g 
portions which were stored at -17°C if not being used immediately A 25g piece of each tissue 
was suspended in lOOmL lOOmM potassium phosphate buffer, pH 7 4 These were
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homogenised at full speed for 15sec using a Sorvall Omni Mixer, followed by 15sec 
intermission to minimise heating and foaming effects Homogenisation was continued until the 
tissue in question was visually disrupted The homogenate (H) was then collected and 
centrifuged at 15,000rpm for 45min at 4°C in a Sorvall RC-SB refrigerated centrifuge fitted 
with an SS-34 rotor The supernatant was decanted and retained (Si) The pellet was 
resuspended in 25mL ice-cold lOOmM potassium phosphate buffer, pH 7 4 and re-centnfuged 
at 15?00rpm for 45min The supernatant was again decanted (S2) The homogenate, pellet and 
two supernatants obtained for each tissue sample were assayed for total protein, PO and ZIP 
activity as described below
2 8 2. Identification of Z-GIy-Pro-MCA Degrading Activities
The substrate preparation and assays used to detect the presence of Z-Gly-Pro-MC A degrading 
activities in the tissue samples was as described in sections 2 4 1, 2 4 2 and 2 4 3 
incorporating the modifications descnbed in section 2 7 9 The inclusion of 2 5x10 4M JTP- 
4819 in 10%v/v MeOH allowed for the identification of ZIP alone The total Z-Gly-Pro-MCA 
activity present was obtained in the absence of the potent inhibitor and PO activity was taken 
to be the residual non-ZIP activity Due to the high-colour content of the samples, the effect 
of filtering was investigated for the pellet, homogenate and supernatants of each tissue type 
MCA standards were prepared (in 4%v/v MeOH) in the range 0-8jiM and the extent of 
filtering was determined as outlined in sections 2 2 1 and 2 2 2 Enzyme levels were quantified 
using the slopes of the filtered standard curves and the fluorescence intensities observed as 
outlined in section 6 2
2 8 3 Protein Determination
The concentration of protein present in each sample was measured using the biuret assay as
outlined in section 2 3 1 and specific activities of ZIP and PO were calculated for each tissue 
(section 6 2 )
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2 9 Ch a r a c t e r is a t io n
2.9 1 Determination of N-terminal Protein Sequence
The N-terminal amino acid sequence of ZIP was determined commercially at the University of 
Durham, England, by Dr John Gilroy It was required that the enzyme be electroblotted onto 
a stained polyvmylidene diflounde (PVDF) membrane and this was achieved as follows
2 9 1 1  SDS Polyacrylamide Gel ELectrophoresis
An SDS PAGE was pre-cast as outlined in section 2 6 1 2  and stored overnight at 4°C to 
prevent N-terminal blocking by free amines lmL post DEAE sepharose ZIP was dialysed 
against 1L 62 5mM Tns/HCl, pH 6 8 at 4°C overnight and then diluted in an equal volume of 
solubilisation buffer (see section 2 6 1 1 )  Denaturation was initiated by boiling for 90sec 
Molecular weight markers listed in section 2 6 11 were again employed for this PAGE and 
were prepared in the same manner
The gel was pre-run at 50V for 30min with 200|iM thioglycolic acid in the upper reservoir to 
provide a scavenger for free radicals The chamber was emptied and rinsed with reservoir 
buffer and further electrophoresis was earned out at a constant current of 25mA for 3hr The 
gel was not stained but was prepared for electroblotting
2 9 1 2  PVDF Electroblotting
1L 10X CAPS buffer was prepared by dissolving 23 13g CAPS in 900mL ultra-pure water and 
adjusting the pH to 11 0 using 2M sodium hydroxide (NaOH) The volume was then adjusted 
to 1L Electroblotting buffer (IX CAPS in 10%v/v MeOH) was prepared and stored at 4°C 
The gel was removed from the electrophoresis chamber and equilibrated in electroblotting 
buffer for lhr Meanwhile the PVDF membrane was dipped in MeOH for lOsec and also 
equilibrated for lhr in electroblotting buffer
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A transblotting sandwich was constructed using 8 layers of pre-soaked filter paper (Sigma 
electrophoresis grade blotting paper) cut to the exact size of the SDS gel The PVDF 
membrane was gently placed on top of the filter paper followed by the gel Eight more layers 
of wet filter paper was added to complete the sandwich A stenle pipette was rolled over the 
sandwich surface to expel air bubbles and the filter paper was extensively moistened 
Electroblotting was earned out at a constant current of 76 8mA (0 8mA x area of gel in cm2) 
for lhr 10mm Removal of the membrane was followed by a rapid membrane wash in ultra- 
pure water The blot was then saturated in 100% MeOH for lOsec and stained in Ponceau S 
(Sigma) for 3min Destaimng m l%v/v acetic acid was repeated three times and the blot was 
extensively nnsed in ultra-pure water The blot was allowed to completely air dry and the 
corresponding ZIP band was identified using the molecular weight markers and marked with a 
ball point pen The blot was wrapped in chng-film, stored and transported at -17°C for 
sequencing
2.9 2 Relative Molecular Mass Determination
The relative molecular mass of the punfied bovine ZIP was determined using polyacrylamide 
gel electrophoresis and size exclusion chromatography
2 9 21 SDS Polyacrylamide Gel Electrophoresis
The SDS PAGE of samples and standards has previously been outlined in section 2 6 1 The 
gel obtained in the assessment of enzyme punty was also employed to estimate the relative 
molecular mass of the punfied enzyme and to determine the number of sub-units present A 
standard curve representing the log of molecular weight versus the relative mobility (Rf) was 
constructed for each of the molecular weight markers electrophoresed (see TABLE 3 3 )  The 
Rf is defined as the distance migrated by the standard or sample divided by the distance 
migrated by the bromophenol blue dye front The relative molecular weight of ZIP was 
determined by calculating its Rf value and using the calibration curve to estimate the log of the 
molecular weight
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2 9 2 2 Size Exclusion Chromatography
The relative molecular mass of ZIP was estimated using three size-exclusion chromatography 
columns namely HiPrep Sephacryl S-200, Sephacryl S-200 and Biosep SEC 3000 For all 
methods a flow rate of lmL/min was maintained TABLE 2 7 lists the molecular weight 
standards and the concentrations at which they were used All standards were prepared in 
lOOmM potassium phosphate, pH 7 4 and samples and standards analysed using S-200 resins 
had 20%v/v glycerol added prior to application on to the column Blue dextran at a 
concentration of 2mg/mL was used to calculate the void volume (V0) for each of the columns 
Each standard was individually applied and its elution volume (Ve) determined A graph of 
Ve/Vo versus log of molecular weight was constructed for each of the resins (TABLE 2 7 lists 
which standards were employed for each resin) ZIP samples were concentrated five-fold using 
PEG 6000 prior to analysis and V JV a determined for the purified enzyme Using the 
calibration curves constructed, the molecular weight of ZIP was estimated by each of the three 
methods The elution of enzyme activity from each column was monitored using the microtitre 
plate assay as described in section 2 4 4
2 9 2 2 1____ S-200 Sephacryl HR Size Exclusion Chromatography
A 200mL Sephacryl S-200 HR size exclusion column (2 5cm x 40cm) was poured and 
equilibrated with 300mL lOOmM potassium phosphate containing 150mM NaCl, pH 7 4 at 
4°C 2mL of each standard or blue dextran were applied directly to the top of the resin, under 
the buffer head using a syringe The column was washed with equilibration buffer until the 
protein of interest had eluted 2 5mL fractions were collected and the absorbance of each 
measured using the biuret assay as outlined in section 2 3 1 A calibration graph of V/Vo 
versus log of molecular weight was constructed for the six standards and the molecular weight 
of ZIP was estimated using the equation of this line
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St a n d a r d M W
kDa
So u r c e C o n c e n t r a t io n
mg/mL
M yosin 12  3 205 Bovine muscle 46
ADH 123 150 Baker’s yeast 2 0
ß-Galactosidase23 116 E cob 2 0
BSA 123 66 Bovine serum 40
Ovalbumin 12 45 Ova 2 0
Horseradish peroxidase 1,3 44 Horseradish root 2 0
Trypsinogen 2 3 25 Bovine pancreas 2 0
Chymotrypsin 1 24 Bovine pancreas 2 0
Ta b l e  2 7 M o l e c u l a r  W e ig h t  M a r k e r s  u se d  in  Siz e -E x c l u sio n  
C h r o m a t o g r a ph y
1 Standards employed for section 2 9 2 2 1
2 Standards employed for section 2 9 2 2 2
3 Standards employed for section 2 9 2 2 3
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2 9 2 2 2 FPLC Size Exclusion Chromatography
A BioRad BioLogic Chromatography System was used to perform fast protein liquid 
chromatography (FPLC) The system consisted of a HR Workstation with two biocompatible 
dual piston pump-heads, fixed wavelength (214nm and 280nm) UV detector and conductivity 
detector A model 2128 fraction collector was attached to the detector outlet The size 
exclusion column employed was a Pharmacia HiPrep Sephacryl S-200 (16mm x 60mm) 
Equilibration was performed at lmL/min using 300mL lOOmM potassium phosphate 
containing 150mM NaCl, pH 7 4 lmL standard or purified ZIP was injected followed by a 
200mL wash lOOmM potassium phosphate containing 150mM NaCl, pH 7 4 at lmL/min The 
elution of each sample was continuously monitored using the UV detector at 280nm ZIP 
elution was determined using Z-Gly-Pro-MCA as described in section 2 4 4 A graph of WJV0 
versus log of molecular weight was generated and the molecular weight of ZIP determined
2 9 2 2 3 HPLC Size Exclusion Chromatography
A Shimadzu LC-9A liquid chromatography system coupled to a Shimadzu SPD-6AV UV-VIS 
Spectrophotometnc detector was used to carry out high performance size exclusion 
chromatography A Phenomonex Bio Sep SEC-3000 column (7 8mm x 300mm) was fitted to 
the system and equilibrated with lOOmM potassium phosphate, pH 7 4 20|iL sample was
applied using a micro-synnge and eluted from the column with 30mL equilibration buffer at 
lmL/min The elution of each standard and concentrated ZIP sample was monitored by 
continuous scanning of the column eluant at 280nm Retention time determinations were made 
using LDC Analytical thermochrom software (version 3 86) from which a plot of Ve/V0 versus 
log of molecular weight was constructed for this system
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2 9.3. Thermostability Studies
2 9 3 1 Stability at Various Temperatures over Time
The effect of pre-incubation on ZIP activity was determined at various temperatures over a 
range of time points Purified enzyme was pre-incubated at 20, 30, 40, 50, 60 and 70°C 
500 i^L aliquots were removed after 0, 10, 20, 30, 40 and 50min and then assayed as outlined in 
section 2 7 10
2 9 3 2 Overnight Stability
The stability of ZIP at 37°C overnight was assessed prior to the substrate specificity studies by 
HPLC analysis Purified ZIP was incubated at 37°C for 14hr Enzyme aliquots of 500pL were 
taken at time 0, 1,2, 4, 6, 8, 10, 12 and 14hr and ZIP activity measured as described in section 
2 7 10
2.9 4. pH Effects
2 9 41 pH Inactivation
5mL purified bovine ZIP was dialysed for 7hr against 4L distilled water at 4°C with water 
changes at 1 and 3hr 50|iL dialysate was pre-incubated at 37°C with 50\\L of each of the 
buffers listed in TABLE 2 8 The concentration of each buffer was 50mM and the pH increments 
were 0 5 pH units The effect of pH on the inactivation of ZIP was determined by assaying 
these samples with 0 ImM Z-Gly-Pro-MCA in 4%v/v MeOH containing 500mM NaCl, as 
outlined in section 2 7 10
p H  R a n g e B u f f e r p H  Ad j u s t e r
2 0-6 0 
6 0-8 0
8 5-9 0
9 5-10 5
Citric acid 50mM potassium phosphate dibasic (K2HP04)
Potassium phosphate 50mM potassium phosphate monobasic (KH2PO4)
Tns 0 1MHC1
Glycine 0 lMNaOH
Ta b l e  2 8 B u f f e r  sy st e m s  u se d  in  pH In a c t iv a t io n  a n d  A c t iv a t io n  o f  ZIP
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2 9 4 2 pH Activation
The activation of ZIP at a range of pH values was determined in a manner similar to that 
outlined in section 2 94  1 50[iL dialysed enzyme was pre-incubated for 15min with 50|jlL 
buffer (TABLE 2 8) at 37°C Z-Gly-Pro-MCA was prepared in a range of 50mM buffer systems 
at various pH values 400fiL of each substrate was added to the appropriate sample buffer pH 
and ZIP activity was determined as detailed in section 2 7 10
2 9 5 Isoelectric Point Determination
2 9 51  Chromatofocusmg Chromatography
A 20mL polybuffer exchanger (PBE 94) column was poured (1 5cm x 10cm) and equilibrated 
with 300mL 50mM lmidazole/HCl pH 7 8 at lmL/min Polybuffer 74 was diluted 1 8 in 
distilled water and the pH adjusted to 4 5 using HC1 15mL of this was applied to the column 
at lmL/min, immediately after equilibration Post DEAE sepharose ZIP was dialysed 
overnight against 5L 50mM lmidazole/HCl pH 7 8 at 4°C Post-dialysis enzyme was applied to 
the top of the chromatofocusmg resin followed by 300mL polybuffer, pH 4 5 wash again at 
lmL/min 5mL fractions were collected throughout and assayed for ZIP activity using the 
microtitre plate assay as described in section 2 4 4 using the substrate preparation method 
described in section 2 7 10 The pH of each fraction was also measured and a plot of both 
fluorescent intensity and pH versus elution volume was constructed
29  5 2 Isoelectric Focusing
A vertical isoelectric focusing (IEF) gel was employed to determine the isoelectric point (pi) of 
ZIP Pre-cast gel, cathode and anode buffers were purchased from Novex Post DEAE 
sepharose ZIP was extensively dialysed (18hr) against 1L lOOmM potassium phosphate, pH 
7 4 at 4°C to remove contaminants and interferents with buffer changes after 3 and 6hr 
Dialysed samples were diluted with an equal volume of sample buffer (TABLE 2  9 )
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Isoelectric focusing markers were purchased from Sigma ( t a b l e  2 10) and reconstituted as 
directed Gels were prepared in an ATTO vertical electrophoresis system (160mm x 160mm x 
1mm) The bottom of the chamber was filled with lx  anode running buffer, the gels placed in 
position and the upper chamber filled with cathode buffer 20|iL of the prepared samples and 
markers were loaded into the wells under cathode buffer Electrophoresis was earned out at 
100V for 60min, 200V for 60min and 500V for 30min, the current running from 5mA- 
6mA/gel Staining was performed as described m TABLE 2 4 using bnlliant blue G colloidal 
stain and the image was captured using a UVP white /UV transluminator camera unit dnven by 
ImageStore 7500 software A standard curve representing the pi versus the Rf was 
constructed for each of the IEF markers electrophoresed The Rf represents the distance 
migrated by the standard or sample divided by the distance to the anoidic lip of the gel The pi 
of ZIP was estimated using the calibration curve by calculating its Rf value from the stained 
gel
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So l u t io n C o m p o sit io n
Anode buffer (50x) 4 7%w/v phosphoric acid
Cathode buffer (lOx) 3 5%w/v arginine, 2 9%w/v lysine
Sample buffer 20%v/v 10X cathode buffer 30%v/v glycerol
Ta b l e  2 9 IE F B u f f e r s  E m pl o y e d  f o r  p I D e t e r m in a t io n  o f  ZIP
M a r k e r So u r c e Pi
Amyloglucosidase Aspergillus mger 3 6
Trypsin Inhibitor Soybean 46
ß-Lactoglobulin A Bovine Milk 5 1
Carbonic Anhydrase II Bovine Erythrocytes 5 9
Carbonic Anhydrase I Human Erythrocytes 6 6
Myoglobin Horse Heart 6 8-7 2
Lentil Lectin Lens culmaris 8 2-8 8
Trypsinogen Bovine Pancreas 93
T a b l e  2 10 EEF M a r k e r s  E m p l o y e d  f o r  pi D e t e r m in a t io n  o f  ZIP
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2 9 6 Catalytic Classification
Stock solutions of a range of functional reagents were prepared, as presented in ta b le  2 11, 
to aid in the catalytic classification of ZIP All stock solutions were prepared in 50mM KH2P04 
or K2HPO4, or both, ensuring a final pH of 7 4 Water insoluble reagents were first dissolved in 
a minimum volume of acetone and then the volume and pH adjusted using the phosphate 
species Lower concentrations of each functional reagent were achieved using 50mM KH2P04 
or K2HP04, pH 7 4 ± acetone as appropriate (TABLE 2 11) 25mL post-DEAE sepharose ZIP 
was dialysed against 4L of 50mM potassium phosphate pH 7 4 overnight at 4°C 50|aL dialysed 
enzyme was pre-incubated for 15min at 37°C with an equal volume of each functional reagent 
under investigation Positive controls were included where the functional reagent was replaced 
with 50mM phosphate buffer, pH 7 4 contaimng the appropriate %v/v acetone as the 
corresponding reagent ZIP activity was determined fluonmetrically in triplicate as detailed in 
section 2 7 10 The fluorescent filtering effect of these functional reagents was assessed by the 
construction of unfiltered and filtered MCA standard curves as described in sections 2 2 1, 
2 2 2 and 2 7 10
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C l a ss Re a g e n t S t o c k  C o n c  1 P r e p a r a t io n
Serine protease inhibitors AEBSF 45mM Buffer
APMSF 20mM 5 %v/v acetone
Aprotimn 2 5mg/mL Buffer
Benzamidine 20mM Buffer
Leupeptin 2mM Buffer
PMSF 5mg/mL Buffer
Metallo-protease inhibitors 1 ,1 0-phenanthrohne3 40mM 10%v/v acetone
1,7-phenanthrohne3 30mM 10%v/v acetone
4,7-phenanthrohne3 40mM 10%v/v acetone
8-hydroxyquinohne3 20mM 5%v/v acetone
CDTA2 20mM Buffer
EDTA 40mM Buffer
EGTA2 20mM Buffer
Imidazole 20mM Buffer
Cysteine protease inhibitors DTNB 20mM Buffer
Iodoacetamide 20mM Buffer
Iodoacetic acid 40mM Buffer
NEM 20mM Buffer
Cysteine protease activators 2 -mercaptoethanol 2%v/v Buffer
DTT 20mM Buffer
T a b l e  2 11 R e a g e n t s  u se d  in  t h e  C a t a l y t ic  C l a s s if ic a t io n  o f  ZIP
Buffer is 50mM KH2P04 or K2HPO4, or both, ensuring a final composition of 50mM
potassium phosphate, pH of 7 4
1 Concentration of the functional reagent before added to the enzyme (1 e 2 x)
2 Samples had to be heated at 37°C to achieve dissolution
3 Samples had to be maintained at 50°C until diluted
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2 9.7 Effect of Other Functional Reagents
The effect of a range of other functional reagents on ZIP activity was also tested As in section 
2 9 6 all stock solutions were prepared in 50mM monobasic or dibasic anhydrous potassium 
phosphate or both with a final pH of 7 4 Addition of minimum volume acetone aided the 
dissolution of water-insoluble compounds and as before 50mM potassium phosphate pH 7 4 ± 
acetone was used as diluant 6mL of purified ZIP was dialysed against 2L of 50mM potassium 
phosphate pH 7 4 overnight at 4°C 50|iL dialysed enzyme was pre-incubated for 15min at 
37°C with an equal volume of each functional reagent to be tested Positive controls and 
blanks were included and ZIP activity was determined fluorimetncally in triplicate as detailed in 
section 2 7 10 The effect of fluorescent filtering by these functional reagents was assessed as 
outlined m section 2 2 2
R e a g e n t In h ib it s St o c k Pr e p a r a t io n
Antipain Papain, Trypsin 5mg/mL Buffer
Bacitracin Protein proteases 2mg/mL Buffer
Carnitine PO 20mM Buffer
Pepstatin A Pepsin, Renin 2mg/mL 5%v/v acetone
HIV-I protease
Puromycin Protein proteases 2mg/mL Buffer
Trypsin Inhibitor Trypsin 2mg/mL Buffer
T a b le  2  1 2 . P r e p a r a t io n  o f  O t h e r  F u n c t io n a l  R e a g e n t s  T e s t e d  
Buffer is 50mM KH2P 04 or K2HP04, or both, ensunng a final composition of 50mM 
potassium phosphate, pH of 7 4 Pepstatin A was initially dissolved in 100%v/v acetone and 
adjusted to stock concentration by addition of 50mM potassium phosphate buffer
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2.9 8 Effect of Metal Ions on ZIP Activity
The effects of metal salts on ZIP activity was assessed using Ca, Cd, Co, Cu, Mg, Mn, Hg, Na, 
Ni, Zn sulphates 2mM stock solutions were prepared in either 50mM Tns or 50mM potassium 
phosphate buffer as outlined in T a b le  2 13 The pH was adjusted to 7 4 using lOOmM HC1 or 
50mM KH2PO4 Post anion exchange ZIP was dialysed against 4L 50mM Tns or 50mM 
potassium phosphate buffer as appropnate for 5hr at 4°C 50|iL metal salt and 50|uL dialysed 
enzyme was pre-incubated in tnphcate at 37°C for 15min Negative controls had ImL 1 5M 
acetic acid added pnor to incubation while positive controls consisted of 50joL preparation 
buffer in place of the metal salt Following pre-incubation, substrate containing no sodium 
chlonde and prepared in either 50mM Tns/HCl or 50mM potassium phosphate buffer, pH 7 4 
was added and assayed as descnbed in sections 2 4 2
M e ta l C o n c e n t r a t io n Pr e p a r a t io n  a n d  D ia l y s is  B u f f e r
mM 50mM
CaS04 2 0 Tns/HCl
CdS04 2 0 Tns/HCl
CoS04 2 0 Potassium phosphate1
CuS04 2 0 Potassium phosphate
HgS04 2 0 Tns/HCl2
MnS04 2 0 Potassium phosphate3
MgS04 2 0 Tns/HCl
NaS04 2 0 Tns/HCl
NiS04 2 0 Tns/HCl
ZnS04 2 0 Tns/HCl
Ta b l e  2 13 Pr e p a r a t io n  o f  M e t a l  Sa l t s  T e st e d  o n  ZIP A c t iv it y
1 Heating at 37°C required
2 Initially dissolved in 1M HC1 then diluted with Tns, final pH 7 4
3 Readily falls out of solution
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2 9.9. Carbohydrate Analysis
A number of carbohydrate tests were performed to detect the presence of glycan moieties in 
purified ZIP
2 9 91 Fehlmg ’s Test for Reducing Sugars
Equal volumes of Fehhng’s solutions A and B were added 2mL of this Fehhng’s working 
solution were incubated with lmL dialysed ZIP at 100°C for 15min The assay was performed 
in triplicate and a control was included where the enzyme had been replaced by lOOmM 
potassium phosphate, pH 7 4 A bnck-red precipitate denoted the presence of reducing sugars
29  9 2 Mohsch, Glucose and Starch Tests
1 drop of Mohsch5 s reagent (10%w/v naphthol in 95 %v/v ethanol) was added to lmL dialysed 
ZIP, followed by the addition of 2mL concentrated sulphuric acid The presence of a violet 
colour at the junction of the two liquids denoted a positive test Chmstix reagent strips were 
used to detect the presence/absence of glucose in ZIP Three drops of I2/KI solution was 
added to lmL dialysed ZIP to test for starch A blue-black colour was indicative of the 
presence of starch
2 9 9 3 Glycoprotein Carbohydrate Estimation
A Pierce Glycoprotein Carbohydrate Estimation Kit was purchased to determine whether ZIP 
was a glycoprotein and subsequently to deduce the percentage of carbohydrate present lOmM 
sodium meta-penodate was prepared using the sodium meta-penodate and glycoprotein assay 
buffer provided Glycoprotein detection reagent was supplied and a 5%w/v solution was 
prepared in IN NaOH lmL glycoprotein assay buffer was used to reconstitute each vial of 
standard or negative control lmL post DEAE sepharose ZIP was dialysed against 3L lOOmM 
sodium phosphate containing 150mM NaCl, pH 7 2 at 4°C overnight The protein content of 
the dialysate was measured using the enhanced BCA assay (section 2 3 3 ) and ZIP was 
concentrated using PEG 6000 until the protein concentration was at 0 25mg/mL 50[iL 
sample, standard or control was placed in the well of a microtitre plate in triplicate 25 ^ L 
lOmM sodium meta-penodate was added to each well and the plate was mixed for 30seconds
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and incubated at room temperature for 10mm 150(iL glycoprotein detection reagent was then 
added to the wells followed by plate shaking and room temperature incubation for 60min A 
dark purple colour indicated the presence of carbohydrates The absorbance of each well was 
recorded at 550nm using a Tecan Spectra Plate Reader A calibration curve of absorbance at 
550nm versus total carbohydrate content was constructed for the standard and the percentage 
of carbohydrate in ZIP was estimated using the equation of the line
2 9 10 Ohgopeptidase Determination
Classification of ZIP as an ohgopeptidase was attempted using high performance liquid 
chromatography and fluorescence analysis a 2-macroglobuhn (ot2M), BSA and insulin B-chain 
were each prepared at a concentration of lmg/mL in lOOmM potassium phosphate, pH 7 4, the 
latter contaimng 10%v/v MeOH
2 9 10 1 Reverse Phase HPLC Analysis
Purified ZIP and PO from bovine serum and brain respectively were dialysed against lOOmM 
potassium phosphate, pH 7 4 overnight at 4°C 400|iL a 2M, BSA or insulin B-chain was 
incubated with 50p,L dialysed ZIP or PO at 37°C for 24hr Negative controls consisting of 
buffer in place of the enzymes and blanks were also included The assay was terminated by the 
addition of 2S\\L 0 5%v/v TFA The resulting solutions were analysed by lon-pair HPLC 
(Vanan Star model, coupled to a UV-VTS detector) A Techmcol Exsil 5 Ci8 analytical column 
(220mm x 4 6mm) coupled to a Beckman Ultrasphere 4 6mm x 4 5mm guard column, was 
employed The columns were equilibrated for 10mm with 70%v/v buffer A, 30%v/v buffer B 
(TABLE 2 14 for buffer compositions) at a flow-rate of lmL/min 20|oL of each post- 
mcubation sample, control and blank were applied at lmL/min followed by a 4mL wash of 
30%v/v buffer A, 70%v/v buffer B Elution was achieved by a 6mL linear gradient of 
increasing MeOH (30%v/v buffer A, 70%v/v buffer B to 0%v/v buffer A, 100%v/v buffer B), 
again at lmL/min The absorbance of the eluant was continuously monitored at 214nm A 
4mL wash of 100%v/v buffer B, succeeded by a lOmL equilibration was earned out between 
each injection
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C o m po n e n t B u f f e r à
%v/v
B u f f e r  B
%v/v
Ultra-pure Water 94 85 20 00
HPLC-grade MeOH 5 00 79 90
TFA 0 15 0 10
Ta b l e  2 14. B u f f e r  C o m p o sit io n  u s e d  in  HPLC A n a l y sis
Buffers were filtered through a 0 45 [am hydrophilic polypropylene membrane filter and
degassed prior to use
2 9 10 2 Fluorimetric Analysis
A range of dilutions of a2M were prepared in lOOmM potassium phosphate, pH 7 4 50piL 
purified ZIP which had been dialysed against phosphate buffer was added to 50^ iL of each oc2M 
dilution These samples were pre-incubated for 15min at 37°C prior to substrate addition and 
assaying as detailed in sections 2 4 2 and 2 7 10
2 9.11 Substrate Specificity
2 9 1 1 1  Ion-Pair Reverse Phase HPLC Analysis
HPLC analysis was earned out to determine the substrate specificity of ZIP towards a number 
of synthetic and naturally occurnng prohne-contaimng bioactive peptides A Vanan Star 
Chromatographic System was employed with a Techmcol Exsil 5 Cig analytical column 
(220mm x 4 6mm) and a Beckman Ultrasphere guard column (4 6mm x 4 5mm) TABLES 2 15 
and 2 16 list the prohne-contaimng peptides tested and the buffers required for their 
preparation lOOmM potassium phosphate, pH 7 4 was always used as diluant and in the cases 
of water-insoluble peptides, the substance was initially dissolved in a minimum volume solvent 
followed by phosphate buffer addition 400|iL of each prohne-contaming peptide was 
incubated with 50|iL punfied, dialysed ZIP or PO at 37°C for 24hr Negative controls (no 
enzyme) and blanks (no peptide) were also included 25|iL 0 5%v/v TFA was added to
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terminate the reaction after 24hr 20joL of each post-incubation sample, control and blank 
were applied at lmL/min to the column which had been equilibrated with 30%v/v buffer A, 
70%v/v buffer B (see TABLE 2 14 for buffer composition) A 4mL wash of 30%v/v buffer A, 
70%v/v buffer B was performed followed by a 6mL linear gradient elution from 30%v/v buffer 
A, 70%v/v buffer B to 0%v/v buffer A, 100%v/v buffer B at lmL/min A further 5mL wash of 
100%v/v buffer B was required to elute certain peptides from the Cig column The column was 
equilibrated between injections The absorbance of the eluant was continuously monitored at 
214nm
2 9 1 1 2  Cadmium Ninhydrin Assay
The cadmium ninhydrin assay is based on a modification of the method descnbed by Doi et a l , 
(1981) (see FIGURE 4 8 for reaction mechanism) This assay was performed in an attempt to 
determine whether or not ZIP could cleave a number of dipeptides 5mL purified ZIP and PO 
were dialysed against 2L lOOmM borate buffer, pH 7 4 for 4hr at 4°C Borate was chosen in 
preference to phosphate to minimise interference effects A range of dipeptides was prepared 
in lOOmM borate buffer, pH 7 4, as outlined in TABLE 2 17 IOjiL of each peptide was 
incubated with 50|iL ZIP or PO and 40|iL lOOmM borate pH 7 4 at 37°C for lhr The assay 
was terminated by the addition of 700juL of cadmium mnhydnn reagent and IOOjxL distilled 
water The cadmium mnhydnn reagent was prepared by dissolving 0 96g nmhydnn in 96mL 
ethanol and adding 12mL 100% acetic acid To this, 1 2g of cadmium chlonde which had been 
dissolved in 1 2mL distilled water was added The samples were incubated at 84°C for 5min 
and the absorbance read at 505nm Blanks were included which consisted of the cadmium 
mnhydnn reagent being added and the samples being heated to 84°C for 5nun pnor to the 37°C 
incubation Negative controls were also included where 50fiL of borate was added in place of 
enzyme
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Sy n t h e t ic  P e p t id e s C o n c e n t r a t io n
mM
Pr e p a r a t io n
Cyclo-(His-Pro) 5 0 Buffer
Gly-Ala-Phe 1 3 Buffer
Gly-Gly-Pro-Ala 2 0 10%v/v MeOH
Gly-Phe-Ala 5 0 Buffer
Gly-Pro-Ala 50 10%v/v MeOH
Lys-Ala-Ala 5 0 Buffer
Pyr-His-Gly 5 0 Buffer
Pyr-His-Pro 50 Buffer
Z-Gly-Pro-Ala 1 3 10%v/vMeOH
Z-Pro-Ala 1 3 10%v/vMeOH
Z-Pro-Gly 1 3 10%v/v MeOH
Z-Pro-Leu-Gly 1 3 10%v/v MeOH
Z-Pro-Pro 1 3 Buffer
T a b le  2.15 P r e p a r a t io n  o f  H PL C  S y n t h e t i c  P r o l i n e - c o n t a i n i n g  p e p t id e s  
Buffer refers to lOOmM potassium phosphate, pH 7 4 which was also used as the diluant for 
water insoluble peptides
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P e pt id e C o n c e n t r a t io n
mM
BUFFER
Aßl 28 0 15 50%v/v acetic acid
Aß M3 0 045 Buffer
Aß 25-3 5 0 2 0 4%v/v TFA
Angiotensin I 2 0 Buffer*
Angiotensin II 2 0 Buffer*
Angiotensin III 2 0 Buffer*
(Arg8)- Vasopressin 1 0 Buffer
Bradykinin 2 0 Buffer
(G1u2)-TRH 1 0 10%v/v MeOH
LHRH 2 0 10%v/v MeOH
Neurotensin 2 0 10%v/v MeOH
(Phe2)-TRH 2 0 10%v/v MeOH
Substance P 1 5 10%v/v 1 5M Acetic Acid*
TRH 1 3 10%v/v MeOH
TRH-Gly 2 0 10%v/v MeOH
T a b le  2  16* P r e p a r a t io n  o f  H PL C  b io a c t i v e  P r o l in e - c o n t a in in g  p e p t id e s  
Samples had to be sonicated in ultrasonic water bath to achieve complete dissolution Buffer 
refers to lOOmM potassium phosphate, pH 7 4 which was always used as diluant
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DIPEPTIDES C o n c e n t r a t io n PREPARATION
mM
Ala-Arg 5 0 Buffer
Ala-Gln 50 Buffer
Ala-Pro 50 Buffer
Arg-Ala 50 Buffer
Arg-Glu 50 Buffer
Asp-Lys 50 Buffer
Asp-Tyr 5 0 20%v/v MeOH
Glu-Lys 50 Buffer
Glu-Val 50 Buffer
Gly-Pro 5 0 Buffer
His-Pro 50 Buffer
Leu-Gly 50 Buffer
Lys-Ile 5 0 Buffer
Lys-Tyr 50 Buffer
Pro-Gly 50 Buffer
Pro-Leu 50 40%v/v MeOH
Pro-Pro 5 0 Buffer
Pyr-Ala 50 Buffer
Pyr-Gly 50 Buffer
Pyr-Phe 5 0 Buffer
Pyr-Val 50 Buffer
Z-Pro 5 0 20%v/v MeOH
T a b le  2 17 P r e p a r a t io n  o f  D ip e p t id e s  u se d  in  t h e  C ad m iu m  N in h y d r in  A s s a y  
Buffer refers to lOOmM borate, pH 7 4 which was also used as the diluant for water insoluble 
peptides
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2 9 1 1 3 Kinetic Analysis
2 9 113 1 Km determinations for Z-Glv-Pro-MCA
Stock solutions of 0 5mM Z-Gly-Pro-MCA in 15%v/v MeOH containing either 500mM NaCl 
or lOmM DTT were prepared 2 5mL lOmM Z-Gly-Pro-MCA in 100%v/v MeOH (section 
2 7 10), 5 625mL MeOH and 1 461g NaCl or 0 077g DTT were made up to a final volume of 
50mL with lOOmM potassium phosphate, pH 7 4 pre-warmed to 37°C Using these solutions 
a range of dilutions were prepared in lOOmM potassium phosphate buffer, pH 7 4 containing 
500mM NaCl or lOmM DTT Purified ZIP and PO were assayed with each concentration of 
the appropriate substrate in triplicate as outlined in sections 2 4 2 and 2 7 10 Various kinetic 
models were applied to the data and the Michaehs constant (KM) for ZIP and PO were 
estimated using Z-Gly-Pro-MCA (section 6 4 1)
2 9 11  3 2 K^Determinations for Prohne-contaming Peptides
The effect of a variety of prohne-contaming peptides on ZIP and PO activities for Z-Gly-Pro- 
MCA was determined The peptides tested and their preparation is outlined in TABLE 2 18 A 
500jliM stock solution of Z-Gly-Pro-MCA in 10%v/v MeOH was prepared containing either 
lOmM DTT or 500mM NaCl for PO or ZIP respectively A range of dilutions were prepared 
from 0-500|iM using lOOmM potassium phosphate, pH 7 4 containing lOmM DTT or 500mM 
NaCl as appropriate as diluant The MeOH concentration was maintained at 10%v/v lmL of 
peptide (tab le  2 18) was added to an equal volume of each substrate dilution ZIP and PO 
activities were assayed in triplicate using these mixtures (sections 2 4 2 and 2 7 10) The data 
was applied to a number of kinetic models and the inhibition constant (K,) and type of 
inhibition observed were determined as outlined in sections 6 4 2 and 6 4 3 respectively
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Peptide S to c k  C onc P rep ara tion  
mM
Assay Conc
mM
Aßi 43 0 09 Buffer 0 06
Angiotensin I 0 10 Buffer* 0 07
Angiotensin II 0 10 Buffer* 0 07
Angiotensin III 0 10 Buffer* 0 07
(Arg8)-Vasopressin 0 02 Buffer 0 01
Bradykinin 0 20 10%v/v MeOH 0 13
(Glu2)-TRH 0 02 10%v/v MeOH 0 01
LHRH 0 40 10%v/v MeOH 0 27
(Phe2)-TRH 0 40 10%v/v MeOH 0 27
Substance P 0 10 10%v/v 1 5M acetic acid 0 07
TRH 0 10 10%v/v MeOH 0 07
TRH-Gly 0 10 10%v/v MeOH 0 07
Gly-Gly-Pro-Ala 1 00 Buffer 0 67
Z-Gly-Pro-Ala 0 13 10%v/v MeOH 0 09
T ab le  2 18 P rep a ra tio n  o f  peptides f o r  K, d eterm in a tion s  
Buffer refers to lOOmM potassium phosphate, pH 7 4
* Samples had to be sonicated in ultrasonic water bath to achieve complete dissolution
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2 9 12 Inhibitor Studies
The potency of a range of peptidase-specific inhibitors towards ZIP and punfied PO was 
assessed T a b le  2 19 outlines the preparation and stock concentration of the inhibitors under 
investigation Stock solutions were diluted in lOOmM potassium phosphate, pH 7 4 (± solvent 
as appropriate) or distilled water to produce a range of serial dilutions of each inhibitor lmL 
of each dilution was added to lmL of double strength substrate, resulting in a final substrate 
concentration of 0 ImM Z-Gly-Pro-MCA in 4%v/v MeOH containing 500mM NaCl for ZIP 
and 0 ImM Z-Gly-Pro-MCA in 4%v/v MeOH containing lOmM DTT for PO IOOjiL of 
punfied ZIP or PO was incubated in tnphcate with 400|iL of appropnate substrate for lhr at 
37°C Suitable blanks and controls were included Due to a shortage of PO, only four inhibitor 
concentrations were tested for this enzyme The IC 50 for each inhibitor were determined for 
PO and ZIP as explained in section 6 5
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Inhibitor Stock Concentration
M
Preparation
Boc-Glu-(NHOB2)-Pyr 86x104 10%v/v DXN
Fmoc-Ala-Pro-CN lx lO 3 10%v/v MeOH
Fmoc-Pro-Pro-CN 2x10 4 10%v/v MeOH
Ile-Pyrrohdide * 1x103 10%v/v MeOH
Ile-Thiazohdide * lx lO 3 10%v/v MeOH
JTP-4819 25x 102 10%v/v MeOH
Postatm 8x10 4 20% v/v DXN
S-17092-1 1x105 Distilled water
S-19825 1x105 Distilled water
Z-Phe-Ala-CMK 5x105 10%v/v acetone
Z-Phe-Pro-Methylketone lxlO'3 Potassium phosphate
Z-Pro-Prohnal 5x105 10%v/v MeOH
Z-Pro-Prohnal dimethylacetate lx lO 3 10%v/v MeOH
Table 219. Preparation of Specific Inhibitors
All inhibitors listed are PO-specific except for * which are DPP IV inhibitors lOOmM 
potassium phosphate, pH 7 4 was used as diluant in the preparation of each stock solution, 
except for S-17092-1 and S-19825, which were prepared in 100%, distilled water
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3.0. R esults
3 0 RESULTS
The majority of upcoming graphs illustrate data points that represent the average of 
triplicate fluorescence or absorbance readings, minus the blank measurement All error 
bars represent the standard error of the mean of these triplicate values (see section 6 1)
3 1. MCA Standard C urves and th e  Inner F i l t e r  E f fe c t  
MCA standard curves were prepared as outlined in section 2 2 1 Plots of fluorescent 
intensity versus MCA concentration were constructed for both MCA ranges and the slope 
of the lines calculated F i g u r e s  3 11 and 3 1 2 represent typical MCA standard curves 
at emission slit widths of 5nm and lOnm respectively Demonstration of the inner filter 
effect was also performed as described in section 2 2 2  to assess the effect on 
fluorescence of including crude serum or post column fractions in the assay mixture 
F i g u r e s  3 13 and 3 14  are plots of fluorescence versus MCA concentration for crude 
serum and the post phenyl sepharose pool Graphs for post calcium phosphate cellulose 
and post DEAE are not shown since the inner filter effect was not observed for these 
samples TABLE 3 1 lists the slopes calculated for each curve and the degree of filtering 
observed for enzyme samples
Sample ................F .......... Slope Filtering
%
lOnm, 5nm
Buffer 0 998 68 82 0 0
Serum 0 999 58 99 14 3
Serum + 5x10 4M Z-Pro-Prohnal 0 995 59 03 14 2
Serum + 2 5x10 4M JTP-4819 0 997 59 07 14 2
Post-phenyl sepharose 0 999 65 99 4 1
lOnm, lOnm
Buffer 0 998 296 26 0 0
Post-calcium phosphate cellulose 0 997 295 81 0 2
Post DEAE 0 999 296 00 0 0
Table 3 1 Slopes of Filtered Standard Curves
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F ig u r e  3 11
700 —
4 6 8
MCA Concentration (fjM)
F ig u r e  3 12.
MCA Concentration (mM)
Figures 3 11 and 3 1 2  MCA Standard Curves
Plot of fluorescent intensity versus MCA concentration Excitation slit width was maintained 
at lOnm, while emission slit widths were 5nm and lOnm for F i g u r e s  3 11 and 3 1 2 
respectively
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F ig u r e  3 1 3
MCA Concentration ([ÌM)
Figure 3.1.4.
MCA Concentration (pM)
Figures 3 13 and 3.1 4 Filtered MCA Standard Curves
Plot of fluorescent intensity versus MCA concentration FIGURE 3 13 illustrates the filter 
effect for serum (•-•) and serum + Z-Pro-Prohnal (■-■) in comparison to unfiltered slope for 
buffer (o-o) F ig u r e  3 14  shows the filter effect for post CPC ZIP (•-•) versus unfiltered 
slope (o-o)
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3 2 Protein Determination
BSA standard curves were prepared according to the methods given in section 2 3 Plots 
of protein absorbance versus BSA concentration are presented in FIGURES 3 2 1 ,3  2 2  
and 3 2 3 for the Biuret, standard BCA and enhanced BCA assays respectively
3 3 MEASUREMENT OF Z-GLY-PRO-MCA DEGRADING ACTIVITIES IN SERUM 
Serum Z-Gly-Pro-MCA degrading activities were determined as outlined in sections 
2 4 2 and 2 4 3 Bovine serum was found to have 2459umts of Z-Gly-Pro-MCA 
degrading activity, which was equally attributable to PO (1232 units) and ZIP (1227umts) 
activities A unit of enzyme activity is defined as one picomole of MCA released per min 
at 37°C FIGURE 3 3 1 illustrates the presence of both PO and ZIP in crude bovine 
serum, differentiated by the addition of Z-Pro-Prohnal or JTP-4819
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F ig u r e  3.2 1
BSA Concentration (mg/mL)
F ig u r e  3 2 1 BSA St a n d a r d  Cu r v e
Plot of Absorbance at 570nm observed using the Biuret Assay versus BSA concentration
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F ig u r e  3 2 2
BSA Concentration (mg/mL)
F ig u r e  3 .2  3
BSA Concentration (ug/mL)
F ig u r e s  3 2 2. a n d  3 2 3 B SA  S ta n d a r d  C u r v e s
Plots of absorbance at 570nm versus BSA concentration FIGURE 3 2 2 was constructed 
using the BCA Assay, while f i g u r e  3 2 3 illustrates the use of the enhanced BCA Assay
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F ig u r e  3 3 1
3000
2500
% 2000 
3
*|  1500o
<
<L>6 1000¿3
500
0
F ig u r e  3 .3 1  Z -G ly -P r o -M C A  D e g r a d in g  A c t i v i t i e s  in  B o v in e  S eru m  
Plot showing the presence of two distinct enzymes capable of cleaving Z-Gly-Pro-MCA ZIP 
is represented by the residual activity □ towards the substrate in the presence of either Z-Pro- 
Prohnal or JTP-4819 PO is inhibited by both Z-Pro-Prolinal and JTP-4819 and so its activity 
is represented by the disappearance of Z-Gly-Pro-MCA degrading activity B in the presence 
of these inhibitors
PO Activity 
□  ZIP Activity
+ Buffer + Z Pro-Prolmal + jn M 8 19
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3.4 PURIFICATION OF BOVINE SERUM ZIP
3 4 1 Serum Preparation
9L fresh bovine whole blood was collected which resulted in the formation of 1 8L 
unclotted blood after 4°C storage for 24hr Centrifugation yielded 1 3L of serum
3 4 2 Phenyl Sepharose Hydrophobic Interaction Chromatography
The crude serum containing 200mM (NH^SC^ was applied to a phenyl sepharose 
hydrophobic interaction chromatography column as outlined in section 2 5 2 Two 
activity peaks were observed in the eluant from this column as shown in FIGURE 3 4 2 1, 
the first during the lOOmL lOOmM potassium phosphate wash containing 200mM 
ammonium sulphate, pH 7 4 and the second eluting with distilled water These activities 
are distinguished according to their sensitivity towards Z-Pro-Prolmal which is evident 
from FIGURE 3 4 2 2 Fractions 54-57 were combined to form a 20mL post-phenyl 
sepharose ZIP sample 2mL of this pool were retained for activity and protein 
determinations
3 4 3 Calcium Phosphate Cellulose Chromatography
The post-phenyl sepharose ZIP pool was further purified using calcium phosphate 
cellulose as outlined in section 2 5 3 The Z-Gly-Pro-MCA degrading peptidase bound to 
the column and eluted following application of an increasing phosphate gradient FIGURE 
3 4 3 illustrates the observed elution profile from the column Fractions 48-50 were 
pooled yielding 15mL of post-calcium phosphate cellulose pool 2mL of this pool were 
retained for activity and protein determinations
3 4 4 DEAE Sepharose Anion-Exchange Chromatography
Dialysed post-calcium phosphate cellulose pool was applied to a DEAE sepharose 
column as described in section 2 5 4 ZIP activity was detected in the bound fractions 
from this amon-exchange column The elution profile may be seen in FIGURE 3 4 4 A 
15mL post-DEAE sepharose pool was formed after combination of fractions 33-35 
inclusive 2mL were retained for estimation of enzyme recovery and protein 
determinations An average yield of 145|ig ZIP was obtained and stored at -17°C until 
required
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F ig u r e  3 4 2 1. Ph e n y l  Se p h a r o s e  E l u t io n  P r o f il e
Plot of fluorescent intensity (•-•), protein (---- ) and ammonium sulphate concentration versus elution volume
from phenyl sepharose resin Elution shows the presence of two distinct Z-Gly-Pro-MCA degrading activities in 
bovine serum which are separable by hydrophobic interactions chromatography
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FIGURE 3 4 2 2 PHENYL SEPHAROSE ELUTION PROFILE
Plot shows the differentiation of the two distinct Z-Gly-Pro-MCA degrading activities (• -• )  by the inclusion of Z-Pro-
Prolinal (o-o) ZIP activity, in fractions 54-57 (270-285mL) binds to the column and is insensitive to Z-Pro-Prohnal, 
while PO (fractions 6-13 (30-65mL)) runs through and is completely inhibited by Z-Pro-Prolinal
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F ig u r e  3 4 3 Ca l c iu m  Ph o s p h a t e  C e l l u l o se  C h r o m a t o g r a p h y  E l u t io n  P r o f il e
Plot of Z-Gly-Pro-MCA degrading activity (•-•), protein (---- ) and potassium phosphate concentration versus
elution volume Bound ZIP activity was eluted using an increasing linear gradient of phosphate Fractions 48-50 were 
pooled to form post calcium phosphate cellulose ZIP sample
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F ig u r e  3 4 4 DEAE S e p h a r o s e  E l u t i o n  P r o f i l e
Plot of Z-Gly-Pro-MCA degrading activity (•-•) , protein (---- ) and NaCl concentration versus elution volume
Bound ZIP activity was eluted isocratically using sodium chloride Fractions 33-35 were combined to form post DEAE 
sepharose ZIP pool 116
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A purification table was constructed to assess the overall effectiveness of the purification protocol ( t a b le  3 2 )  Calculations were 
performed as highlighted in section 6 3
P u r if ic a t io n  St a g e T o t a l  A c t iv it y
unit
T o t a l  P r o t e i n  
mg
Sp e c if ic
A c t iv it y
unit/mg
P u r if ic a t io n
F a c t o r
Y ie l d
%
Serum 5 29 1743 0 003 1 0 100
Post PS 4 5 23 94 0 188 63 85
Post CPC 3 74 0 764 4 895 1632 71
Post DEAE 1 75 0 145 12 07 4023 33
T a b l e  3 2 Pu r if ic a t io n  Ta b l e  f o r  B o v in e  Z IP
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3 5. Pu r it y  D e t e r m in a t io n
3 5 1 SDS Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis was performed as described in section 2 6 1 
F i g u r e s  3 5 1 and 3 5 2 represent images of the silver and brilliant blue stained gels 
respectively, showing molecular weight markers and the various post-column ZIP pools 
T a b l e  3 3 summarises the labels used to identify each of the markers on the gels and the 
relative molecular weight of each
3 5 2 The Activity of ZIP Using Fluonmetnc Substrates
The presence of contaminating peptidase activities in the purified ZIP pool was 
determined by the detection of the hydrolysis of a number of fluonmetnc substrates 
These substrates were prepared and tested as outlined in section 2 6 2 TABLE 3 4 
illustrates that no cleavage of these substrates was detected in the presence of purified 
ZIP activity
Su b st r a t e HYDROLYSIS Su b st r a te H y d r o l y sis
Ala-MCA No Na-benzoyl-Arg-MCA No
Arg-MCA No Pyr-His-Pro-MCA No
Glu-Phe-MCA No Pyr-MCA No
Gly-Pro-MCA No Pro-MCA No
Leu-MCA No Z-Arg-MCA No
Lys-Ala-MCA No Z-Gly-Pro-MCA Yes
Lys-MCA No Z-Phe-Arg-MCA No
Ta b l e  3 4 Pu r it y  A sse ssm en t  u s in g  F lu o r im et r y
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1. 2. 3. 4. 5. 6.
Figure 3.5.1. S ilv e r  Stained SDS P olyacry lam id e  G e l
L abel M arker M o l e c u l a r  W eig h t
kDa
I Myosin 205
II ß-Galactosidase 116
III BSA 66
IV Fumarase 48.5
V Carbonic anhydrase 29
T ab le  3.3. M o le c u la r  W eight M arkers used in SDS PAGE
119
L a n e  S a m p l e A   I
A  II
« «I
< IV
4— V
6. 5. 4. 3. 2. 1.
Figure 3.5.2. B r ill ia n t  B lu e  Stained SDS P olyacry lam id e  G e l
Label Marker Molecular Weight
kDa
I Myosin 205
II ß-Galactosidase 116
III BSA 66
IV Fumarase 48.5
V Carbonic anhydrase 29
T able 3.3. M o le c u la r  W eight M arkers used in SDS PAGE
1.
2.
3.
4.
5.
6.
Markers 
Serum 
Post PS 
Post CPC 
Post DEAE 
Markers
1 2 0
3 5.3. Purity Assessment Using Reverse Phase HPLC
The cleavage of fluorimetnc substrates was also investigated using HPLC analysis as an 
alternative means of elucidating the purity o f the enzyme Fluorimetnc substrates (tab le
2 4 )  were prepared and analysed as described in section 2 6 3  Liberated MCA from 
these substrates was identified based on the knowledge that MCA has a retention time of
3 lmin Table 3 5 summarises the results obtained, while FIGURES 3 5 3 1 , 3 5 3 2  and 
3 5 3 3 illustrate the lack of hydrolysis o f Pyr-His-Pro-MCA, Glu-Phe-MCA and Lys- 
Ala-MCA respectively by ZIP Figure 3 5 3 4 demonstrates the cleavage o f Z-Gly-Pro- 
MC A by purified ZIP
Su b st r a te H y d r o l y sis Su b st r a t e H y d r o l y sis
Ala-MCA No Na-benzoyl-Arg-MCA No
Arg-MCA No Pyr-His-Pro-MCA No
Glu-Phe-MCA No Pyr-MCA No
Gly-Pro-MCA No Pro-MCA No
Leu-MCA No Z-Arg-MCA No
Lys-Ala-MCA No Z-Gly-Pro-MCA Yes
Lys-MCA No Z-Phe- Arg-MCA No
T a b le  3 5. P u r i t y  A s s e s s m e n t  u s in g  HPLC
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Fig u r e  3 5 3 1
Tune (min)
F ig u r e  3 5.3 2
Time (min)
F ig u r e s  3 5 3 1 a n d  3 5 3 2 P u r it y  A sse ssm en t  U sin g  H PL C
Plots of fluorescent intensity versus time for ZIP incubated with substrate (___) and free
MCA (— ) Figure 3 5 3 1 represents the chromatograms for ZIP incubated with Pyr-His- 
Pro-MCA, while FIGURE 3 5 3 2 illustrates the chromatograms obtained for ZIP incubated 
with Glu-Phe-MCA
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F ig u r e  3.S.3.3.
Time (mm)
F ig u r e  3 5 3 4
Time (min)
F ig u r e s  3 5 3.3 . a n d  3 5 3 4 P u r i t y  A s s e s s m e n t  U s in g  HPLC
Plots of fluorescent intensity versus time Figure 3 5 3 3 represents the chromatograms of
Lys-Ala-MCA when incubated with ZIP (___) and free MCA (------ ) FIGURE 3 5 3 4
illustrates the chromatograms of free Z-Gly-Pro-MCA (— ) and that of ZIP incubated with Z- 
Gly-Pro-MCA (___) The liberated MCA peak is also shown
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3 6 A ssa y  D e v e l o pm e n t
3 6 1 Optimum MCA Excitation and Emission Wavelengths
Scans of fluorescence versus wavelength were performed on free MCA as outlined in 
section 2 7 1 in order to determine the optimum excitation and emission wavelengths for 
this compound FIGURES 3 6 11 and 3 6 12 show that the optimum excitation and 
emission wavelengths for MCA are 370nm and 440nm respectively
3 6 2 Substrate Solvent Determination
Stock substrates were prepared as outlined in section 2 7 2 in DMSO, DMF, DXN, EtOH 
and MeOH The effects of using these solvents on ZIP activity is illustrated in FIGURE 
3 6 2 Methanol was chosen to be the most suitable solvent and was thus used for 
subsequent substrate solubilisation
3 6 3 Solvent Concentration Determination
Figure 3 6 3 shows the effect o f increasing methanol concentration in substrate 
preparations on purified ZIP Although 2% and 3%v/v MeOH yielded higher activities of 
ZIP, the solubility of the substrate at these low concentrations was problematic, triplicates 
were poor and standard errors increased with decreasing methanol content Therefore 
4%v/v MeOH was chosen as the most suitable final solvent concentration in the substrate 
for the assaying of ZIP
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F ig u r e  3.6 1 1 .
Excitation Wavelength (nm)
FIGURE 3 6 1 2 .
Emission Wavelength (nm)
F ig u r e s  3.6 1.1. a n d  3 6.1.2. MCA E x c i t a t i o n  a n d  E m iss io n  S c a n s .
Plot of fluorescent intensity versus wavelength for free MCA in solution FIGURE 3 6 11 
illustrates an optimum excitation wavelength of 370nm for MCA while figu re 3 6 12 shows 
an emission wavelength o f 440nm as optimal
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F ig u r e  3 6.2
300
DMSO EtOH DMF DXN MeOH 
Substrate Solubilisation Solvent
F ig u r e  3 6  3
Control 2 3 4 5 6
Methanol Concentration (%)
F ig u r e s 3  6  2  a n d  3.6 3 O p t im a l S u b s t r a t e  S o l v e n t  a n d  S o l v e n t  C o n c e n t r a t io n  
Plot of enzyme activity versus substrate solubilisation solvent (FIGURE 3 6 2 )  FIGURE 3 6 3  
illustrates a plot of enzyme activity versus methanol concentration Enzyme activities are 
expressed as a percentage of the fluorescence observed using substrate solubilised in 4% 
DMSO
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3 6 4 Linearity of Enzyme Assays with Respect to Time
The linearity of the Z-Gly-Pro-MCA degrading activity assay as a function of time was 
examined as described in section 2 7 4 Figure 3 6 4 1 illustrates that ZIP activity in 
post DEAE purified sample is linear over a period of 60 minutes (R2 0 9997) Similarly, 
total Z-Gly-Pro-MCA activity in crude serum is linear (R2 0 9999) over the same time 
period (FIGURE 3 6 4 2 )  The activity o f ZIP in serum was assessed by the inclusion of Z- 
Pro-Prohnal, or JTP-4819 Figures 3 6 4 3 and 3 6 4 4 illustrate the linearity of ZIP in 
crude serum with respect to time using Z-Pro-Prohnal and JTP-4819, yielding regression 
coefficients of 0 9999 and 0 9989 respectively Continuous assays of post phenyl 
sepharose and post calcium phosphate cellulose ZIP also yielded linear progress curves 
with respect to time
3 6 5 Linearity of Enzyme Assays with Respect to Enzyme Concentration
Linearity of the Z-Gly-Pro-MCA degrading activity assays with respect to enzyme 
concentration was determined as outlined in section 2 7 5 FIGURE 3 6 5 indicates that 
the purified ZIP assay is linear (R2 0 9980) with respect to enzyme concentration
3 6.6. Optimum Assay Temperature
The effect of incubating purified ZIP at different temperatures was investigated according 
to section 2 7 6 The optimal temperature for the assay of bovine serum ZIP was 
determined to be 37°C as FIGURE 3 6 6 illustrates
3 6 7 Effect of DTT on ZIP Activity
The incorporation of DTT into Z-Gly-Pro-MCA was carried out as detailed in section 
2 7 7 FIGURE 3 6 7 illustrates the effect on purified ZIP activity of the inclusion of DTT 
into the substrate DTT inhibited ZIP activity with over 35% inhibition observed at 
20mM DTT
3.6 8. Effect of NaCI on ZIP Activity
The inclusion of NaCI in the substrate resulted in proportional enhancement of purified 
ZIP activity, up to a concentration of 400mM NaCI at which point the activity o f ZIP 
began to plateau Figure 3 6 8 shows the pattern observed
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F ig u r e  3 6.4 1
Time (min)
F ig u r e  3 6  4 2
Time (min)
F ig u r e s  3 6  4.1 a n d  3 6  4 2 L in e a r i t y  w i t h  R e s p e c t  t o  T im e
Plots of fluorescent intensity versus time FIGURE 3 6 4 1 shows the linearity of the assay 
using purified ZIP, while figure 3 6 4 2 illustrates linearity using crude serum
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F ig u r e  3 6 4 3.
Time (mm)
F ig u r e  3 6  4 4
Time (mm)
F ig u r e s  3 6  4 3 a n d  3 6  4 4 L in e a r i t y  w i t h  R e s p e c t  t o  T im e  
Plots of fluorescent intensity versus time for crude serum FIGURE 3 6 4 3 
maintenance of linearity on the inclusion of Z-Pro-Prohnal and FIGURE 3 6 4 4 
JTP-4819 does not effect the linearity of the enzyme assay with respect to time
illustrates 
shows that
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F ig u r e  3 6 5.
Enzyme Concentration (%)
F ig u r e  3 6.5 L in e a r i t y  w i t h  R e s p e c t  t o  E n zy m e  C o n c e n t r a t io n
Plot of fluorescent intensity versus enzyme concentration (100% enzyme represents
50|ig/mL)
F ig u r e  3 6 6
Assay Temperature (°C)
F ig u r e  3.6.6 O ptim um  A s s a y  T e m p e r a tu r e
Plot of enzyme activity versus temperature for purified ZIP Enzyme activity is expressed as 
a percentage of the fluorescence observed at 37°C
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F ig u r e  3 6 7
DTT Concentration (111M)
F ig u r e  3 6  8
0 200 400 600 800 1000
NaCl Concentration (mM)
F ig u r e s  3 .6  7 a n d  3.6.8. E ffe c t  o f  D T T  an d  N a C l  o n  ZIP A c t iv it y
Plots of enzyme activity versus DTT (FIGURE 3 6 7 )  or NaCl (FIGURE 3 6 8 )  concentration 
Enzyme activities are expressed as a percentage of fluorescence recorded with neither DTT 
nor NaCl
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3 6 9 Prolyl Oligopeptidase Inhibitor Studies
Initially Z-Pro-Prohnal was employed as the potent PO inhibitor in crude samples to 
differentiate the two distinct Z-Gly-Pro-MCA degrading activities FIGURE 3 6 9 1 
shows the inhibition profile observed on the incubation of PO with increasing 
concentrations of Z-Pro-Prohnal while FIGURE 3 6 9 8 verifies that PO cannot be further 
inhibited by increased pre-incubation
On depletion of this source a number of inhibitors were tested as outlined in section 
2 7 9 2 in an attempt to find one which could completely inhibit PO yet be ineffective on 
ZIP activity This was necessary to allow for the detection o f ZIP alone in crude samples 
containing both Z-Gly-Pro-MCA degrading activities FIGURES 3 6 9  2, 3 6 9  3, 3 6 9  4, 
3 6 9 5 , 3 6 9 6  and 3 6 9 7 show the inhibition of Z-Gly-Pro-MCA degrading activities 
in crude serum by Z-Pro-Prohnal dimethylacetate, Fmoc-Pro-Pro-CN, Fmoc-Ala-Pro- 
CN, Z-Indohnyl-Prohnal, postatin and JTP-4819 respectively FIGURE 3 6 9 9 shows the 
effect o f pre-incubating serum with JTP-4819
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F ig u r e  3 6 9 1
Z-Pro-Prolinal Concentration (M)
F ig u r e  3 6  9 2
1 0  10 1 0 9 1 0 -8  1 0  7 1 0 6  1 0 5 1 0 -4  1 0 3  I Q  2
Z-Pro-Prohnal Dunethylacetate Concentration (M)
F ig u r e s  3 6  9 1 a n d  3 6  9 2. E f f e c t  o f  Z - P r o - P r o l in a l  a n d  Z - P r o - P r o l in a l  
d i m e t h y l a c e t a t e  o n  Z -G ly -P r o -M C A  D e g r a d in g  A c t i v i t i e s  in  S eru m  
Semi log plots of enzyme activity versus specific inhibitor concentration Enzyme activity is 
expressed as a percentage of uninhibited enzyme (100%)
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F ig u r e  3 6 9 3
Fmoc-Pro-Pro-CN Concentration (M)
F ig u r e  3 .6.9.4.
1012 1011 1010 109 108 107 106 105 10-4 103 
Fmoc-Ala-Pro-CN Concentration (M)
F ig u r e s  3 6 9 3 a n d  3 6 9 4. E f f e c t  o f  F m o c -P r o -P r o  -CN a n d  F m o c -A la -P r o -C N  
o n  Z -G ly -P r o -M C A  D e g r a d in g  A c t i v i t i e s  in  S eru m
Semi log plots of enzyme activity (expressed as a percentage of uninhibited activity) versus 
specific inhibitor concentration
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F ig u r e  3.6 9 5
1015 10M 1013 1012 1011 1010 109 10-8 107 10-6 105 10^ 103 
Z-Indolinyl-Prolinal Concentration (M)
F ig u r e  3 6  9 6
Postatin Concentration (M)
F ig u r e s  3 6  9 5. a n d  3 6 9 6  E f f e c t  o f  Z - I n d o l in y l - P r o l in a l  a n d  P o s t a t i n  o n  Z- 
G ly -P r o -M C A  D e g r a d in g  A c t i v i t i e s  in  S eru m .
Semi log plots of enzyme activity versus specific inhibitor concentration Enzyme activity is 
expressed as a percentage of uninhibited activity (100%)
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F ig u r e  3,6 9 7
JTP4819 Concentration (M)
F ig u r e  3 6  9 7. E f f e c t  o f  JT P-4819 o n  Z -G ly -P r o -M C A  D e g r a d in g  A c t i v i t y  in  
S eru m .
Semi log plot of enzyme activity versus JTP-4819 Concentration Enzyme activity is 
expressed as a percentage of uninhibited enzyme (100% activity)
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F ig u r e  3 6.9.8.
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Pre-mcubation Time (mm)
F ig u r e s  3.6  9.8. a n d  3 6  9 9. E f f e c t  o f  P r e - in c u b a t io n  W it h  Z - P r o - P r o l in a l  o r  
JT P -4819 ON Z-GLY-PRO-M CA DEGRADING ACTIVITIES IN SERUM 
Plots of enzyme activity versus pre-incubation time F ig u r e  3 6 9 8 illustrates the effect of 
pre-incubating serum with Z-Pro-Prohnal over time, while FIGURE 3 6 9 9 shows the effect of 
pre-incubation with JTP-4819 over time Enzyme activity is expressed as a percentage of 
activity observed using no inhibitor
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3 7 L o c a l isa t io n  St u d ie s
Bovine tissue samples were obtained and homogenised as outlined in section 2 8 1 The 
resulting homogenate, pellet and two supernatants were assayed for both Z-Gly-Pro- 
MCA degrading activities using JTP-4819 as a potent inhibitor of PO activity (section
2 8 2 )  The effect of filtering was examined and FIGURES 3 7 1  to 3 7 6 represent the 
filtered standard curves for each fraction from brain, kidney, liver, lung, spleen and 
serum samples respectively T a b l e  3 6 lists the degree of filtering estimated from each 
filtered standard curve F ig u r e  3 7 7 shows the linearity o f the Biuret standard curve 
used to estimate total protein content in the samples Significant PO and ZIP activities 
were not detected in the pellets or in the second supernatants of any of the tissues T a b l e
3 7 summarises the units of enzyme activity, the total protein and the specific activity in 
each of the supernatant (SI) samples obtained for ZIP and PO (see section 6 2 for 
calculations) T a b l e  3 8 lists the percentage of the total Z-Gly-Pro-MCA degrading 
activity due to each peptidase FIGURES 3 7 8 and 3 7 9 graphically illustrate specific 
activities in the supernatant (SI) of each tissue for ZIP and PO respectively
B o v in e
Tissu e
D e g r e e  o f  f il t e r in g  o b se r v e d
%
Homogenate (H) Pellet (P) Supernatant (SI) Supernatant (S2)
Brain 56 40 23 15
K idney 55 22 31 16
L iver 52 23 45 23
L ung 45 23 41 16
Spleen 83 43 60 16
Serum - - 17 -
T a b le  3 6  F i l t e r i n g  E f f e c t s  o f  B o v in e  T is su e s
Degree of filtering is expressed as a percentage of the slope of the unfiltered standard 
curve constructed using lOOmM potassium phosphate buffer
138
F ig u r e  3 .7.1.
1000
2  4  6
MCA Concentration (uM)
Figure 3.7.2.
MCA Concentration (uM)
F ig u r e s  3.7.1. a n d  3.7.2. F i l t e r e d  MCA S ta n d a r d  C u r v e s
Plots of fluorescent intensity versus MCA concentration for various samples; unfiltered (•), 
Si (■), S2 (o), pellet (□) and homogenate (♦). FIGURE 3.7.1. represents filtering effects of 
these samples in brain tissue, while f i g u r e  3.7.2. in kidney tissue.
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F ig u r e  3 7 3.
MCA Concentration (pM)
F ig u r e  3 7 4
MCA Concentration (jiM)
F ig u r e s  3 7 3 a n d  3 7 4 F i l t e r e d  MCA S ta n d a r d  C u r v e s
Plots of fluorescent intensity versus MCA concentration for various samples, unfiltered (•), 
S2 (o), S1 (■), pellet (□) and homogenate (♦) FIGURE 3 7 3 represents filtering effects of 
these samples in liver tissue, while FIGURE 3 7 4 in lung tissue
140
F ig u r e  3 .7.5.
MCA Concentration (uM)
F ig u r e  3.7.6.
MCA Concentration (uM)
F ig u r e s  3.7.5. a n d  3.7.6. F i l t e r e d  MCA S ta n d a r d  C u r v e s
Plots of fluorescent intensity versus MCA concentration for various samples; unfiltered (•), 
S2 (o), SI (■), pellet (□) and homogenate (♦). F ig u r e  3.7.5. represents filtering effects of 
these samples in spleen tissue, while FIGURE 3.7.6. represents serum
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F ig u r e  3 7.7
Or-«n
cd
oL)
BSA C oncentration (m g/m L)
F ig u r e  3.7 7 BSA S ta n d a r d  C u r v e
Plot of absorbance at 570nm versus BSA concentration Biuret Assay standard curve 
employed for the estimation of protein content in tissue samples
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T issue
SI samples
ZIP
Brain
Kidney
Liver
Lung
Spleen
Serum
PO
Brain
Kidney
Liver
Lung
Spleen
Serum
T o t a l  A c t i v i t y  
unit
37 3 
172 0 
1189 
50 5 
44 3
122 7
565 3 
1071 8 
1601 4 
469 8 
846 0
123 7
mg
179
455
663
405
486
660
179
455
663
405
486
660
T o ta l  P r o t e in Sp e c if ic  A c t iv ity
umt/mg
0 209 
0 379 
0 179 
0 125
0 091 
0 186
3 158 
2 356 
2415
1 161 
1 741 
0 187
T a b le  3 7 ZIP a n d  PO A c t iv i t y ,  p r o t e in  a n d  S p e c if ic  A c t i v i t y  in  B o v in e  
E x t r a c t s
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F ig u r e  3.7 8
W)
1GA
Brain Kidney Liver Lung Spleen Serum 
Tissue
F ig u r e  3 7.9.
04  - r
Brain Kidney Liver Lung Spleen Serum 
Tissue
F ig u r e s  3 7 8 a n d  3 7 9 PO AND ZIP L e v e l s  in  t h e  Si F r a c t io n  o f  V a r io u s  B o v in e  
T issu e s
Plots of specific activity versus organ tissue Specific activity is a ratio of total protein to total 
enzyme activity F ig u re  3 7 8 shows PO levels and FIGURE 3 7 9 illustrates ZIP levels found 
in the range of organs
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T issu e
SI samples
ZIP A c t i v i t y
%
PO A c t i v i t y
%
Brain 6 94
Kidney 14 86
Liver 7 93
Lung 10 90
Spleen 5 95
Serum 50 50
T a b le  3 8  L e v e l s  o f  ZIP a n d  PO A c t i v i t i e s  in  V a r io u s  B o v in e  S a m p le s  
Activities are expressed as a percentage o f the total Z-Gly-Pro-MCA degrading activity 
(100%)
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3 8 C h a r a c t e r isa t io n
3 8 1 N-terminal Sequence Determination
SDS PAGE was performed as detailed in section 2 9 11 followed by electroblotting on 
to a PVDF membrane (section 2 9 1 2 )  The Ponceau S-stained blot was sent to Dr John 
S Gilroy, Department of Biological Sciences, University of Durham, South Rd, Durham 
DHI 3LE to be sequenced Despite many attempts, the N-terminal sequence o f ZIP could 
not be successfully determined An initial attempt at sequencing by Dr Brian Dunbar 
(Protein Sequencing Department, University of Dundee, Scotland) revealed the presence 
of two equimolar components with the following sequence following a run of six cycles 
on the sequencer
C y c l e  1 2 3 4 5 6
R e s id u e  ND Glu/Pro Asn/Gly Asn/Glu Gln/Arg Asn/Gln
3 8 2 Relative Molecular Mass Determination
3 8  2 1  S D S  P A G E
A non-native SDS gel was prepared as outlined in section 2 6 1 and employed to 
estimate the relative molecular weight of the purified ZIP activity The distance migrated 
by the bromophenol blue dye front was calculated to be 66mm and 69mm for the silver 
and colloidal blue stained gels respectively A plot of log of molecular weight versus 
relative mobility (Rf) was constructed for the five standards as described in section 
2 9 2 1 Figures 3 8 2 1 1 and 3 8 2 1 2 show the calibration curves obtained for the 
gels when stained with silver stain and brilliant blue respectively From the equations of 
the lines (TABLE 3 9 )  the molecular weight of ZIP was determined to be 87,8 lODa (silver 
stained gel) and 95,820Da (blue stain) It was deduced from this that ZIP is a dimer
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F ig u r e  3 8 .2 .1 1
Rf
F ig u r e  3 .8 .2 .1 2
Rf
F ig u r e s  3 8 2 1 1 a n d  3 8 2 1 2  SDS PAGE S ta n d a r d  C u r v e s  f o r  M o l e c u l a r  
W e ig h t  D e t e r m in a t io n
Plots of log molecular weight versus Rf value, where the Rf value is the distance migrated by 
the standard (•) or sample (o) divided by the distance migrated by the bromophenol dye front 
Figure 3 8 2 1 1 illustrates the standard curve constructed from the silver stained gel, while 
figure 3 8 2 1 2 shows that of the colloidal blue stained gel
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3 8 2 2 Size Exclusion Chromatography
The relative molecular mass o f purified ZIP was estimated using three different size- 
exclusion chromatography resins, namely sephacryl S-200, HiPrep sephacryl S-200 fast- 
performance and a Bio Sep SEC-3000 HPLC column Each of these columns was 
calibrated with a range of standards as outlined in sections 2 9 2 2 1  - 2 9 2 2 3  The 
void volume of the Sephacryl S-200 was 81mL, the HiPrep Sephacryl S-200 was 36mL 
while that of the BioSep SEC-3000 was 5 69mL This allowed for the production of a 
calibration graph for each resin representing the log molecular weight versus V /V o as 
described in section 2 9 2 2 These graphs (FIGURES 3 8 2 2 1 , 3 8 2 2 2  and 3 8 2 2 3 ) 
were then used to estimate the molecular weight of purified ZIP TABLE 3 9 shows the 
equation of the lines obtained and the deduced molecular weights obtained using PAGE 
and size exclusion chromatography
M eth o d E q u a t io n  o f  L ine
------------2 -----------------R M W
Da
SDS PAGE (silver stain) Log M W  - -0 92 (Rj) + 2 38 0 958 175,620*
SDS PAGE (blue stain) Log M W  = -0 84 (Rj) + 2 34 0 962 191,640*
Sephacryl S-200 Log M W  = -0 6(VJV0)  + 5 91 0 999 194,922
HiPrep sephacryl S-200 Log M W  - -0 95(V/Vo) +6 32 0 977 172,288
BioSep SEC-3000 Log M W  - - 10 41 (V/V0)  +6 03 0 976 164,369
Ta b l e  3.9. M o l e c u l a r  w e ig h t s  d e t er m in e d
* These molecular weights are estimated based on the SDS PAGE indication that ZIP is a 
hetero-dimer
The average molecular weight was determined to be 179,768 ± 1 l,670Da
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Fig u r e  3 .8 .2  2 1
V„/V„e o
F ig u r e  3 8.2.2 2
ve/v0
F ig u r e s  3 8  2 2.1 a n d  3 .8 .2 2 2. S iz e  E x c lu s io n  C h r o m a to g r a p h y  S ta n d a r d  C u r v e s  
f o r  M o l e c u l a r  W e ig h t  D e t e r m in a t io n
Plots of log molecular weight versus Ve/V0, where Ve is the elution volume of the standard (•) or 
sample (o) and V0 is the void volume Figure 3 8 2 2 1 illustrates the standard curve constructed 
using Sephacryl S-200, while FIGURE 3 8 2 2 2 shows that of a HiPrep Sepahcryl S-200 resin
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F ig u r e  3 .8 .2 .2  3
5 25
| 500 £
%
1  4 7 5  
I
j ?  4 50 
4 25 
4 00
5 50
0
F ig u r e s  3 82 23 S iz e  E x c lu s io n  C h r o m a to g r a p h y  S ta n d a r d  C u r v e  f o r  
M o l e c u l a r  W e ig h t  D e t e r m in a t io n
Plot of log molecular weight versus V JV 0, where Ve is the elution volume of the standard (•) 
or sample (o) and V0 is the void volume of the column (5 69mL) A HPLC BioSep SEC- 
3000 column was employed
15 2 0  2 5  3 0  3 5  4
ve/vo
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3 8 3 Thermostability Studies
3 8 31 Stability at Various Temperatures over Time
The effect of pre-incubating ZIP at a range of temperatures for different times prior to 
assaying at 37°C was investigated as described in section 2 9 3 1 Figure 3 8 3 1 
illustrates that ZIP activity is completely inhibited by pre-incubation at 60°C, however 
70% enzyme activity remains after 55min pre-incubation at 50°C ZIP is unaffected by 
pre-incubation at temperatures less than 50°C
3 8 3 2 Overnight Stability
The stability of ZIP at 37°C over 24hr was examined as outlined in section 2 9 3 2 
Enzyme activity remained relatively stable over this time frame, with a maximum loss of 
30% activity after 4hr However ZIP activity was restored following further incubation 
for 24hr Figure 3 8 3 2 illustrates the activity profile at 37°C overnight for purified 
ZIP
3 8 4 p H  E f f e c t s
The effects o f pH on ZIP activity were monitored in two ways Primarily, ZIP was 
incubated at a range of pH values and then assayed for activity as described m section 
2 9 4 1 This inactivation of ZIP is graphically illustrated in FIGURE 3 8 4 1 The bell- 
shape curve illustrates inhibition of enzyme activity at pH 2 0 and pH 10 5 Above pH 
2 0, ZIP is surprisingly active with 70% activity being observed, similarly at pH 10 0 
ZIP is insensitive to pH inactivation between pH 4 0 and pH 8 0
The activation of ZIP by pH was also assessed as described in section 2 9 4 2 where the 
enzyme was incubated with substrates prepared in a range of pH values FIGURE 3 8 4 2 
illustrates this pH activation profile, suggesting activity is optimum between pH 7 4 and 
pH 8 0 The enzyme exhibits a slight preference towards a potassium phosphate 
buffering system
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F ig u r e  3.8 3 1
Time (min)
F igure 3 8.3.2.
Time (mm)
F igures 3.8 3 1 and 3.8 3 2 Thermostability Studies
Plots of enzyme activity versus time at various temperatures Figure 3 8 3 1 shows the 
stability of ZIP at 20°C (o), 37°C (•), 40°C (a), 50°C (♦) and 60°C (□) over time Enzyme 
activity is expressed as a percentage of unheated enzyme FIGURE 3 8 3 2 illustrates the effect 
of a 24 hour pre-incubation on ZIP activity
152
F ig u r e  3 8 4 1.
pH of Incubation
F ig u r e  3 8  4 2
pH of Incubation and Substrate Buffer 
F ig u r e s  3 8  4 1 a n d  3 8  4.2 pH  E f f e c t s  o n  ZIP
Plots of enzyme activity versus pH Buffers tested were citrate (o), phosphate (•), Tns (□) 
and glycine (■) F ig u re  3 8 4 1 represents the pH inactivity profile of ZIP while FIGURE 
3 8 4 2 corresponds to the pH activation of ZIP Enzyme activity is expressed as a 
percentage of activity obtained at pH7 4 which is represented as 100%
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3 8 5 Isoelectric Point Determination
3 8 51 Chromatofocusing
A PBE 94 chromatofocusing resin was employed in an attempt to determine the 
isoelectric point of ZIP as described in section 2 9 5 1 The elution profile obtained from 
this column can be seen in FIGURE 3 8 5 1 ZIP activity was eluted in a decreasing linear 
pH gradient and activity was detected in fractions 78-83 inclusive corresponding to a pH 
of between 5 5 and 5 8 The pH of this pool was measured to be 5 7, which was taken to 
be the pi o f bovine ZIP
3 8 5 2 Isoelectric Focusing
A vertical EEF acrylamide gel was run as outlined in section 2 9 5 2 and stained with 
brilliant blue G colloidal FIGURE 3 8 5 2 represents the stained gel image showing the pi 
markers and purified ZIP The relative mobility (Rf) of each standard and ZIP was 
calculated as described in section 2 9 5 2 The distance to the anoidic edge of the plate 
was 7 1cm A plot of Rf versus pi was constructed (FIGURE 3 8 5 3 ) and the pi o f ZIP 
was estimated using the following equation of the line
p i = -4 47 xRf+ 7 62
The pi of ZIP was calculated to be 5 68
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F ig u r e  3 8 5 1
8
6
5
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Elution Volume (mL)
F ig u r e  3 8 5.1. C h r o m a to fo c u s d v g  E l u t i o n  P r o f i l e
Plot of fluorescent intensity ( • - • )  and pH (— ) versus elution volume
zzu
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Figure 3.8.5.2.
F ig ur e  3.8.5.3.
Rf
Fig u r es  3.8.5.2. an d  3.8.5.3. Iso e l ec tr ic  Fo c u sin g
Figure 3.8.5.2. represents a copy o f the isoelectric focusing gel produced. The distances 
migrated by each standard or sample was calculated and divided by the length o f the plate to 
yield a R f value. These values for standards ( • )  and samples ( o )  are plotted versus pi in 
F igure 3.8.5.3.
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3 8 6 Catalytic Classification
The effect of various functional reagents on ZIP activity was investigated as outlined in 
section 2 9 6 T a b le s  3 10, 3 11, 312 and 3 13 outline residual ZIP activity following 
incubation with a range of serine protease inhibitors, metallo-protease inhibitors, cysteine 
protease inhibitors and cysteine protease activators respectively Residual enzyme 
activity is expressed as a percentage of positive control activity where no functional 
reagent was added (represented as 100% activity) The concentration listed is the 
concentration of functional reagent in the pre-incubation mixture (lOOjoL) These results 
suggest that ZIP is inhibited by the serine protease inhibitors, AEBSF (58% inhibition at 
22 5mM) and aprotmin, (35% inhibition at 1 25mg/mL) 1,7-phenanthroline inhibited ZIP 
by 77% at 30mM, while 20mM 4,7-phenanthroline caused 90% inhibition The cysteine 
protease inhibitors, DTNB and NEM inhibited activity by 60% and 47% respectively at 
concentrations of lOmM
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Ser in e  Pr o t e a se  C o n c e n t r a t io n  R e sid u a l  ZIP
In h ib it o r  A c tivity
%
AEBSF 22 50mM 42 49
1125mM 50 06
4 50mM 64 66
2 25mM 67 18
APMSF 10 OOmM 95 74
5 OOmM 93 75
2 50mM 92 20
1 25mM 90 65
Aprotinm 1 25mg/mL 66 56
0 63mg/mL 68 27
0 25mg/mL 73 12
0 13mg/mL 79 30
Benzamidine 10 OOmM 90 27
5 OOmM 90 41
1 OOmM 98 68
Leupeptin 1 OOmM 97 52
0 50mM 93 76
0 26mM 98 13
PMSF 2 50mg/mL 95 47
1 25mg/mL 97 15
0 50mg/mL 99 34
0 25mg/mL 106 94
T a b l e  3 .10 E f fe c t s  o f  Ser in e  Pr o t e a se  In h ib it o r s
%
0 28
4 26 
9 94 
0 06
9 78
2 97
3 49 
1 05
3 77
0 23
1 13 
8 65
1 20
2 87
5 42
2 01
2 25
3 57
2 27 
1 58
3 67 
3 37
St a n d a r d  E r r o r
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M e ta ll o - C o n c e n t r a t io n R e sid u a l  A ctivity St a n d a r d  E rr o r
pr o t e a se
In h ib it o r mM % %
1,10-phenanthrohne 20 00 96 73 5 24
10 00 100 94 7 75
5 00 100 79 0 42
1 00 102 87 1 67
1,7-phenanthroline 30 00 23 32 2 22
7 50 55 09 5 38
3 75 76 38 7 79
0 75 76 65 0 47
4,7-phenanthroline 20 00 9 56 1 90
10 00 10 43 0 28
5 00 28 30 1 57
1 00 98 67 4 41
8-hydroxyquinoline 10 00 91 57 2 29
5 00 96 77 6 12
2 50 98 64 231
CDTA 10 00 69 64 4 65
5 00 80 51 3 88
1 00 85 91 1 85
EDTA 20 00 86 04 2 91
10 00 86 37 0 26
5 00 88 94 0 16
1 00 95 99 0 44
EGTA 10 00 92 82 1 82
5 00 96 13 4 14
1 00 94 73 2 65
Imidazole 10 00 85 20 2 93
5 00 106 01 7 99
1 00 93 27 0 10
Ta b l e  3 11 E f fe c t s  o f  M e t a l l o -p r o t e a se  In h ib it o r s
159
C y ste in e C o n c e n t r a t io n R e sid u a l  ZIP St a n d a r d  E r r o r
Pr o t e a se A c tivity
In h ib it o r mM % %
DTNB 10 0 39 26 5 89
5 00 58 56 4 84
1 00 79 82 7 53
NEM 10 00 53 22 2 60
5 00 72 82 2 50
1 00 77 66 3 20
Iodoacetamide 10 00 90 31 2 65
5 00 85 63 2 71
1 00 88 94 1 58
Ta b l e  3 .12 E f fe c t s  o f  Cy s t e in e  Pr o t e a se  In h ib it o r s
C y ste in e C o n c e n t r a t io n R e sid u a l  ZIP St a n d a r d  E r r o r
Pr o t e a se A c tivity
A c tiv a t o r mM % %
2-mercaptoethanol 10 00 78 56 2 22
5 00 74 69 2 46
1 00 79 08 4 11
DTT 10 00 95 61 1 05
5 00 97 27 1 41
1 00 79 29 2 94
T ab l e  3 13 E ffe c t s  o f  C y ste in e  Pr o te a se  A ct iv a t o r s
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3 8 7 Effect of Other Functional Reagents
The effect of a range of other functional reagents on ZIP activity was also examined as 
outlined in section 2 9 7 The residual activities and standard error of the means detected 
following incubation with these reagents are listed in TABLE 3 14 2 5mg/mL antipain,
lmg/mL bacitracin, lmg/mL pepstatin A and lmg/mL puromycin inhibited ZIP by 55%, 
41%, 42% and 41% respectively Carnitine and trypsin inhibitor had no effect on enzyme 
activity
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F unctional
R ea g en t
C o n c en tr a tio n R e s id u a l  ZIP 
A c t i v i t y
%
Standard  E r r o r
%
Antipain 2 50mg/mL 
1 25mg/mL 
0 50mg/mL
45 70 
54 13 
58 33
4 37 
0 74 
3 56
Bacitracin 1 OOmg/mL 
0 50mg/mL 
0 lOmg/mL
58 58 
69 27 
73 55
2 48
0 89
1 24
Carnitine lOOOmM 
5 OOmM 
1 OOmM
96 27 
85 81 
78 21
8 53 
0 55 
4 97
Pepstatin A 1 OOmg/mL 
0 50mg/mL 
0 20mg/mL
57 94 
79 22 
72 81
1 70 
3 72 
1 15
Puromycin 1 OOmg/mL 
0 50mg/mL 
0 20mg/mL
59 18 
66 25 
68 30
4 26 
1 13 
1 29
Trypsin Inhibitor 1 OOmg/mL 
0 50mg/mL 
0 lOmg/mL
131 58 
101 98 
94 12
21 08 
5 05 
5 71
T a b l e  3  14 E ffe c t  o f  Ot h e r  F u n c t io n a l  R e a g e n t s
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3.8 8 Effect of Metal Ions on ZIP Activity
The effect of metal salts on purified ZIP activity was investigated by incorporating the 
metal salts into the fluorimetric assay as outlined in section 2 9 8 The results are 
presented in TABLE 3 15 HgS(> 4  had the most detrimental effect on activity, with a loss 
of 66% activity, followed by zinc, manganese, cadmium, sodium and calcium sulphates
M eta l  Su l ph a t e Z IP R e sid u a l  A c t iv ity St a n d a r d  E r r o r
% %
Control 100 00 8 5x104
Cobalt 99 57 4 0x1 O'4
Copper 97 53 5 1x104
Nickle 92 86 6 9x1c4
Magnesium 92 66 7 6 x 1 0 4
Calcium 70 38 5 5x104
Sodium 69 72 5 6x1 O’4
Cadmium 63 57 6 9x1 O’4
Manganese 61 10 6 6 x 1 0 4
Zinc 56 60 6 2x1 O’4
Mercury 44 29 2 lxlO-4
T a b l e  3 15 E ffe c t  o f  M eta l  Io n s  on  ZIP A c t iv ity
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3 8 9 Carbohydrate Analysis
3 8 9 1  Fehling 's Test for Reducing Sugars
The Fehling’s test for reducing sugars was performed as outlined in section 2 9 9 1 
Following 15min incubation at 100°C, the formation of a brick red precipitate was 
observed, indicating the presence of reducing sugars in the enzyme sample
3 8 9 2 Mohsch, Glucose and Starch Test
Purified ZIP was tested for carbohydrates using the Mohsch test and was also tested for 
glucose and for starch as outlined in section 2 9 9 2 The addition of Mohsch’s reagent to 
ZIP followed by sulphuric acid addition produced a violet colour at the junction of the 
two liquids, indicating a positive result ZIP tested negative for both glucose and starch
3 8 9 3 Glycoprotein Carbohydrate Estimation
The classification of ZIP as a glycoprotein was determined using a Pierce glycoprotein 
estimation kit as described in section 2 9 9 3 Figure 3 8 9 shows the standard curve 
constructed on plotting total carbohydrate content versus absorbance at 550nm for each 
of the standards The absorbance of ZIP was measured and the total carbohydrate content 
estimated using the following equation of the line
Total carbohydrate content = 4 06 x absorbance at 550nm + 0 43
ZIP was determined to be a glycoprotein according to this kit with 33% total 
carbohydrate content
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F ig u r e  3 8 9.
O '
i?o
3o
0 2 4 6  8  10 12
Absorbance at 550nm
F ig u r e  3.8 9 G l y c o pr o t e in  C a r bo h y d r a t e  E st im a t io n
Plot of total carbohydrate content versus absorbance at 550nm for various glycoproteins ( • )  
and ZIP (O)
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3 8 10 Oligopeptidase Determination
3 8 10 1 Reverse Phase HPLC Analysis
Ion-pair HPLC was performed as outlined in section 2 9 10 1 on three peptides, namely 
0C2M, BSA and insulin B-chain, to determine whether or not ZIP was an oligopeptidase 
FIGURES 3 8 1 0 1 , 3 8 1 0 2  and 3 8 10 3 are the chromatograms illustrating the failure 
of ZIP to cleave (X2M, BSA and insulin B chain respectively PO, a known 
oligopeptidase, also failed to cleave any of the tested peptides (results not shown)
3 8 10 2 Fluorimetric Analysis
Purified ZIP and PO were incubated with a range of 012M concentrations as described in 
section 2 9 10 2 F ig u r e s  3 8 10 4 and 3 8 10 5 highlights the inhibition profiles 
observed It is clearly evident that neither PO nor ZIP was inhibited by (X2M, although a 
slight activation ofPO was evident with increasing concentrations of the macroglobulin
3 8 11 Substrate Specificity
3 8111  lon-Pair Reverse Phase HPLC
The ability of purified ZIP and PO activities to hydrolyse a range of synthetic and 
bioactive peptides was investigated using ion-pair HPLC as outlined in section 2 9 111 
T a b le  3 16 lists the peptides which were tested and whether or not cleavage was 
detected The cleavage of Angiotensin I, Angiotensin II, LHRH and TRH by both PO 
and ZIP can be seen in the chromatograms of absorbance versus retention time in 
FIGURES 3 8 1 1 1  to 3 8 1 1 8  respectively Cleavage products are highlighted
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F ig u r e  3 8 10 1.
T i m e  f tn i f r i
F ig u r e  3 .8.10 2
0 2 4 6  8  10
Time (mm)
F ig u r e s  3 8  10 1. a n d  3 8.10.2. O l ig o p e p t id a s e  D e t e r m in a t io n
Plots of absorbance at 214nm versus time for peptide (- -) and peptide ZIP incubation (___)
Figure 3 8 10 1 illustrates the failure of ZIP to cleave a2-macroglobulin while FIGURE 
3 8 10 2 shows that ZIP also fails to cleave bovine serum albumin
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F ig u r e  3 8 10 3
Time (mm)
F ig u r e  3 8  1 0  3 O l ig o p e p t id a s e  D e t e r m in a t io n
Plot of absorbance at 214nm versus time for insulin B chain (----- ) and ZIP incubated with
insulin B chain (____ )
F ig u r e  3 8 10 4
Alpha-2-macroglobulin Concentration (ing/mL)
F ig u r e  3 8 1 0  5
Alpha-2 -macroglobulm Concentration (mg/mL)
F ig u r e s  3 8.10.4. a n d  3 8  10 5 c x i-M a c r o g lo b u lin  T e s t  f o r  O l ig o p e p t id a s e s  
Plot of enzyme activity versus ot2M concentration for ZIP ( f ig u r e  3 8 10 4 )  and PO ( f ig u r e  
3 8 10 5 )
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P e p t id e  H y d r o ly s i s  b y  PO H y d r o ly s i s  b y  Z IP
Aß! 28 No No
Aß 143 No No
Aß25-35 No No
Angiotensin I Yes Yes
Angiotensin II Yes Yes
Angiotensin in  Yes Yes
(Arg8)-Vasopressin No No
Bradykinin Yes No
(G1u2)-TRH Yes No
LHRH Yes Yes
Neurotensin No No
(Phe2)-TRH Yes No
Substance P No No
TRH Yes Yes
TRH-Gly Yes No
CycJo (His-Pro) No No
Gly-Ala-Phe No No
Gly-Gly-Pro-Ala No No
Gly-Phe-AJa No No
Gly-Pro-Ala No No
Lys-Ala-Ala No No
Pyr-His-Gly No No
Pyr-His-Pro No No
Z-Gly-Pro-Ala Yes Yes
Z-Pro-Ala No No
Z-Pro-Gly No No
Z-Pro-Leu-Gly No No
Z-Pro-Pro No No
Ta b l e  3 1 6 .  Io n-P a i r H PLC  Su b st r a t e  Sp e c ific it y  A n a l y sis
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Fig u r e  3 8 1 1 1
90
3=- 80
70
I  60 ,
50
40
Retention Time (mm)
F ig u r e  3 8 1 1 2
90
60
50
40
O
Retention Time (min)
Fig u r e s  3 8 1 1 1  an d  3 8 1 1 2  Io n -p a ir  H PL C  Su b st r a t e  Spe c if ic it y  Stu d ie s
Plots of absorbance at 214nm versus time for Angiotensin I (---- ) and enzyme incubated with
Angiotensin I (____ ) FIGURE 3 8 111 illustrates the cleavage of Angiotensin I by PO while
FIGURE 3 8 112 represents Angiotensin I cleavage by ZIP Cleavage products are denoted *
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F ig u r e  3 .8 .1 1 3
65  7 0  75 8 0  85 90 95
Retention Time (min)
F ig u r e  3 8.11 4
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-  i t i i 1___  I___1___L
78
72
—  66
—  60
—  54
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Retention Time (mm)
F ig u r e s  3 8.11.3. a n d  3.8.11.4. Io n -p a ir  HPLC S u b s t r a t e  S p e c i f i c i t y  S tu d ie s  
Plots of absorbance at 214nm versus time for Angiotensin II (— ) and enzyme incubated with
Angiotensin II (____ ) Figure 3 8 113 shows Angiotensin II cleavage by PO while figure
3 8 114 illustrates the cleavage of Angiotensin II by ZIP Cleavage products are denoted *
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F ig u r e  3 8 11 5.
Retention Tune (nun)
F ig u r e  3 8 1 1 6
Retention Time (mm)
F ig u r e s  3.8.11.5. a n d  3.8.11.6. I o n -p a ir  HPLC S u b s t r a t e  S p e c i f i c i t y  S tu d ie s  
Plots of absorbance at 214nm versus time for LHRH ( ) and enzyme incubated with LHRH
( ) Figure 3 8 115 illustrates cleavage by PO while figure 3 8 116 represents LHRH
cleavage by ZIP Cleavage products are denoted *
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F ig u r e  3 .8.11.7.
Retention Time (min)
F ig u r e  3.8.11.8.
50
45
4 0  Ì4)
35 ^
30
25
3.0 3.5 4.0 4.5 5.0 5.5 6.0
Retention Time (min)
F ig u r e s  3.8.11.9. a n d  3.8.11.10. Io n -p a ir  HPLC S u b s t r a t e  S p e c i f i c i t y  S tu d ie s
Plots of absorbance at 214nm versus time for TRH (--) and enzyme incubated with TRH ( ).
FIGURE 3.8.11.7. illustrates TRH cleavage by PO while FIGURE 3.8.11.8. represents the 
cleavage o f TRH by ZIP. Cleavage products are denoted *.
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3 8112  Cadmium Ninhydrin Assay
The ability o f ZIP to cleave a number of dipeptides was examined using the cadmium- 
nmhydnn assay as outlined in section 2 9 112 Spectrophotmetric analysis at 504nm of 
samples and blanks allowed for the detection of cleavage products, recognisable as an 
increase in absorbance The affinity of ZIP towards these dipeptides could be quantified 
on construction of free amino acid standard curves, however as TABLE 3 17 illustrates, no 
cleavage was detected
Su b st r a te H y d r o l y sis Su b st r a te H y d r o l y sis
Ala-Arg No Leu-Gly No
Ala-Gln No Lys-Ile No
Ala-Pro No Lys-Tyr No
Arg-Ala No Pro-Gly No
Arg-Glu No Pro-Leu No
Asp-Lys No Pro-Pro No
Asp-Tyr No Pyr-Ala No
Glu-Lys No Pyr-Gly No
Glu-Val No Pyr-Phe No
Gly-Pro No Pyr-Val No
His-Pro No Z-Pro No
T a b l e  3  17 Ca d m iu m -N in h y d r in  A ssay  f o r  D ipe ptid e s
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3 8 1 1  3 Kinetic Analysis
3 8 113 1 Km Determinations for Z-Glv-Pro-MCA
The Km values for the reactions between Z-Gly-Pro-MCA and ZIP and between Z-Gly- 
Pro-MCA and PO were determined experimentally as described in section 2 9 113 1 
Km values were determined using Michaells-Menten, Lineweaver-Burk, Eadie-Hofstee 
and Hanes-Woolf analysis as described in section 6 4 1 T a b le  3 18 lists the Km values 
deduced using these models FIGURES 3 8 1 1 9  to 381 1  12 illustrate Michael ls-Menten, 
Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf plots for ZIP assayed using Z-Gly- 
Pro-MCA The same plots for PO assayed with Z-Gly-Pro-MCA are shown in FIGURES 
3 8 11 13 to 3 8 11 16
M o del K M FOR ZIP V maX K m FOr PO V maX
juM Fluorescent juM Fluorescent
units units
Michaelis-Menten (MM) 50 36 80 450
Lineweaver-Burk (LB) 65 45 108 376
Eadie-Hofstee (EH) 57 37 102 562
Hanes-Woolf (HW) 41 ND 106 ND
Average 54 39 99 463
T a b le  3.18. K in e t ic  A n a ly s i s  o f  ZIP a n d  PO u s in g  Z -G ly -P r o -M C A
3 8 11 3 2 K, Determinations for Proline-containmg Peptides
The effect of the inclusion of various proline-containmg peptides on the kinetic 
interaction between enzyme activities and Z-Gly-Pro-MCA was determined as described 
in section 2 9 1 1 3 2  A Km value was determined for both ZIP and PO using the kinetic 
models described in section 3 8 113 1 Kapp values were graphically deduced for each of 
the proline containing peptides and subsequently a K, value was estimated for each of the 
peptides tested (see appendix, section 6 4 2 )  The nature of the inhibition was 
determined as outlined in section 6 4 3 The K, values for the ZIP and PO interactions 
studied are presented in t a b le s  3 19 and 3 20 respectively F ig u r e s  3 8 11 17 and
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F ig u r e  3 .8  11 9
Z-Gly-Pro-MCA Concentration (|xM)
F ig u r e  3 8 1 1 1 0 .
l/Z-Gly-Pro-MCA Concentration (fiM'1)
F ig u r e s  3 8 .11.9. a n d  3 8  1 1 1 0  K M d e t e r m in a t io n  f o r  ZIP U s in g  Z -G ly -P r o -M C A
F ig u re  3 8 119 represents the Michaelis-Menten plot (fluorescent intensity versus Z-Gly- 
Pro-MCA concentration) for ZIP F ig u re  3 8 11 10 illustrates a plot of 1/fluorescent 
intensity versus l/Z-Gly-Pro-MCA concentration (Lineweaver-Burk plot) for ZIP
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F ig u r e  3.8 II 11
Z-Gly-Pro-MCA Concentration (p.M)
F ig u r e  3,8 1112
Fluorescent Intensity/Z-Gly-Pro-MCA Concentration (jjM ')
F ig u r e s  3.8.11.11 a n d  3 8 11.12 KM D e t e r m in a t io n s  f o r  Z IP U s in g  Z -G ly -P r o -M C A
Figure 3 8 1 1 1 1  is a plot of Z-Gly-Pro-MC A concentration/fluorescent intensity versus Z- 
Gly-Pro-MCA concentration (Hanes-Woolf plot) for ZIP, while FIGURE 3 8 11 12 is a plot of 
fluorescent intensity versus fluorescent intensity/Z-Gly-Pro-MCA concentration (Eadie-Hofstee 
plot)
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F ig u r e  3 8.11.13
Z-Gly-Pro-MCA Concentration (jiM) 
F ig u r e  3 8  11.14
l/Z-Gly-Pro-MCA Concentration (|iM *)
F ig u r e s  3 8  11.13. a n d  3 8  1 1 1 4  K M D e t e r m in a t io n s  f o r  PO  U s in g  Z -G ly -P r o -M C A
FIGURE 3 8 1113 represents the Michaehs-Menten plot of fluorescent intensity versus 
substrate concentration F ig u re  3 8 11 14 shows the double reciprocal Lineweaver-Burk plot 
(1/fluorescent intensity versus 1/Z-Gly-Pro-MCA concentration)
F ig u r e  3 8 .1 1 15
Z-Gly-Pro-MCA Concentration (jiM) 
F ig u r e  3  8 i l  16
Fluorescent Intensity/Z-Gly-Pro-MCA Concentration (pM'1)
F ig u r e s  3 81115. a n d  3 811.16 KM D e t e r m in a t io n s  f o r  PO U s in g  Z -G ly -P r o -M C A
F ig u re  3 8 11 15 illustrates the Hanes-Woolf plot of substrate concentration/fluorescent 
intensity versus substrate concentration F ig u re  3 8 11 16 represents a plot of fluorescent 
intensity versus fluorescent intensity/Z-Gly-Pro-MCA concentration (Eadie-Hofstee plot)
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3 8 11 18 illustrate the competitive inhibition of ZIP by angiotensin I and uncompetitive 
inhibition by LHRH respectively Competitive inhibition of PO by angiotensin I and 
angiotensin II and that of bradykinm and Z-Gly-Pro-Ala are represented in f ig u r e s  
3 8 11 19 and 3 8 11 20 respectively F ig u re  3 8 11 21 shows uncompetitive inhibition 
of purified PO by substance P
Peptide Inhibition Type Ki FOR ZIP
jjM
Model MM LB EH HW
Aßi 43 Mixed - - - -
Angiotensin I Competitive 90 24 73 37
Angiotensin II Mixed - - - -
Angiotensin III Mixed - - - -
(Arg8)-Vasopressin Mixed - - - -
Bradykinin Mixed - - - -
(G1u2)-TRH Mixed - - - -
LHRH Uncompetitive 100 45 15 56
(Phe2)-TRH Mixed - - - -
Substance P Mixed - - - -
TRH Mixed - - - -
TRH-Gly Mixed - - - -
Gly-Gly»Pro-Ala Mixed - - - -
Z-Gly-Pro-Ala Mixed - - - -
T a b l e  3 19. K in e tic  A n a l y sis  o f  Z IP  in  t h e  Pr e se n c e  o f  Pr o l in e  C o n t a in in g  
P e pt id e  In h ib it o r s
- means not calculated Assay concentrations of inhibitors as given in t a b l e  2 18 
Models used MM=Michaelis-Menten, LB=Lineweaver-Burk, EH=Eadie Hofstee, 
HW=Hanes Woolf (see section 6 4 for calculations)
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Peptide
Model
Inhibition  Type
MM LB
K * f o r  PO 
EH HW
Aßl 43 Mixed - - - -
Angiotensin I Competitive 75 16 26 27
Angiotensin II Competitive 150 19 31 35
Angiotensin III Mixed - - - -
(Arg8)-Vasopressin Mixed - - - -
Bradykinin Competitive 275 133 0 78 707
(G1u2)-TRH Mixed - - - -
LHRH Mixed - - - -
(Phe2)-TRH Mixed - - - -
Substance P Uncompetitive 177 161 192 165
TRH Mixed - - - -
TRH-Gly Mixed - - - -
Gly-Gly-Pro-Ala Mixed - - - -
Z-Gly-Pro-Ala Competitive 476 171 167 154
T a b l e  3 20 K in e t ic  An a l y s is  o f  PO in  t h e  P r e s e n c e  o f  P r o l in e  C o n t a in in g  
P e p t id e  I n h ib it o r s
- means not calculated Assay concentrations of inhibitors were as given in TABLE 2 18 
Models used MM=Michaelis-Menten, LB=Lineweaver-Burk, EH=Eadie Hofstee, 
HW=Hanes Woolf (see section 6 4 for calculations)
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F ig u r e  3.8.11.17.
l/Z-Gly-Pro-MCA Concentration (mM 1)
F ig u r e  3.8.11.18.
l/Z-Gly-Pro-MCA Concentration (fiM'1)
F ig u r e s  3.8.11.17. a n d  3.8.11.18. I n h ib it io n  o f  Z IP  b y  P r o l in e - c o n t a in in g  P e p t id e s  
Lineweaver-Burk reciprocal plots of fluorescent intensity versus Z-Gly-Pro-MCA 
concentration for proline containing peptides (o-o) when assayed with Z-Gly-Pro-MCA (•-•). 
FIGURE 3.8.11.17. illustrates the competitive inhibition of ZIP by angiotensin I, while f i g u r e  
3.8.11.18. shows the uncompetitive inhibition ofZIP activity by LHRH.
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F ig u r e  3 8 1 1 1 9 .
l/Z-Gly-Pro-MCA Concentration (fiM ')
F igure 3 8 11 20.
l/Z-Gly-Pro-MCA Concentration (/¿M-1)
F ig u re s  3 8 1 1 1 9  and  3 8 1 1 20 In h ib itio n  o f  PO by P ro lin e -c o n ta in in g  P ep tid es 
Lineweaver-Burk reciprocal plots of fluorescent intensity versus Z-Gly-Pro-MCA 
concentration F ig u r e  3 8 1119 illustrates the competitive inhibition o f PO by angiotensin 
I (♦-♦) and angiotensin II (o-o) when assayed with Z-Gly-Pro-MCA (•-•) FIGURE 3 8 11 20 
shows the competitive inhibition of PO by bradykmin (♦-♦) and Z-Gly-Pro-Ala (o-o) when 
assayed with Z-Gly-Pro-MCA (•-•)
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F ig u r e  3 8 11.21
l/Z-Gly-Pro-MCA Concentration (jxM *)
F ig u r e  3 8 11 21. I n h ib it io n  o f  PO b y  P r o l in e - c o n t a in in g  P e p t id e s  
Lmeweaver-Burk reciprocal plot of fluorescent intensity versus Z-Gly-Pro-MCA 
concentration, illustrating the uncompetitive inhibition of PO by substance P (o-o) when 
assayed with Z-Gly-Pro-MCA (•-•)
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3 8 12 Inhibitor Studies
The effect of specific prolme containing peptidase inhibitors on ZIP and PO activities 
was determined (see section 2 9 12 1) Plots of enzyme activity versus inhibitor 
concentration were constructed and are shown in FIGURES 3 8 1 2 1  - 3 8 1 2 1 2  T a b l e  
3 21 summarises the IC50 values determined for ZIP and PO as described in section 6 5
Inhibitor IC 50FORZIP IC50 f o r PO
M M
Boc-Glu-(NHOB2)-Pyr 5x10 ia lxlO '5
Fmoc-Ala-Pro-CN ND 1x10 12
Fmoc-Pro-Pro-CN ND 5 xlO 7
Ile-Pyrrolidide ND ND
Ile-Thiazolidide ND lxlO*8
JTP-4819 ND 2 SxlO"6
Postatin ND 5x1 O'7
S-17092-1 ND
000n
S-19825 ND 1x10 9
Z-Phe-Ala-CMK 1x10 4 ND
Z-Phe-Pro-Methylketone ND lxlO'7
Z-Pro-Prohnal ND 5x10 7
Z-Pro-Prolinal dimethylacetate lx lO 4 1x105
T a b l e  3 21 E f f e c t  o f  Sp e c if ic  I n h ib it o r s  o n  ZIP a n d  PO A c t iv it ie s  
ND implies IC50 value could not be determined Concentrations as given in TABLE 2 19
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F ig u r e  3 8.12 L
Boc-Glu-(NHO-Bz)-Pyr Concentration (M)
Fig u r e  3 8 12 2
Fmoc-Ala-Pro-CN Concentration (M)
FIGURES 3 8 12 1 AND 3 8.12 2. INHIBITOR STUDIES
Semi log plots of ZIP (•-•) or PO (o-o) activity versus specific inhibitor concentration 
FIGURE 3 8 12 1 illustrates the effect o f Boc-Glu(NHO-Bz)-Pyr on enzyme activities while 
FIGURE 3 8 12 2 represents the enzyme inhibition profiles observed using Fmoc-Ala-Pro-CN 
Enzyme activities are expressed as percentages of uninhibited enzyme
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F ig u r e  3.8 12 3.
Fmoc-Pro-Pro-CN Concentration (M) 
FIGURE 3.8 12 4
Ile-Pyrrolidide Concentration (M)
F ig u re s  3 8 12 3 an d  3 8 12 4 In h ib i to r  S tu d ies
Semi log plots of ZIP (•-•) or PO (o-o) activity versus specific inhibitor concentration 
FIGURE 3 8 12 3 illustrates the effect of Fmoc-Pro-Pro-CN on enzyme activities while FIGURE 
3 8 12 4 represents the effect of Ile-Pyrrolidide Enzyme activities are expressed as a 
percentage o f uninhibited enzyme activity
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F ig u r e  3.8.12.5.
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IO15 IO14 IO*13 IO12 IO11 io-10 io-9 io-8 IO7 ÌO 6^ IO*5 io-4 io-3 
Ile-Thiazolidide Concentration (M)
F i g u r e  3.8.12.6.
JTP-4819 Concentration (M)
F i g u r e s  3.8.12.5. a n d  3.8.12.6. I n h i b i t o r  S tu d ie s
Semi log plots of ZIP (•-•) or PO (o-o) activity versus inhibitor concentration. F igure  
3.8.12.5. represents the effect of Ile-Thiazolidide on activity while FIGURE 3.8.12.6. illustrates 
the effect of JTP-4819 on enzyme activity. Enzyme activities are expressed as a percentage of 
uninhibited enzyme activity.
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F ig u r e  3 8 12 7
Postatm Concentration (M) 
F ig u re  3 8 12 8
S-17092-1 Concentration (M)
F ig u re s  3 8 12 7 and  3.8 12 8 In h ib i to r  S tud ies
Semi log plots of ZIP (•-•) or PO (o-o) activity versus specific inhibitor concentration FIGURE 
3 8 12 7 illustrates the effect of postatm on activity and FIGURE 3 8 12 6 illustrates the effect 
of S-17092-1 on enzyme activity Enzyme activities are expressed as percentages of 
uninhibited enzyme
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F ig u r e  3 8 12.9.
S-19825 Concentration (M)
F ig u r e  3  8.12.10
Z-Phe-Ala-Chloromethylketone Concentration (M)
F ig u r e s  3 8 12 9 an d  3 8.12 10 In h ib ito r  Stu d ie s
Semi log plots of ZIP (•-•) or PO (o-o) activity versus inhibitor concentration F ig u re  
3 8 12 9 shows the effect o f S-19825 on activities while FIGURE 3 8 12 10 illustrates the 
effect of Z-Phe-Ala-Chloromethylketone on enzyme activities Activities are expressed as a 
percentage of uninhibited enzyme
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F ig u r e  3 8 12.11
Z-Phe-Pro-Methylketone Concentration (M)
F ig u r e  3 8 12.12
Z-Pro-Prolinal Concentration (M)
F ig u r e s  3 8 12 11. an d  3 8 12 12 In h ib it o r  Stu d ie s
Semi log plots of ZIP (•-•) or PO (o-o) activity versus inhibitor concentration FIGURE 
3 8 12 11 represents the effect o f Z-Phe-Pro-Methylketone on enzyme levels while FIGURE 
3 8 12 12 illustrates the effect of Z-Pro-Prolinal on enzyme activities Enzyme activities are 
expressed as percentages of uninhibited enzyme
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F ig u r e  3 8.12 13
Z-Pro-Prohnal Dimethylacetate Concentration (M)
F i g u r e  3.8.12 13 I n h i b i t o r  S tu d ie s
Semi log plots of ZIP (•-•) and PO (o-o) activity versus inhibitor concentration FIGURE 
3 8 12 13 represents the effect of Z-Pro-Prohnal dimethylacetate on enzyme activities 
Enzyme activities are expressed as a percentage of uninhibited enzyme
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4.0. D iscussio n
4 0 Discussion
4 1 F l u o r e sc e n c e  Sp e c t r o m e t r y  u s in g  7-A m in o -4 -M e th y l -C o u m a rin
This work focused on the study of two specific peptidases, namely ZIP and PO from 
bovine serum and brain respectively A method capable of detecting low-levels of these 
enzyme activities was essential Walter et a l , (1971) employed a radiometric assay using 
oxytocin for the detection of PO, however the superionty of the fluorimetnc assay has 
resulted in its preferential use Generally, fluorescence spectroscopy offers increased 
safety, sensitivity, and specificity over colorimetric, spectrophotometnc and radiometric 
assays The high sensitivity results from the wavelength difference between the exciting
v and fluorescence radiation, resulting in minimal background, while the high specificity is 
due to the dependence on both an excitation and emission spectra (Willard e t  a l , 1988)
Z-Gly-Pro-MCA was first synthesised and applied in the detection of PO by Yoshimoto 
et a l , m 1979, who determined a Km of 0 02mM and increased sensitivity over selected 
proline derivatives This externally quenched fluorimetnc substrate allows for peptide 
cleavage on the carboxyl side of the proline residue thus liberating the fluorophore, MCA 
(FIGURE 4 1) Excitation to a higher energy state occurs at 370nm due to constant 
absorption of electromagnetic radiation by MCA By the nature o f fluorescence, this is 
followed by the return of the molecule to a lower state and the subsequent reemission of 
radiation at 440nm The sensitivity of fluorimetnc assays may be improved by expansion 
of the emission slit width, which consequently broadens the bandwidth over which light 
is integrated For instance, at an emission wavelength of 440nm and a slit width of 5nm, 
the fluorimeter integrates light radiated from 437 5nm to 442 5nm, while if the slit width 
is increased to lOnm, light radiated from 435nm to 445nm is integrated Therefore, for 
samples of particularly low enzyme activity and hence low fluorescence, adaptation of 
the emission slit width ensures improved sensitivity
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iV-benzyloxycarbonyl-Gly-Pro-7-amino-4-methyl-coumarin (Z-Gly-Pro-MCA)
O:
ZIP or PO at 37°C
Z-Gly-Pro
c h3
MCA
Fluoresces at excitation and emission wavelengths of 
370nm and 440nm respectively
F igure 4 1 Z-G ly-Pr o MCA Assay M echanism
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A major disadvantage o f fluonmetnc assays is the occurrence of two phenomena, namely 
quenching and the inner filter effect Both effects lead to an apparent reduction in 
fluorescent intensity and hence can be problematic where quantitation of fluorescence is 
important Quenching involves the removal o f energy from a molecule in the excited 
state by another molecule, the most common form (collisional impurity quenching) is due 
to the collision of molecules This type o f quenching may be attributed to the presence of 
heavy metals or dissolved oxygen in samples (Willard et a l , 1988) The inner filter 
effect is a result of an overlap of the excitation or emission band o f the fluorescing 
sample with the absorption band of a contaminating compound
4.11 MCA Standard Curves and the Inner Filter Effect
Liberated MCA by peptide cleavage was quantified by reference to standard curves as 
described in section 2 2 1 F ig u r es  3 1 1 and 3 1 2  clearly exhibit the linear 
relationship between MCA concentration and fluorescence at excitation and emission 
wavelengths of 370nm and 440nm respectively However, the presence of contaminants 
in samples, particularly those which excite and emit at the same wavelengths as the 
fluorophore (the inner filter effect), compromise assay sensitivity and hence hinder 
accurate quantitation of liberated MCA This becomes problematic in the cases of crude 
biological samples such as serum and tissue extracts and thus appropriate compensation 
is required
Section 2 2 2 descnbes a protocol involving the incorporation of biological samples into 
the MCA standard curves This allows for the difference in fluorescence to be measured 
between free MCA and MCA in the presence of samples FIGURES 3 1 3  and 3 1 4  
clearly demonstrate the effect of filtering on fluorescence The observed decrease in 
fluorescence when serum is incorporated into the assay is characteristic o f the inner filter 
effect This decrease is reflected in a reduced slope, which is indicative of the reduction 
in sensitivity Expansion o f the emission slit width would consequently broaden the 
bandwidth, thus improving sensitivity, however this would undoubtedly result in a 
corresponding increase in the inner filter effect Bovine serum was responsible for the 
highest degree of filtering, with 14% filtering observed at excitation and emission slit
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widths of lOnm and 5nm respectively Post column chromatography fractions, namely, 
post phenyl sepharose and post calcium phosphate cellulose samples were responsible for 
4% and 0 2% filtering respectively Purified ZIP did not exhibit the inner filter effect
These results raise two interesting issues Firstly, they suggest that crude, highly 
coloured, high protein-content samples, such as serum, are more likely to exhibit the filter 
effect than a purified sample Subsequently, this emphasises the importance of 
considering the effect of filtering on experiments, particularly in the assessment of a 
purification procedure Starting material for such a process would generally constitute a 
crude sample, highly susceptible to the inner filter effect Failure to consider filtering 
would reveal a lower activity in the crude starting material than actually present, which 
could in turn could lead to inaccuracies in the estimation o f the overall effectiveness of 
the purification procedure Therefore, it was evident that the inclusion of filtered MCA 
standard curves was paramount if reliable, accurate results were to be obtained from 
fluonmetric assays
Preparation of a filtered MCA standard curve, consisting of ten MCA concentrations each 
in triplicate, required 3mL of enzyme sample Obviously, this is a considerable volume 
just to establish the effect of filtering It was observed that although a decrease in the 
slope occurred on inclusion of a biological sample, there was no apparent deviation from 
linearity (see FIGURES 3 13 and 3 1 4 )  Therefore, in order to limit the amount of 
sample required, filtered standard curves were prepared using only three MCA 
concentrations This method still yielded an accurate slope and hence the effect of 
filtering could be determined while minimal enzyme volume was required
In addition to biological samples such as serum and post column fractions, many other 
compounds contributed to the inner filter effect Therefore, for all characterisation 
studies carried out, the inner filter effect of buffers, functional reagents, inhibitors and 
metal salts was always considered This was achieved by construction of a three-point 
MCA filtered curve prior to calculation of the exact enzyme activity or specific activity
-V
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4 2 Protein  Determination
The fluorimetnc assay described previously was essential for the determination of 
enzyme activity in a particular sample, however, the determination of the total protein 
concentration was equally important This was particularly true in relation to the 
purification of ZIP, where calculation of the specific activity relied heavily on accurate
assessment of the protein content in a sample Many techniques for protein determination
/
have evolved, each of which have advantages and limitations (Dunn, 1989) The use of 
ultraviolet spectrometry, most commonly the measurement of absorbance at 280nm, 
provides an inexpensive, rapid and non-destructive method of protein determination The 
assay exploits the ability of the aromatic amino acids, tyrosine and tryptophan to absorb 
at 280nm The method requires 0 5 to 5 Omg protein and unfortunately is inaccurate 
unless the extinction coefficient of the protein (dependant on precise amino acid 
composition) is known or the protein is relatively pure This technique is also very 
sensitive to interference from nucleic acids, nucleotides and haem-contaimng compounds 
which absorb at 280nm and can be very abundant in crude biological samples (Stevens, 
1992)
H O  R H C
II II N C CH N C-
 C N CH' ■C N'
ii i i ii iO H R O H
F ig u re  4 2. B asis o f  th e  B iu re t  A ssay
Copper ions (Cu2+) readily complex with adjacent peptide bonds yielding a 
purple colour formation with an absorbance maximum at 562nm
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A method unaffected by the amino acid composition of the protein and less prone to 
interference is the Biuret assay for protein determination Under alkaline conditions 
copper ions readily complex adjacent peptide bonds, producing a purple colour with an 
absorption between 540 and 590nm (maximum of 562nm) (FIGURE 4 2 )  This assay 
proved ideal for the determination of total protein concentration in relatively crude 
samples (containing 2-10mg/mL protein) as described in section 2 3 1 The linear 
relationship observed between protein concentration and absorbance at 570nm (FIGURE 
3 2 1 ) allowed for the estimation of total protein in enzyme samples or fractions The 
major advantage of the Biuret assay over the UV spectrophotometric procedure was the 
reduction in interference effects The Biuret assay was performed in a microtitre plate, 
requiring only 50jxL sample thus minimising the sample volume required
Samples containing less than 2mg/mL protein were assayed using the bicinchonmic acid 
(BCA) assay first developed in 1985 (Smith et a l ,) This assay, although closely related 
to the Lowry procedure (Lowry e t  a l , 1951), is generally more tolerant to the presence of 
interferents and hence was chosen for the determination of total protein in purified 
samples The Pierce BCA assay used combines the biuret reduction of Cu2+ by protein to 
Cu1+ with the highly sensitive and selective colorimetric detection of the cuprous cation 
by a unique reagent containing bicinchonmic acid (FIGURE 4 3 )  Alteration of the 
standard BCA assay temperature (section 2 3 2 )  allows for the accurate estimation of 
protein as low as 100(ig/mL (section 2 3 3 ) As with the Biuret assay, 50|iL sample is
sufficient for the analysis and protein content can be graphically estimated (fig u res
3 2 2 and 3 2 3 )
T able  4 1 sum m arises the com m on protein  assays available, the  lim itations and
advantages o f  different procedures
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Na02C COzNa
V
Protein + Cu'
BCA Reagent
OH', H20
BCA-Cu1+ Complex
F ig u re  4 3 B ic inc iio n in ic  a c id  (BCA) A ssay  M echan ism
Biuret reaction o f protein with Cu2+ results in the formation o f Cu1+ These ions subsequently react with protein 
the presence of BCA to produce a purple coloured BCA-Cu1+ complex with a maximum absorbance at 562nm
M e t h o d  a n d In t e r f e r e n t s C o m m e n t s
D e t e c t io n  R an g e
A 280 Nucleic acids, nucleotides, Relatively insensitive, affected by amino acid composition,
0 5-5mg/mL haem-containmg compounds, prone to interferents^, inaccurate unless protein is pure
sulphydryl groups Rapid and non destructive
Biuret Bile pigments, ammonia Low sensitivity Relatively few interferents, unaffected by
2-10mg/mL Sucrose*, Tns*, glycerol* ammo acid composition, simple to perform, stable reagent
Lowry Amino acids, sulphydryl pH dependent reaction, prone to interferents, standard curve
0 1-lmg/mL reagents, salts, detergents, is non-linear at high concentrations, unstable reagents,
drugs, sugars, lipids, nucleic complicated assay Sensitive
acids
B C A Reducing agents Extremely sensitive, particularly the enhanced assay, very
0 02-1 2mg/mL Sugars*, protease inhibitors* few interferents
T a b l e  4 1 C o m pa r iso n  of a  Se l e c t io n  o f  Pr o t e in  D e t e r m in a t io n  A ssa y s  
* The presence of these interferents may be compensated for by the inclusion o f an appropriate blank
^Interference can be minimised by measuring absorbance at 260nm and applying a correction formula (Layne, 1957)
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4.3 E n z y m e  A ssa y s
The activities of the Z-Gly-Pro-MCA degrading peptidases studied in this work were 
determined by measurement of MCA released As described in section 4 1 enzyme 
assays were fluorimetnc, monitoring the liberation of MCA from the substrate, leaving 
the TV-blocked dipeptide Z-Gly-Pro The linear relationship between fluorescence and 
MCA concentration allowed for the subsequent quantification of enzyme activity (section 
6 2 )  Yoshimoto et a l , (1979) classified Z-Gly-Pro-MCA as a specific substrate for PO 
detection based on its resistance to degradation by 0 1-0 5mg/mL a-chymotrypsin, 
carboxy peptidase A, elastase, leucine aminopeptidase, post-prohne dipeptidyl 
aminopeptidase, thrombin, trypsin and urokinase
However, the discovery of a second Z-Gly-Pro-MCA hydrolysing activity in this 
laboratory (Cunningham and O’Connor, 1997a) questioned this specificity Cunningham 
identified ZIP, a Z-Pro-Prohnal Insensitive Z-Gly-Pro-MCA degrading Peptidase Z- 
Pro-Prolinal (FIGURE 4 4 )  was shown to be a potent PO inhibitor with a reported K, of 
14nM (Wilk and Orlowski, 1983) It is a transition state analogue, which forms a 
tetrahedral complex with prolyl ohgopeptidase at its catalytic serine site irreversibly 
inhibiting enzyme activity (Kahyaoglu et a l , 1997)
o o
F ig u r e  4 4 St r u c t u r e  o f Z -Pr o -P r o l in a l
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The identification of this second activity induced the development of the selective PO 
assay (Cunningham and O’Connor, 1997a) Inclusion o f Z-Pro-Prolinal in the 
fluorimetrie assay allows for the differentiation o f both activities The assay described in 
section 2 4 2 was employed for the detection of total Z-Gly-Pro-MCA hydrolysing 
activity, while the protocol outlined in section 2 4 3 was for the determination of ZIP 
activity alone It should be noted at this stage that samples shown to be free of PO 
activity (e g post column pools) were assayed according to section 2 4 2
These assays were therefore ideal, proving specific for both PO and ZIP activities, highly 
sensitive, quantifiable, rapid and simple and therefore met the requirements of any 
enzyme assay Coupled to this, was the fact that both described assays were cuvette 
based The magnitude and characteristics of inner filter effects strongly relies on the 
sample-cell geometry The use of a cuvette-based assay ensured perpendicular geometry 
between the sample and the incident beam In this case the fluorescence emitted is 
collected along an axis at right angles to the excitation beam Because of its freedom 
from the effects of scattered and transmitted excitation, this is the preferential geometric 
orientation for fluorimetrie assays (Lloyd, 1981)
The third fluorimetrie assay described in this work (section 2 4 4 )  again depended on Z- 
Gly-Pro-MCA as substrate and the enzymatic liberation of the fluorophore MCA This 
microtitre plate assay was developed to enable rapid identification of enzyme activities in 
post column chromatography fractions Although not of the preferred perpendicular 
geometrical orientation, this assay proved invaluable in the initial stages of purification 
This assay employed front surface geometry (FIGURE 4 5 )  where the fluorescence is 
collected and measured through the illuminated surface This arrangement increases 
inner filter effects and light scattering while the fibre optical cable in the plate-reader 
attachment itself was responsible for a sharp reduction in assay sensitivity Despite these 
factors, the microtitre plate assay was ideal for non-quantitative enzyme detection, using 
less sample, substrate and acid volumes than the cuvette form of the assay and taking 
only a fraction of the time
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Using these assays the levels o f Z-Gly-Pro-MCA hydrolysing activities in bovine serum 
were determined FIGURE 3 3 1 clearly illustrates the presence of two distinct activities, 
PO and ZIP in a ratio of 1 1 The level of ZIP activity determined here was slightly 
higher than previously reported (Cunningham and O’Connor, 1997a), where only 40% of 
the total Z-Gly-Pro-MCA degrading activity was attributed to ZIP This may be due to 
batch to batch variations in bovine whole blood or serum samples Similar ratios 
between PO and ZIP levels in human serum were observed, where 47 8% of Z-Gly-Pro- 
MCA degrading activity was credited to the Z-Pro-Prohnal insensitive peptidase
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440nm A
440nm
370nm
C ~ 2 >
B
Fig u r e  4 5 Sa m p l e -C e ll  G e o m e t r y
MCA absorbs electromagnetic radiation at 370nm ( —►) and emits fluorescence at 440nm ( •►)
A Cuvette-based assay - Fluorescence is emitted along an axis at 90° to the excitation beam - Perpendicular geometry 
B Microtitre plate assay - Fluorescence is emitted along the same axis as the excitation beam - Front surface geometry
4 4 P u r if ic a t io n  o f  B ovine Serum  ZIP
Protein purification involves the isolation of a single protein from a mixture that may 
only constitute 1% of the species of interest It is achieved by the exploitation of known 
physical, chemical and/or biological characteristics of the target protein Prior to any 
purification protocol, there are a number of factors which must be considered The most 
important of these is the final purpose of the punfied protein This in turn will dictate the 
amount required and the acceptable purity and whether or not maintenance o f biological 
activity is necessary This research revolved around the characterisation of ZIP, a 
relatively novel prohne-specific peptidase and therefore called for the production of large 
volume of high-purity enzyme Obviously, the most important factor to be considered in 
this particular application was the conservation of biological activity ZIP proved to be a 
fairly labile enzyme, which hampered purification procedures and limited the range of 
techniques that could be applied Coupled to this was the fact that the enzyme had not 
been well charactensed and so limited understanding on its biochemical properties was 
available Despite this a highly effective purification procedure was established
4 41 . Serum Preparation
A large volume of purified enzyme was required for optimisation of the purification 
protocol, necessitating a correspondingly large amount of starting material Therefore, a 
reliable, commercially available, inexpensive source that was high in ZIP content was 
essential Bovine serum fulfilled these requirements and was thus selected as an ideal 
source for the purification of ZIP Serum was prepared as outlined in section 2 5 1 by 
centrifugation of the non-clotted portion of bovine whole blood Storage at -17°C had no 
effect on the stability o f the Z-Pro-Prohnal insensitive Z-Gly-Pro-MCA degrading 
activity, however PO activity began to diminish after one month storage Fortunately, 
this did not cause problems as it was maintenance of the biological activity o f ZIP which 
was imperative An alternative method of serum preparation was assessed, which would 
eliminate the 24hr shrinkage step This involved the collection of whole blood which had 
the anti-coagulant, hepann added Although the yield of serum was similar to that 
achieved using the clotting method, the behaviour of the ZIP on the initial
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chromatography column was compromised Because of this and a difficulty in effective 
heparin removal, the initial method of serum preparation was preferred
4 4 2 Phenyl Sepharose Hydrophobic Interactions Chromatography
Unacceptable yields of active ZIP following ammonium sulphate precipitation lead to the 
idea of applying crude serum directly to a chromatography column Phenyl sepharose is 
classified as a high capacity resin, well able to withstand protein concentrations of 20mg 
protein/mL resin (Roe, 1989) Therefore, the hydrophobic interaction resin was selected 
as the first column in the purification procedure The number, size and distribution of 
hydrophobic regions is different for each protein and it is this characteristic that is 
exploited in hydrophobic interactions chromatography (HIC)
The addition of salt to crude serum and running buffers prior to column use was essential 
since ionic strength controls hydrophobicity (Roe, 1989) Solid (NH^SCU, to a final 
concentration of 200mM, was added to serum samples as outlined in section 2 5 2 This 
method of salting avoided unnecessary dilution and dialysis, which were shown to 
substantially decrease biological activity F ig u r e  3 4 2 1 illustrates the elution profile 
obtained from the HIC resin, clearly showing the presence o f two distinct Z-Gly-Pro- 
MCA degrading activity peaks Based on the knowledge of the existence of ZIP, it was 
assumed that one peak could be attnbuted to PO activity while the other reflected the 
presence of ZIP in bovine serum This was readily shown by incubation of the column 
fractions with Z-Pro-Prolinal, the potent PO inhibitor As expected, PO was completely 
inhibited (fig u r e  3 4 2 2 )  as illustrated by the disappearance of the first peak Z-Pro- 
Prolinal had no effect on the second Z-Gly-Pro-MCA hydrolysing activity, which was 
hence deduced to be ZIP
Considering the purification of ZIP alone, this column successfully separated the 
peptidase from the bulk of contaminating protein Three protein peaks were observed 
(FIGURE 3 4 2 1 ) The first is evident in the column run-through (fractions 5-15), the 
second loosely bound to the column and was eluted on reduction of ammonium sulphate
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concentration The third protein peak bound tightly to the HIC resin and co-eluted with 
ZIP in the complete absence o f salt
The effectiveness of this resin in the purification of ZIP is reflected in the values obtained 
for the specific activity and enzyme yield, presented in TABLE 3 2 A 63-fold purification 
factor is due to the successful reduction in total protein (1743mg to 23 94mg) coupled to 
the minimal loss (15%) of ZIP activity Phenyl sepharose therefore served a dual 
purpose, primarily as a method of partially purifying ZIP but also as a tool for separating 
the two Z-Gly-Pro-MCA hydrolysing activities Because ZIP and PO both cleave the 
same substrate it was essential that they be separated at an early stage in the purification
4 4 3 Calcium Phosphate Cellulose Chromatography
The second step used in the purification of ZIP was a calcium phosphate cellulose 
column This resin was produced in the laboratory according to a modification of the 
methods described by Barranger (1976) and Donlon and Kaufman (1980) Although, an 
elaborate procedure, the production of a home-made resin considerably reduced expense 
and concerns of batch to batch variation were minimised by bulk production The precise 
mechanism of action of calcium phosphate cellulose (CPC) chromatography is unknown, 
limiting its popularity as a routinely used purification tool However, it is generally 
accepted that CPC crystals have two absorption sites on their surface, phosphate and 
calcium, and that these are responsible for the binding of basic and acidic groups of 
proteins respectively (Bemardi and Kawasaki, 1968, Bernardi et a l , 1972) Due to the 
fact that the modes of protein adsorption and desorption are different from the majority of 
other techniques, CPC may be a successful purification step where other procedures have 
failed This indeed proved to be the case in the purification of ZIP
The elution profile generated using CPC is presented in FIGURE 3 4 3 illustrating 
excellent resolution between enzyme and contaminating protein ZIP readily bound to 
the resin and was isocratically eluted with increasing phosphate concentration The 
second wash at lOOmM phosphate (section 2 5 3 ) was warranted for two reasons 
Primarily it successfully removed a portion of contaminating protein, but more
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importantly it was responsible for the separation of ZIP from a number of contaminating 
peptidases First-time analysis o f post CPC ZIP indicated the presence o f a number of 
peptidases, namely Z-Phe-Arg-MCA, Lys-Ala-MCA and Gly-Pro-MCA hydrolysing 
enzymes Attempts at size-exclusion chromatography were successful in the removal of 
the Lys-Ala-MCA and Z-Phe-Arg-MCA degrading peptidases, however almost total loss 
of ZIP activity made this method unacceptable Replacement of the CPC linear 
phosphate gradient with two isocratic washes successfully separated the contaminating 
peptidases from ZIP activity
An 86% recovery of applied peptidase activity, coupled to a mass reduction (97%) in 
protein, resulted in a remarkable purification factor of 1632 (TABLE 3 2 )  Therefore this 
CPC resin, although often unpredictable, proved invaluable in the overall purification of 
ZIP from bovine serum
4.4 4 Diethylaminoethyl Sepharose Ion Exchange Chromatography
Diethylaminoethyl (DEAE) sepharose is a weak anion exchanger, frequently employed in 
the purification of enzymes with isoelectric points (pi) below 7 0 Despite the fact that 
the pi of ZIP was unknown at this stage, it was expected to fall between pH 5 0 and pH 
7 0 (similar to other mammalian peptidases) Since anion exchange uses buffers at a pH 
above rather than below the pi, it was selected over cation exchange due to the 
preferential stability o f ZIP at neutral-slightly alkaline pH values Ion exchange provides 
medium resolution and capacity and therefore is ideal when the volume and protein 
content of the extract have been reduced (Doonan, 1996), as was the case for ZIP
ZIP was dialysed and applied to a DEAE sepharose resin as outlined in section 2 5 4 
F ig u r e  3 4 4 shows the elution of peptidase activity and protein observed ZIP bound to 
the resin at pH 8 0 (indicative of pi below this) and its isocratic elution could not be 
improved using a linear chloride gradient, which actually resulted in peak tailing A 
number of parameters were investigated in an attempt to improve this elution profile, 
including pH, salt concentration, resin volume and sample volume, however, this 
procedure appeared to be optimal for the purification of ZIP using DEAE sepharose
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Table 3 2 illustrates the effectiveness of the resin as a final clean-up step in the 
purification of ZIP The 38% loss of biological activity observed is excellent for such a 
late stage in a purification procedure and a substantial reduction in protein (0 76mg to 
0 15mg) was also achieved
In summary, the purification of ZIP proved difficult and time consuming, however 
appropriate precautions and considerations were taken throughout A temperature o f 4°C 
was constantly maintained, dialysis and concentration steps were avoided where possible, 
neutral buffers were used and the different stages was earned out consecutively to 
minimise enzyme degradation An overall purification factor of 4023 and a conservation 
of 33% Z-Pro-Prolmal insensitive Z-Gly-Pro-MCA hydrolysing activity proved it to be a 
worthwhile, successful endeavour
4 5 Purity  Determination
The concept of purity in relation to proteins is not entirely straightforward A pure 
protein would imply that the punfied sample contains, in addition to water and buffer 
ions, only one population of molecules all with identical covalent and three-dimensional 
structures This is an unattainable and often unnecessary goal (Doonan, 1996) For the 
purpose of this work, punty was assumed if the sample was shown not to contain any 
species which would interfere with the experiments for which ZIP was intended This 
was achieved using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS 
PAGE) and fluonmetry-based analysis
Figures 3 5 1 and 3 5 2 represent images of silver and brilliant blue stained 
polyacrylamide gels respectively Multiple bands were visualised following 
electrophoresis of crude serum and post-phenyl sepharose samples (lanes 2 and 3), 
however as the purification progressed there was an evidential reduction m the number of 
bands present Post DEAE sepharose ZIP is represented by a faint single band 
corresponding to a molecular weight of 88kDa for the silver stained gel and 96kDa for 
the blue stained gel (lanes 5) The discrepancy in molecular masses determined is not 
related to the staining procedure but rather to experimental error and is less than 5%
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Although the band is relatively faint, this deduced molecular weight for ZIP was 
confirmed by size-exclusion chromatography (section 2 9 2 2 )
A number of fluorimetric assays were performed to detect the presence of contaminating 
peptidases in the post DEAE sepharose ZIP pool The substrates employed are listed m 
TABLE 2 5 and the presence of the appropriate peptidase was determined by a measure of 
liberated MCA Two detection methods were employed The PE luminescence 
spectrophotometer was used to measure possible release o f MCA as described m section 
2 6 2 The second detection technique involved HPLC analysis on a Ci8 column, 
followed by eluant monitoring on a fluorescence detection system (section 2 6 3 ) No 
cleavage of any substrate other than Z-Gly-Pro-MCA was detected for either method 
(TABLES 3 4 , 3  5 and fig u r es  3 5 3 1 -3 5 3 3 ) The absence o f these peptidases, 
particularly PO, DPP II and DPP IV, was essential since their presence would ultimately 
interfere with future experiments Based on SDS PAGE and fluonmetnc analysis, post 
DEAE sepharose ZIP was deemed to be acceptably pure for further applications
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4 6 Assay Development
Using the purified ZIP sample, a number of experiments were earned out to assess the 
effectiveness of the Z-Gly-Pro-MCA assays in an attempt to enhance peptidase detection 
levels
4 6 1 MCA Excitation and Emission Wavelengths
The use o f the fluorophore MCA in the production of fluonmetric peptide substrates is 
well documented (Kanaoka et a l, 1977, Kato et a l, 1978, Fujiwara and Tsuru, 1978, 
Yoshimoto e t  a l, 1979, Blackmon et a l, 1992) However, there does appear to be slight 
variations in the reported excitation and emission wavelengths at which it fluoresces The 
most frequently employed excitation wavelength is 380nm (Kanaoka et a l, 1977, Kato e t  
a l, 1978, Nishikata e t  a l, 1986, Bakker e t  a l, 1990, Blackmon et a l, 1992), while 
Fujiwara and Tsuru (1978), and Yoshimoto et al (1979) report an optimal excitation 
wavelength of 370nm The emission wavelength of the fluorophore also seems to be in 
question, ranging between 440nm and 460nm by the above researchers It must be noted 
though that none of these studies make any mention of the slit widths at which the 
fluorescence was measured Optimum wavelengths were tested as desenbed in section 
2 7 1 and 370nm and 440nm were concluded to represent the optimum excitation and 
emission wavelengths of MCA respectively (FIGURES 3 6 11 and 3 6 1 2 )  However, if 
the excitation slit width of lOnm employed is considered, MCA excites between 365 and 
375nm Similarly, the emission wavelength broadens to anywhere between 435 and 
445nm when read at slit widths o f 2 5, 5 0 or 10 Onm Considering this, these results 
obtained are in keeping with those reported in the literature
4 6 2 Substrate Solvent Studies
The substrate employed for the detection of ZIP and PO activities, Z-Gly-Pro-MCA, is 
water insoluble, so the addition of a non-aqueous organic solvent was essential for 
solubilisation The majority of enzymes, excluding lipases, esterases, dehydrogenases, 
which function in natural hydrophobic environments (Dordick, 1989), did not evolve to 
function in non-aqueous environments and so the use of organic solvents is never 
favoured Having said this, it has been hypothesised that although water remains
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essential for catalysis, an enzyme molecule in aqueous solution becomes fully hydrated 
when surrounded by a few layers of water (Gorman and Dordick, 1992) Therefore, bulk 
water is not crucial for catalytic activity and replacement of the remaining water with an 
organic solvent should be possible without adversely affecting the enzyme (Klibanov, 
1986)
A non-aqueous solvent was sought which proved optimal for both substrate solubility and 
enzyme activity Z-Gly-Pro-MCA was prepared in a range of organic solvents and 
assayed with purified ZIP as described in section 2 7 2 F ig u r e  3 6 2 compares the 
effect on ZIP activity of EtOH, DMF, DXN and MeOH as substrate solvent to that of 
DMSO, the previously favoured solvent (section 2 4 1 ) All solvents yielded identical 
solubility patterns when used at 4%v/v It is clearly evident that there was a 2 5-fold 
increase in ZIP activity when MeOH was used in comparison to DMSO This, coupled to 
its effective solubilisation properties, resulted in MeOH being selected as the optimal 
solvent for Z-Gly-Pro-MC A preparation
Generally short chain aliphatics cause a lower degree of denaturation than solvents such 
as butanol (Harris, 1989), and this may explain why ZIP activity was least affected by the 
presence of MeOH in the substrate Organic solvents effect both the denaturation and 
catalytic activity o f enzymes, but not necessarily in a parallel manner Aliphatic solvents 
(EtOH and MeOH) show only moderate effect on activity denaturation and loss of 
catalysis DMF on the other hand, is a strong denaturant which also reduces catalytic 
activity, while dioxane does not induce denaturation but does diminish catalytic power 
This may explain why DXN and DMF resulted in lower peptidase activities than MeOH 
(Harris, 1989) Similar results have been cited in the literature Ulbnch-Hofmann and 
Sehsko (1993) observed that DMF, DXN and DMSO showed greater inactivating 
influences against glucoamylase and mvertase activity than MeOH They also suggested 
that the pH of a buffer and MeOH mixture was more likely to remain at the pH value of 
the added buffer component (in this case pH 7 4), than in mixtures composed of DXN, 
DMSO, DMF and acetomtrile This may offer another explanation as to why optimal 
enzyme activity was observed using MeOH as the substrate solvent
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Once MeOH had been selected as the optimal solvent for substrate preparation, the 
concentration at which it was most effective had then to be determined Experiments 
were earned out according to section 2 7 3 in which the concentration of MeOH used in 
Z-Gly-Pro-MCA preparation was varied As expected, enzyme activity decreased with 
increasing concentrations o f solvent (fig u re  3 6 3 ) This graph reiterates the results 
obtained in FIGURE 3 6 2 , in that methanol is less inhibitory on ZIP activity than DMSO 
even at 6%v/v More importantly though, this result illustrates that 2%v/v MeOH is 
optimal for substrate preparation, yielding over three times the activity observed with 
4%v/v DMSO Z-Gly-Pro-MCA was therefore prepared in 2%v/v MeOH, however a 
difficulty arose with respect to solubility The substrate solution constantly precipitated 
unless heated to at least 45°C Related to this was a marked increase in the standard error 
observed between tnphcate fluorescent readings For these reasons, high ZIP activity due 
to low concentrations o f solvent (2%v/v and 3%v/v) was compromised for acceptable 
substrate solubility and accurate triplicate values As outlined in section 2 7 10, the 
substrate preparation described in section 2 4 1 was modified to incorporate 4%v/v 
MeOH in place of 4%v/v DMSO
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4 6 3 Linearity Studies
A typical progress curve for an enzyme-catalysed reaction is presented in FIGURE 4 6 
The time course is initially linear but the rate of product formation starts to decline after 
prolonged incubation This departure from linearity may be due to a number of factors, 
most frequently, substrate depletion, enzyme or substrate instability, products inhibiting 
the reaction, or a change in assay conditions It can be deduced from this that enzyme 
activity should only be quantified at a point where these factors are known not to be an 
issue This point is known as the initial velocity of the reaction and can be calculated by 
drawing a tangent through the origin to the linear part of the progression curve as shown 
in FIGURE 4 6 Using a continuous assay system, this decrease in reaction velocity with 
respect to time is evident and generally due to substrate depletion
Time (nun)
F ig u re  4 6. T y p ic a l P ro g re s s  C u rv e  o f  a n  E n z y m e -c a ta ly se d  R e a c t io n  
Plot of product formation versus time
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However in a discontinuous assay, activity measurements are determined at one discrete 
point along the reaction progression curve, and deviation from linearity may not be 
readily detected Quantification of ZIP activity using a discontinuous assay system 
cannot be relied upon unless the linearity of the assay has previously been assured using a 
continuous assay system
Because quantification of ZIP activity in a number of fractions was required for the 
purification table construction, the linearity with respect to time of crude serum (in the 
presence and absence of PO inhibitors) and post column chromatography samples was 
deemed necessary FIGURES 3 6 4 1 and 3 6 4 2 represent the progress curves obtained 
for serum in the absence of inhibitor and purified ZIP respectively It is clearly evident 
that the degradation of Z-Gly-Pro-MCA was linear over the 60min time frame examined 
Identical linear progress curves were generated for post phenyl sepharose and post 
calcium phosphate cellulose enzyme pools (results not shown) The inclusion of Z-Pro- 
Prolinal and JTP-4819 in the continuous assay system was necessary to ensure that these 
compounds were not responsible for any deviation from linearity A slight downward 
curvature of the line may have been expected on the inclusion of inhibitors as illustrated 
for trypsin by Dixon and Webb, (1979) However, this was not the case and FIGURES 
3 6 4 3 and 3 6 4 4 clearly indicate that linearity was maintained The fact that the serum 
was pre-incubated for 5min with each inhibitor pnor to the execution of the assay implies 
that the pre-incubation totally inhibited PO and that the linear velocity observed is due 
solely to ZIP This was further verified in section 3 6 9 where prolonged incubation 
failed to alter the level o f ZIP activity detected from that measured after 5min
Another parameter that was important to consider in the quantification of ZIP, was the 
linearity of the assay with respect to enzyme concentration FIGURE 3 6 5 illustrates that 
fluorescent intensity increased linearly with increasing concentrations of enzyme thus 
allowing quantification of enzyme levels based on a fluorescent reading (section 6 3 )  
Therefore both the Z-Gly-Pro-MCA degrading activities assay and the Z-Pro-Prohnal 
insensitive Z-Gly-Pro-MCA degrading activities assay were linear with respect to time 
over the 60min assay time frame and with respect to enzyme concentration
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4.6 4 Optimum Assay Temperature
The effect of assay temperature on purified ZEP activity was investigated as outlined in 
section 2 7 6 Samples were allowed to reach thermal equilibrium by pre-incubation for 
15mm at the appropriate temperature prior to assaying This ensured that the observed 
activity genuinely reflected the activity of the peptidase at the temperature under 
investigation Optimal activity was observed when the Z-Gly-Pro-MCA degrading 
activity assay was performed at 37°C as FIGURE 3 6 6 illustrates The rapid decline in 
fluorescent intensities observed in assays performed at greater than 37°C is most 
probably due to instability of the Z-Gly-Pro-MCA rather than inactivation of ZIP This 
was verified by the large background fluorescence recorded for the blanks at these 
temperatures and the fact that ZIP remained active when incubated at 40°C and then 
assayed at 37°C (see FIGURE 3 8 3 1 ) This result is not surprising considering the 
mammalian origin of this enzyme and that optimal physiological temperature is 37°C 
Yoshimoto et a l , 1987 and 1988, reported an identical optimal assay temperature for the 
detection of PO from D  c a r o t a  and L  c in e r a s c e n s  respectively using Z-Gly-Pro-MCA 
This assay temperature has previously been shown to be optimal for the detection of 
bovine serum PO (Cunningham and O’Connor, 1998) Cited assay temperatures for PO 
range from 37°C to 47°C depending on the source (TABLE 4 2 )
4 6 5 Effect of DTT and NaCl on ZIP Activity
Purified ZIP was incubated with a range of dithiothreitol (DTT) concentrations in an 
attempt to study the effects of this thiol-reducing agent on its Z-Gly-Pro-MCA degrading 
ability F ig u r e  3 6 7 illustrates the pattern observed Increasing concentrations of DTT 
caused a rapid decline in ZIP activity when compared to a peptidase sample containing 
no DTT (100% activity) Inclusion of 5mM DTT in the substrate resulted in a loss of 
over 10% activity, while 35% inhibition was observed in the presence of 20mM DTT
This result is quite interesting as it illustrates a distinct difference between the two Z-Gly- 
Pro-MCA degrading activities present in bovine serum Numerous reports have shown 
PO to be substantially activated by DTT (Walter, 1976, Orlowski et a l , 1979,
217
Source Assay MW Therm al Optim um Pi Reference
tem p kDa Stability p H
° C r
Bovine brain 40 62-65 ND 7-7 5 4 8 Yoshimoto et a l , 1983
Bovine serum 37 69 7 37 8 0 ND Cunningham and 
O’Connor,1998
Daucus carota 37 75 ND 7 3 4 8 Yoshimoto e /a / ,  1987
Flavobacterium menmgosepticum 40 74 ND 7 0 9 6 Yoshimoto et a l , 1980
Human lymphocytes ND 76 ND ND 4 8 Goossens e/ a l , 1995
Lamb brain 45 74-77 40 7 0 4 9 Yoshimoto e/ a / , 1981
Lamb kidney 47 74-77 45 7 7 4 8 Koida and Walter, 1976
Lyophyllum cinerascens 37 76 ND 6 8 5 2 Yoshimoto et a l , 1988
Porcine liver 37 72-74 ND 6 5 4 9 Monyama and Sasaki, 1983
Rabbit brain ND 66 ND 83 ND Orlowski £ /a / , 1979
Rat brain 37 70 ND 5 8-6 5 ND Kato et a l , 1980
Treponema denticola ND 75-77 37 6 5 6 5 M akm ene/a/, 1994
T a b le  4 2. Sum m ary o f  PO P h y s io c h e m ica l P r o p e r t ie s
ND means not determined
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Kalwant and Porter, 1991) Cunningham and O’Connor, 1998, reported a twelve-fold 
increase in PO activity in the presence of lOmM DTT It is generally accepted that this 
marked increase is due to the reduction of disulphide bridges (S-S) to thiol groups (SH 
+SH) by DTT This suggests the existence of a cysteine residue, situated near the active 
site, which when reduced increases the ability of PO to initiate a nucleophilic attack upon 
a bound substrate (Polgar, 1991) The results obtained suggest that ZIP, although not 
activated by DTT, may have a cysteine residue near its active site (see also section 4 8 6 )  
which in the presence o f thiol-reducing agents somehow contributes to the inactivation of 
enzyme activity
Salt exerts effects on proteins that can be denaturing or stabilising depending on the 
nature and concentration of the salt employed SO42 and Cl 10ns are classified as protein 
stabilisers, reducing the solubility of hydrophobic groups on the protein molecule by 
increasing the ionic strength of the solution (Volkm and Klibanov, 1990) Salts such as 
sodium chloride (NaCI) and ammonium sulphate ((NH4)2S0 4 ) therefore enhance water 
clusters around proteins inducing stability by compacting proteins This phenomenon is 
known as preferential hydration (Timasheff and Arakawa, 1989) The effect of NaCI was 
tested on purified ZIP as described in section 2 7 8 F ig u r e  3 6 8 represents the salt 
enhancement o f enzyme activity As the concentration of NaCI was increased there was 
a noticeable 220% ZIP activity in comparison to the control (100%) Unfortunately, this 
increase could not be extended by further increasing the salt concentration, evident by the 
graphical plateau, and most probably due to poor substrate solubilisation at high NaCI 
concentrations Based on these observations, lOmM DTT was included in substrates for 
the determination of PO, but since the thiol reducing agent had detrimental effects on ZIP 
activity it was omitted from the ZIP substrate Similarly, 500mM NaCI was incorporated 
into substrate preparations for the detection of ZIP activity Due to conflicting reports on 
the effect of salt on PO activity (Orlowski, 1979 and Polgar, 1991), NaCI was omitted 
from the PO substrate
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4 6 6 Prolyl Ohgopeptidase Inhibitor Studies
The original ZIP-specific assay was defined by Cunningham and O’Connor (1997a), 
involving the incorporation of the prolyl ohgopeptidase inhibitor, Z-Pro-Prolinal into the 
assay mixture as described m section 2 4 3 FIGURE 3 6 9 1 represents a typical 
inhibition curve of the inhibitor in crude serum Z-Pro-Prolinal appears to inhibit Z-Gly- 
Pro-MCA degrading activity by approximately 50%, however even at increased 
concentrations there is negligible further inhibition The residual Z-Gly-Pro-MCA 
hydrolysing activity has been attributed to ZIP as previously discussed The effect of 
extending the pre-incubation period was also examined, however no further inhibition of 
the Z-Pro-Prolinal insensitive activity could be achieved (FIGURE 3 6 9 8 )  These 
profiles are in keeping with the findings of Cunningham and O’Connor (1997a)
Unfortunately stocks of Z-Pro-Prolinal became unavailable and unsuccessful attempts to 
synthesise the aldehyde led to the search for an alternative inhibitor, which could exert 
identical behavioural characteristics to Z-Pro-Prolinal A number of specific PO 
inhibitors, listed in TABLE 2 6 , were purchased or kindly donated (section 2 1 ) The 
effect of each inhibitor on Z-Gly-Pro-MCA degrading activities in serum was assessed 
and the results are illustrated in FIGURES 3 6 9 2  - 3 6 9 7  Fmoc-Ala-Pro-CN and 
postatin were deemed unsuitable as they both inhibited the total Z-Gly-Pro-MCA 
degrading activities in serum and therefore could not distinguish between PO and ZIP 
The commercially available Z-Pro-Prolinal dimethylacetate successfully inhibited almost 
40% of the total Z-GIy-Pro-MCA hydrolysing activity, although it was difficult to 
establish if ZIP activity was affected A defined plateau was not observed and higher 
concentrations could not be examined as this would have required inhibitor preparation in 
100%v/v solvent
Fmoc-Pro-Pro-CN, Z-Indohnyl-Prolinal and JTP-4819 however showed potential as 
specific PO inhibitors each illustrating the presence of an inhibitor-insensitive residual 
activity (see FIGURES 3 6 9 3 , 3 6 9 5  and 3 6 9 7 )  JTP-4819 was selected as the Z - P r o -  
P r o l m a l  r e p la c e m e n t  primarily because there was an ample supply and also because,
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similar to Z-Pro-Prolmal, no further inhibition was observed on increased pre-incubation 
(FIGURE 3 6 9 9 )
Accumulation o f the assay development results allowed for the development of an 
optimal Z-GIy-Pro-MCA degrading activities assay (section 2 7 10) The sensitivity and 
suitability o f the assay was assured and the linearity studies allowed for accurate 
quantification of enzyme concentrations The incorporation of 4%v/v MeOH and 
500mM NaCl m the substrate solution, resulted in a 5-fold increase in ZIP activity
4 7 Localisation  Studies
The presence of PO and ZIP activities in a number of bovine tissues was determined as 
outlined in section 2 8 The purpose of this study was to ascertain the tissue of origin of 
the two Z-Gly-Pro-MCA degrading peptidases and/or to establish the optimum source for 
future study of either enzyme Extraction of soluble proteins from the animal tissues is 
relatively straightforward due to the weakness of the cell membranes and the absence o f a 
cell wall A combination of mechanical and centrifugal forces were employed in the 
extraction of Z-Gly-Pro-MCA hydrolysing activities from each tissue as outlined in 
section 2 8 1 Lung tissue proved the most difficult to homogenise, due to its tough 
cellular composition and so was semi-thawed prior to homogenisation
Z-Gly-Pro-MCA degrading activities were measured in the tissues and serum as 
described in section 2 8 2 As discussed in section 4 1 1 the inner filter effect becomes a 
problem in coloured samples of high protein content, therefore filtered MCA standard 
curves were prepared for each extract The degree of filtering did not vary greatly 
between the same fraction of individual tissues (with the exception of spleen extracts) as 
is evident in TABLE 3 6 Considering this effect, fluorescent intensities were converted 
into enzyme units (one unit of enzyme activity is defined as the amount of enzyme which 
releases lpicomole MCA per minute at 37°C) as outlined in section 6 3 Following 
quantification of ZIP and PO activities, and total protein determination (Biuret assay, 
section 2 3 1), specific activities were estimated for ZIP and PO (TABLES 3 7  and 3 8 
respectively) For all samples, the bulk peptidase activity was contained in the SI
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fraction and so the discussion will focus on specific activities calculated in these 
supernatants
FIGURE 3 7 8 clearly shows that PO activity was most abundant in bovine brain, liver and 
kidney extracts with specific activities of 3 2, 2 4 and 2 4umt/mg respectively Spleen 
was also an acceptable source of PO while the low levels of activity in serum correlate to 
the results of Kato et a l  (1980) who observed a similar pattern in humans PO 
distribution studies performed in rat (Yoshimoto et a l , 1979), human (Kato et a l , 1980), 
rabbit (Orlowski et a l , 1979) and mouse (Dauch et a l , 1993) tissues have revealed an 
ubiquitous distribution with uniformly high levels in the brain The results presented are 
in agreement It is highly possible that kidney or liver may be the site of origin of bovine 
PO since significant species-to-species variation has been observed in such peripheral 
tissues Although liver is rich in PO activity, it is not an ideal tissue source Clarified 
homogenates are difficult to obtain due to the presence of nucleic acids and large 
quantities o f fats It also contains much larger proportions of soluble protein than kidney 
or brain, which increases subsequent purification problems (Doonan, 1996) Therefore, 
brain or kidney would appear to be the most practical PO sources and are in fact most 
commonly employed in the extraction of prolyl oligopeptidase (TABLE 4 3 )
FIGURE 3 7 9 clearly displays positive identification of ZIP activity in bovine kidney, 
brain, serum, liver, lung and spleen As previously mentioned, this ubiquitous 
distribution has also been reported for PO In general, ZIP specific activity levels were 
considerably lower than those for PO in the same tissue extracts, with the exception of 
serum which revealed a l l  ratio of ZIP PO TABLE 3 8 lists the percentages of total Z- 
Gly-Pro-MCA degrading activity attributed to each peptidase Although fig u r e  3 7 9 
illustrates the highest ZIP activity to be present in bovine kidney, TABLE 3 8 shows that 
this activity only represents 14% of the total Z-Gly-Pro-MCA hydrolysing activities in 
the organ Despite the low levels, ZIP was identified in all tissues, its presence in the 
brain being of particular importance Previous attempts in our laboratory failed to detect 
ZIP in bovine brain yet these results suggest activity, albeit only 6 2% of the total 
activity However further studies, such as subcellular fractionation of the brain, would be
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required before the presence of brain ZIP could be confidently claimed Observation of 
the actual enzyme activity values (ta ble  3 7 )  shows that kidney and liver contained 
comparable levels of ZIP to serum and could therefore serve as acceptable alternative 
sources for ZIP purification, although extraction procedures are more difficult and time- 
consuming
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Sources Reference
B rain
Bovine Blumberg e t a l ., 1980, Hersh, 1981, Yoshimoto e t a l ., 1983, O’Leary and O ’Connor, 1995.
Human Kato e t a l. ,  1980, Kalwant and Porter, 1991.
Lamb Yoshimoto e t a l., 1981.
Mouse Fukunari e t a l . ,  1994.
Rabbit Carvalho and Camargo, 1981, De Camargo e t a l ,  1982, Dresdner e t a l ,  1982.
Rat Kato e t a l. ,  1980, Healy and Orlowski, 1992.
Kidney
Porcine Dehm and Nordwig, 1970, Hauzer e t a l ,  1984, Odya e t a l ,  1987.
L iver
Porcine Moriyama and Sasaki, 1983.
Rat Yamakawa et a l ,  1994, Matsubara e t a l ,  1998.
O ther
Rat heart Cicilini e t a l ,  1994.
Human uterus Walter e t a l. ,  1971
Porcine pancreas Yoshimoto e t a l ,  1982.
T a b le  4.3. Comm on M am m alian  S o u rc e s  o f  PO A c tiv i ty
4 8 Characterisation
T able  4 2 summarises biochemical characteristics of PO reported and will be referred to 
throughout this section
4 8 1 Determination of N-terminal Sequence
As explained in section 3 8 1 unfortunately the N-terminal sequence of ZIP was not 
determined using the method described in section 2 9 11 Although it was possible that 
the N-terminal was blocked, this was unlikely since a previous attempt at sequencing 
discovered no blocking group present (see section 3 8 1 ) In addition to this, the method 
employed involved pre-casting of the gel coupled to pre-electrophoresis in thioglycohc 
acid, two procedures known to reduce the occurrence of N-terminal blocking by amines 
during electrophoresis The most plausible reason for the unsuccessful sequencing is due 
to the large molecular weight of ZIP, as the larger the volume of amino acid residues 
present the more difficult it is to sequence It was recommended that ZIP be digested 
using a protease such as V8 protease which cleaves at glutamic acid residues, resulting in 
smaller fragments which may then be sequenced and aligned (method employed by 
Malfroy e t a l , 1987 for the sequencing of rat nepnlysin) This is currently being 
investigated and should allow the N-terminal sequencing o f this novel prohne-specific 
peptidase to be determined
The sequence obtained for ZIP, shown in section 3 8 1 was actually obtained following 
an acetone precipitation of the purified enzyme The presence o f two equimolar 
components was initially believed to be due to the presence of a contaminant however, it 
was more likely that the acetone had a detrimental effect on ZIP activity, and hence the 
electroblotting method was attempted Irrespective of the dual sequence obtained, it is 
worth noting that no sequence homology between it and PO is evident in the first six 
residues The N-terminal ammo acid sequence (residues 1-50) of prolyl ohgopeptidase 
from porcine brain is {Met-Leu-Ser-Phe-Gln-Tyr-Pro-Asn-Val-Tyr-Arg-Asn-Glu-Thr- 
AJa-Ile-Gln-Asn-Tyr-His-Gly-His-Lys-Val-Cys-Asn-Pro-Tyr-Ala-Trp-Leu-Glu-Asn-Pro- 
Asn-Ser-Glu-Gln-Thr-Lys-Ala-Phe-Val-Glu-Ala-Gln-Asp-Lys-Ile-Thr} as deduced by 
R ennexeia/ (1991)
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4 8 2 Relative Molecular Mass Determination
The anionic detergent sodium dodecyl sulphate (SDS) readily binds to proteins in a ratio 
of 1 4 1, effectively masking the intrinsic charge of the polypeptide chains (Dunn, 1989) 
The net charge per unit mass becomes approximately constant, therefore separation of 
SDS-treated proteins is effectively based on molecular weight alone SDS 
polyacrylamide gel electrophoresis (PAGE) was employed in the estimation of the 
molecular mass of purified ZIP as outlined in section 2 9 2  1 A 10%v/v gel was 
prepared since the molecular weight was expected to be in the range 15-200kDa 
F ig u r es  3 5 1 and 3 5 2 represent images of the silver and blue stained gels 
respectively Measurement of the molecular weight marker Rf values allowed for the 
construction of standard curves (FIGURES 3 8 2 1 1 and 3 8 2 1 2 )  Using these, 
molecular masses of ZIP were determined to be 87,810Da (silver stain) and 95,820Da 
(blue stain) The interaction of SDS with proteins causes the irreversible denaturation of 
the 3-dimensional structure and proteins are thus broken down into individual 
polypeptide chains (monomers) Therefore SDS-PAGE yields no insight into the native 
molecular mass of a protein and so a second method for the determination of molecular 
mass is regularly performed
Size-exclusion chromatography (SEC) is frequently employed as a non-denatunng 
technique for molecular mass estimation Separation is based on the hydrodynamic 
volume of a protein or simply its size, larger proteins eluting faster than smaller ones that 
interact with the pores of the column Three SEC columns were run as described in 
section 2 9 2 2 , namely a low-pressure sephacryl S-200, a medium pressure HiPrep 
„ sephacryl and a high pressure BioSep SEC-3000 FIGURES 3 8 2 1 3  to 3 8 2 1 4  
represent the standard curves of log molecular weight versus elution volume/void volume 
for each resin Molecular masses of 194,922, 172,288 and 164,369Da were estimated 
from these graphs for S-200, HiPrep and SEC-3000 sephacryl resins respectively The 
2 4 %  discrepancy between these values is lower than the frequently reported 10% 
inaccuracy for SEC (Welling and Welling-Wester, 1989) Based on these results, it was 
assumed that the estimated 88kDa and 96kDa SDS PAGE bands corresponded to the 
mass of a subunit of the peptidase It was deduced, due to the presence of a single band
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following PAGE analysis that ZIP exists as a dimer of two subunits of equal molecular 
weight Combination of SDS PAGE and SEC for the determination o f molecular weight, 
compensated for the inadequacies of each technique and so an average molecular weight 
of 179,768Da (table  3 9 )  can be confidently postulated for ZIP Conversely, PO is 
generally accepted to be a monomer, with a molecular weight in the range 62-77kDa 
depending on the source (TABLE 4 2 )  This provides yet another biochemical 
dissimilarity between the two Z-Gly-Pro-MCA degrading peptidases
4 8 3 Thermostability Studies
The inactivation profile of ZIP following pre-incubation at various temperatures for 
different times is presented in FIGURE 3 8 3 1 Naturally, stability of this mammalian 
enzyme would be expected at temperatures up to 37°C, and this was clearly the case 
However, ZIP activity was less than 40% inhibited after incubation at 50°C for lhour 
Relatively high thermostability can be attributed to the presence of p r o t e c t in g  proteins, 
which increase interactions between water molecules thus strengthening hydrophobic 
interactions (explaining why BSA is often added to purified enzyme samples, Chang and 
Mahony, 1994) Progression of a purification procedure causes the protein of interest to 
become more heat-labile, due to the removal of such stabilising proteins Although ZIP 
was highly pure, there was no requirement for protein addition because of its excellent 
thermostability profile ZIP activity could be maintained at 4°C for up to a week or at 
room temperature for 3hr Reports of similar thermostability profiles have not been 
reported for PO and it appears that the peptidase is quite susceptible to temperatures 
above 40°C (TABLE 4 2 )
The substrate specificity studies performed by HPLC analysis on purified ZIP required an 
overnight incubation at 37°C and so the stability of ZIP over this time frame was 
examined FIGURE 3 8 3 2 illustrates the interesting profile observed It is evident that 
the activity decreased with prolonged incubation showing a maximum inactivation of 
30% after 4hr However, Z-Gly-Pro-MCA degrading activity measured after this time 
began to exhibit a steady increase in activity, 100% catalytic activity being restored after 
24hr incubation One possible explanation for this unusual profile can be attributed to the
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\nature of protein denaturation and subsequent unfolding Although rare, an enzyme can 
unfold to an intermediate state that does not possess any activity and then further unfold 
to exhibit some activity (Sadana, 1993) Further work into this unusual observation 
would have to be performed to obtain a greater understanding of the mechanism of ZIP at 
37°C Irrespective o f the mechanism by which this phenomena occurred, this assay 
showed the stability of ZIP at 37°C overnight and hence the HPLC procedure could be 
performed without concern over the thermal degradation of the peptidase
4 8 4 pH Effects
Two distinct investigations into the effects of pH on ZIP stability and activity were 
performed Section 2 9 4 1 descnbes how the pH range over which the Z-Gly-Pro-MCA 
degrading peptidase remained stable was examined This was achieved by pre-incubation 
at a range of pH values followed by assaying with substrate prepared in buffer at pH 7 4 
Citrate, phosphate, Tns and glycine buffer systems (pKa values 4 76, 7 20, 8 06 and 9 78 
respectively, Blanchard, 1984) were chosen to reflect a range of pKa values, since 
buffering capacity is maximal at the pKa FIGURE 3 8 4 1 represents the bell-shaped 
inactivation curve constructed for ZIP It is surprising how stable ZIP activity appeared 
to be with respect to pH, inactivation being observed only below pH 2 0 or above pH 
10 5 In fact, 70% ZIP activity was detected at pH 2 5 and at pH 10 0 and over 80% at 
pH 3 0 This broad pH stability range implies that ZIP is little affected by the pH of the 
incubation buffer over 15min On closer examination of the graph it is clear that 
maximum Z-Gly-Pro-MCA degrading activity occurred at pH 7 5 in a phosphate buffer 
system
The second study served to determine the buffer system and substrate buffer pH at which 
ZIP activity was optimal Pre-incubation of purified enzyme with a range of buffers was 
conducted followed by assaying in a range of substrates each prepared at a different pH 
value as detailed in section 2 9 4 2 It was deduced from FIGURE 3 8 4 2 that >90% ZIP 
activity was observed between pH values of 7 4 (control-100%) and pH 10 0 in 
phosphate, Tns and glycine buffer species Optimal activity was observed using Z-Gly- 
Pro-MCA prepared in phosphate buffer at pH 7 0
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Despite the availability o f zwitteromc G o o d  b u f f e r s  (Good e t  a l , 1966), such as HEPES 
and MES, inorganic buffers including phosphate are less expensive for protein 
purification where large buffer volumes are required Phosphate buffer was selected over 
Tns where possible due to Tns’ ineffectiveness below pH 8 0, its highly temperature 
dependent pKa and its interference with a number of protein assays due to primary amine 
presence (Blanchard, 1984) Inactivation and activation pH ranges determined for ZIP 
are very similar to those reported for PO from numerous sources (TABLE 4 2 )  On 
comparison with an identical source, bovine serum PO was optimally active at pH 8 0- 
8 5, demonstrated a preference for phosphate buffer and remained stable over a pH range 
of 5 0-9 0 (Cunningham and O’Connor, 1998)
4 8 5. Isoelectric Point Determination
Chromatofocusing was employed in the determination of the isoelectric point (pi) of ZIP 
It differs from ion exchange in that the anion exchange matrix, pre-adjusted to a given 
pH, has distinct buffering properties that allows the creation of a pH gradient on the 
column rather than outside it Chromatofocusing can be employed as an isoelectric 
focusing or purification technique Section 2 9 5 1 outlines the conditions at which a 
PBE 94 resin was run Binding of ZIP was achieved at the initial pH of 7 8 and eluted 
during a pH gradient between pH 5 5 and 5 8 (FIGURE 3 8 5 1 ) This implies that in this 
range ZIP had no net charge and therefore is a good indication of its pi
Chromatofocusing could have been applied in the purification protocol, but the low 
working pH range was not optimal for ZIP activity, although it did not cause a high 
degree of inactivation (section 4 8 4 )  DEAE sepharose proved to be a more successful 
anion exchanger in comparison, yielding higher activity and greater reduction in total 
protein Coupled to this, polybuffer can be difficult to remove, requiring a further step 
such as ammonium sulphate precipitation, size-exclusion or affinity chromatography 
Despite this, chromatofocusing has successfully been reported in various PO purifications 
(Browne and O’Cuinn, 1983, Rennex e t a l , 1991)
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In order to confirm the pi deduced using chromatofocusing, vertical isoelectric focusing 
(IEF) was performed which is based on the following theory In the presence of an 
electric field and pH gradient, charged proteins migrate towards the anode or cathode 
until they reach their isoelectric point at which they have no charge and hence cannot 
further migrate Vertical IEF systems are becoming more common due to their simplicity 
and there is no need for a separate IEF system as PAGE electrophoresis equipment can be 
employed The relatively large pore size of agarose made it an ideal matrix for the large 
MW ZIP FIGURES 3 8 5 2 and 3 8 5 3 represent an image of the blue stained gel and the 
standard curve constructed as described in section 2 9 5 2 respectively The isoelectric 
point of ZIP was estimated to be 5 68 using this technique This value correlates with the 
chromatographic estimate of 5 5-5 8 and due to the superior resolving capabilities of IEF, 
the pi of ZIP was concluded to be 5 68 TABLE 4 2 highlights similar isoelectric points 
estimated for PO
4 8 6 Catalytic Classification and Effect of Other Functional Reagents
Sensitivity to specific active-site-directed inhibitors coupled to ammo acid sequence 
analysis is frequently investigated to determine the catalytic class of an enzyme In this 
study a number of serine, metallo- and cysteine protease inhibitors were incubated with 
purified ZIP to establish inhibition effects Cysteine protease activators and some non­
specific inhibitors were also examined as detailed in sections 2 9 6 and 2 9 7
Inhibition of ZIP by classic serine protease inhibitors, 4-(2-aminoethyl)- 
benzenesulphonyl-fluoride (AEBSF) and aprotimn was observed to be 58%  and 35%  
respectively (TABLE 3 1 0 )  AEBSF was employed as a safer, more stable, water-soluble 
alternative to di-isopropyl fluorophosphate (DFP) However, APMSF (4-amidino-phenyl 
methane-sulphonyl fluoride), a reportedly specific, irreversible serine protease inhibitor 
had no effect on ZIP activity Similarly the reversible cysteine and serine protease 
inhibitors, phenylmethyl-sulphonyl fluoride (PMSF) and leupeptm, failed to inhibit the Z- 
Gly-Pro-MCA degrading peptidase
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PO has been classified as a serine protease based on its sensitivity towards inhibitors such 
as DFP and PSMF (Monyama and Sasaki, 1983, Rennex e t  a l , 1991) A number of 
researchers have reported contrasting results, Yoshimoto et a l , (1983) for example, 
reported complete inhibition of PO by DFP yet none on incubation with PMSF, and still 
classified PO as a serine protease Similarly Goossens e t  a l , (1995) demonstrated PO’s 
sensitivity towards DFP and PMSF yet it exhibited resistance towards aprotimn It can 
be concluded from this that peptidases are often classified as serine proteases despite not 
exhibiting sensitivity towards a l l  of the active-site-targeted senne protease inhibitors 
Based on results of a similar pattern and the identical substrate specificity o f PO and ZIP, 
it is highly possible that ZIP too is of the serine protease catalytic family, although it is Z- 
Pro-Prohnal insensitive
O f the metallo-protease inhibitors examined (TABLE 2 11), ZIP showed no sensitivity 
towards the chelators, EDTA, EGTA, 8-hydroxyquinoline, imidazole and 1,10- 
phenanthrohne The most substantial ZIP inhibitions noted were 90% by 4,7- 
phenanthrohne and 77% by 1,7-phenanthrohne This sensitivity may justify 
classification of ZIP as a metallo-protease, however similar inhibition by such non- 
chelating phenanthrohnes has been reported in the cases of non-metallo-proteases One 
possible explanation put forward by Czekay and Bauer (1993) for pyroglutamyl 
aminopeptidase II, is that non-specific hydrophobic interactions occur between the 
aromatic ring structure on the phenanthrohnes and some hydrophobic region of the 
enzyme The presence of a hydrophobic pocket on ZIP has previously been illustrated by 
its ability to strongly bind to a HIC resin (fig u r e  3 4 2 1 ) Similar inhibition data for 
these phenanthrohnes was acquired for bovine serum PO (classified a serine protease) 
which also readily interacts with phenyl sepharose resins (Cunningham and O’Connor, 
1998)
It has been speculated that PO possesses a non-catalytically effective cysteine residue 
near its active serine site (Polgar, 1991) This explains the reported sensitivity towards 
classic sulphydryl inhibitors, such as PCMB (p-chloromercuribenzoate) by various 
researchers (Daly et a l , 1985, Rosen et a l , 1991, Cunningham and O’Connor, 1998) A
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range of cysteine protease inhibitors and activators were incubated with purified ZIP to 
establish the presence or absence of a similar cysteine residue TABLES 3 12 and 3 13 
summarise the results obtained Purified ZIP was inhibited by lOmM 5,5-dithio-bis2- 
mtrobenzoic acid (DTNB), and lOmM N-ethyl maleimide (NEM) by 60% and 47% 
respectively ZIP could be a cysteine protease or at least house a cysteine residue near its 
active site, since these compounds have been reported to interact with non-active site 
residues (Andrews et a l , 1980) This theory, may also explain why ZIP was inactivated 
in the presence of thiol-reducing agents, DTT (when incorporated into the substrate 
buffer) and 2-mercaptoethanol A second hypothesis is that the ZIP cysteine residue, 
unlike that of PO, is in the reduced form (SH) and so is not activated by the presence of 
DTT If this were the case, what would explain the observed inhibition by DTNB and 
NEM? Polgar (1991) surmised a relationship between the size o f the thiol reagent and 
the extent of enzyme inhibition The larger the reagent to interact with the cysteine 
residue, the greater the stenc effects causing the active site to become less accessible to 
the substrate This may clarify why DTNB inhibited ZIP to a greater extent than NEM 
and lodoacetamide (decreasing size), and further proposes the presence of a cysteine 
residue in close proximity to the active serine site
The effect of a number of non-specific functional reagents was also explored 55% 
inhibition was observed on incubation of ZIP and 2 5mg/mL antipain, while lmg/mL 
bacitracin, puromycin and pepstatin A, each inhibited ZIP by 41% These results verify 
the non-specificity o f these functional reagents, which probably share a common 
inhibition mechanism which is not specific for any one type of peptidase No inhibition 
by carnitine or trypsin inhibitor was observed because these functional reagents are 
relatively more specific (ta b le  2 12)
No firm conclusions can be drawn based on these results It is highly probable that ZIP is 
a serine protease that contains a cysteine residue near its active site but for some reason is 
not activated in the presence of DTT Further analysis e g ammo acid sequence analysis 
needs to be performed on this novel peptidase to elucidate its exact catalytic 
classification
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4.8 7 Effect of Metal Ions on ZIP Activity
The effect of metal ions on ZIP activity was examined as detailed in section 2 9 8 
Dissolution of some of the metal salts in phosphate buffer proved difficult, and so for 
these salts, Tns/HCl buffer species was employed (TABLE 2 13 ) All salts had the 
counterion sulphate and controls in both buffer systems were included, so that effects 
observed were wholly due to the presence of the metal ion T a b le  3 15 illustrates that 
the ZIP was not affected significantly by cobalt, copper, mckle or magnesium ions 
Considerable inhibition of 30%, 31% and 37% was reported for Ca2+, Na+ and Cd2+ 
respectively ZIP showed the greatest sensitivity towards zinc and mercury, with 56% 
and 44% activity remaining following incubation Inactivation by heavy metals is well 
documented (Vallee and Ulmer, 1972, Falkous et a l , 1995) Heavy metal cations such as 
mercury are known to react with histidine and tryptophan residues (Volkin and Klibanov, 
1990) and dithiols Therefore, it is  not surpnsing that ZIP was substantially inactivated 
by HgS04 Inhibition of PO by zinc and mercury ions is well documented in the 
literature (Kalwant and Porter, 1991, Strohmeier et a l , 1994) These results verify that 
ZIP is not a metallo-protease and may offer support for the presence of a non- 
catalytically active cysteine residue, since mercury has also been reported to 
hydrolytically degrade disulphide bridges (Volkin and Klibanov, 1990)
4 8 8 Carbohydrate Analysis
Since the majority o f extracellular proteins of higher animals are glycosylated, it was 
decided to carry out a preliminary investigation into the detection of carbohydrate 
(oligosaccharide) moieties in purified ZIP The Mohsch test for general carbohydrates 
was performed as outlined in section 2 9 9 2 Although a positive violet result was 
obtained, this test is non-specific for glycan moieties and so a more conclusive 
experiment had to be attempted ZIP tested positive for reducing sugars using the more 
specific Fehling’s test as outlined in section 2 9 9 1 Most mono- and disaccharides are 
classified as reducing sugars based on the presence of potentially free aldehyde or ketone 
groups Detection of glucose and starch in the purified ZIP sample supplied negative 
results The data indicates that purified ZIP does contain carbohydrate residues, probably 
reducing sugar residues, and is a glycoprotein A Pierce glycoprotein estimation kit was
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employed to investigate this possibility and to subsequently estimate the extent of 
glycosylation FIGURE 3 8 9 illustrates the standard curve constructed from which it was 
estimated that ZIP was indeed a glycoprotein, 33% of its total weight represented by a 
carbohydrate component To date it does not appear that PO is glycosylated
Glycosylation is regarded as an extension of protein biosynthesis and is one of the major 
metabolic activities in the lumen of the endoplasmic reticulum Oligosaccharide side 
chains most commonly attach to asparagine residues on the backbone of the protein in 
sequences Asn-X-Ser/Thr where X^Pro (termed ^/-linked oligosaccharides) and there 
may be more than one attachment site (Einspahr, 1989) In contrast the 0-glycosidic 
bond presents a wide variety o f linkages including serine and threonine linkages The 
oligosaccharide moiety can have a significant effect on the physiochemical properties of 
the protein although the purpose of the carbohydrate is not always clear Glycoproteins 
display a greater increased resistance to dénaturation factors, depending on the degree of 
glycosylation, including thermal stability and solubility It is believed that the 
carbohydrate moiety attached to the protein molecule affects its hydration, therefore 
enhancing stability (Cabral and Kennedy, 1993)
Different molecules o f a glycoprotein may contain different sequences and locations of 
oligosaccharides (Voet et a / ,  1999) and recent studies suggest that some glycoproteins 
may have the same protein core, yet different biological activity, determined by their 
respective oligosaccharide moieties This has been shown to be the case with two IgE 
factors, one of which stimulates IgE production (IgE-pF) while the other (IgE-sF) inhibits 
the synthesis of IgE by lymphocytes (Goochee and Monica, 1990) It may be possible 
that PO and ZIP share a common backbone structure and differ by way of the degree of 
glycosylation After glycoprotein formation, modification of the core polysaccharide can 
occur, such as the removal o f a mannose group (McGilvery, 1979) and such a phenomena 
can result in the formation of glycoproteins of identical origin which differ slightly in 
terms of the final glycosylation If  this does prove to be the case with ZIP and PO, it may 
explain some of the dissimilarities observed in the physiochemical characterisation of the 
peptidases The presence of carbohydrate moieties would obviously affect the relative
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molecular mass, which may explain why ZIP appears heavier than PO Glycosylation of 
ZIP may also explain differences in binding affinities to HIC and CPC resins and may 
even be responsible for the resistance of ZIP towards Z-Pro-Prolinal and DTT Since 
glycosylation is tissue and cell type specific within a given species, it may be possible 
that ZIP is a glycosylated form of PO
4.8 9 Oligopeptidase Determination
PO has been classified as an oligopeptidase (Camargo e t  a l , 1979, Barrett and Rawlings, 
1992) based on the substrate-size limitation of its specificity In general, short peptides 
or positively charged peptides have been found to be efficient PO substrates while longer 
peptides are less favourable Polgar (1992a) proposed a hypothesis of a tunnel-like 
binding site with a negatively charged active site, allowing the enzyme to exclude large, 
negatively charged peptides from the active site and hence classify PO as an 
oligopeptidase Considering this, the possibility that ZIP may too be an oligopeptidase 
was investigated as outlined in section 2 9 10 The cleavage of <X2-macroglobulin (0C2M), 
BSA and insulin B chain by purified ZIP was analysed using lon-pair reverse phase 
HPLC F ig u r es  3 8 1 0 1  -3 8 1 0 3  represent the chromatograms showing the failure of 
ZIP to cleave all three peptides This data implies that ZIP is an oligopeptidase since it 
did not interact with a 2M (FIGURE 3 8 10 1) a characteristic of all oligopeptidases 
(Barrett and Rawlings, 1992) Secondly there was no hydrolysis o f BSA (66kDa) or the 
prohne-containing insulin B chain {Phe-Val-Asn-Gln-His-Leu-Cys[S0 3 H]-Gly-Ser-His- 
Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys[S0 3 H]-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro- 
Lys-Ala} presumably due to the size of these peptides Oligopeptidases can only cleave 
small oligopeptides usually less than 20 amino acid residues
The effect of a 2M on ZIP and PO activities was fluonmetrically assessed as detailed in 
section 2 9 10 2 FIGURES 3 8 10 4 and 3 8 10 5 clearly show that this plasma serine 
protease inhibitor had no inhibitory effect on Z-Gly-Pro-MCA degrading activities up to 
0 5mg/mL The failure of PO and ZIP to cleave the bait region of the macroglobulin, 
which is sensitive to the action of the great majority of endopeptidases of all catalytic
types (Barrett and Starkey, 1973), is a clear demonstration o f the oligopeptidase 
specificity of PO and ZIP
4.8.10 Substrate Specificity
The substrate specificity o f PO has been well documented from various sources and the 
peptidase has been classified as a proline specific oligopeptidase (Cunmgham and 
O’Connor, 1997b) Bovine brain PO which had been previously purified in our 
laboratory was analysed with bovine serum ZIP to allow comparison o f their substrate 
specificities HPLC, colorimetric and kinetic analyses were carried out to gain an insight 
into the specificity of ZIP
The excellent resolving power of reverse phase high performance liquid chromatography 
(RP HPLC) has resulted in it becoming the predominant HPLC technique for peptide 
separation In this study lon-pair RP HPLC was used to detect cleavage products 
following incubation of peptides with purified enzyme (PO or ZIP) A silica based 
analytical column containing octadecyl ligands (Cis) was employed as the non-polar 
stationary phase The polar mobile phase of water and MeOH contained the hydrophobic 
ion-pairing reagent tnfluoroacetic acid (TFA) In the pH range dictated by the stability of 
the Cis column, basic ammo acids and the terminal amino group are fully ionised It has 
been suggested that TFA ion pairs with basic charges and this interaction tends to 
increase the affinity of the peptide for the column (Bennett, 1991) Thus, lon-pair RP 
HPLC was chosen as the optimum analytical tool for this substrate specificity 
investigation
A range of synthetic peptides was examined (TABLE 2 15) and the results are presented in 
ta ble  3 16 ZIP and PO had matching specificities and both peptidases failed to cleave 
any tn- or N-blocked di-peptides, such as Gly-Pro-Ala or Z-Pro-Gly It is well 
documented that PO fails to cleave any peptides less than four residues in length or of 
three residues with a blocked N-terminus (Walter and Yoshimoto, 1978) Identical 
cleavage products were detected following the hydrolysis o f Z-Gly-Pro-AJa by ZIP and 
PO This result was hardly surprising since both enzymes readily cleave Z-Gly-Pro-
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MCA One interesting result though, was that no hydrolysis was detected for the proline- 
containmg tetrapeptide, Gly-Gly-Pro-Ala by either ohgopeptidase Based on the size of 
this peptide, these results are not in keeping with the current understanding o f PO 
specificity, and it may be possible that the enzyme levels were not sufficient to mediate 
detectable hydrolysis
T able  4 4 outlines the ammo acid sequences o f the bioactive peptides investigated as 
described in section 2 9 111 Disappointedly, the peptides that were hydrolysed by ZIP 
were also cleaved by PO (TABLE 3 16) and so the two peptidases appear to have identical 
substrate specificities There were a number of peptides which were only hydrolysed by 
PO, namely, bradykinin, (Glu2)-TRH, (Phe2)-TRH and TRH-Gly, however this was most 
probably due to low enzyme concentration rather than differences in specificity 
characteristics ZIP and PO cleaved all three of the angiotensin peptides tested 
presumably at the Pro-Phe bond (TABLE 4 4 )  It is evident from the chromatograms in 
F ig u r es  3 8 1 1 1 , 3 8 1 1 2 , 3 8 1 1 3  and 3 8 114 that ZIP and PO share a common 
cleavage site for all angiotensin I and II, based on the identification of a similar cleavage 
products Angiotensin III (chromatogram not shown) exhibited a similar chromatogram 
to angiotensin I and II and again it was clear that both peptidases readily hydrolysed the 
bioactive peptide at the same scissile bond The cleavage of angiotensin I, II and III has 
been previously reported for porcine brain PO (Monyama et a l , 1988) LHRH and TRH 
were both hydrolysed by PO and ZIP at the carboxyl side of the proline residue while PO 
was found to also cleave the TRH analogues, (Giu2)-TRH, (Phe2)-TRH and TRH-Gly 
Although cleavage of these bioactive peptides by PO is well documented (Tate, 1981, 
Mendez et a l , 1990), the precise role this peptidase plays in the turnover of these 
peptides in  v iv o  remains unclear
Amyloid p-protein (Ap), a 4kDa protein subunit present in the neuntic plaques, 
neurofibrillary tangles and cerebrovascular deposits in Alzheimer’s disease (AD) patients 
is the hallmark of the disease Although the specific biochemical events leading to the 
deposition of amyloid are not known, Ap is believed to be involved in the pathogenesis 
of AD (Tanzi et a l , 1988) Ap is derived from the amyloid precursor protein (APP)
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which is known to be metabolised by at least two major pathways that are mutually 
exclusive and involve distinct proteolytic activities (Almkvist e t  a l , 1997) F ig u r e  4 7 
shows the proposed major pathways involving an enzyme activity known as a-secretase 
that produces a soluble derivative of APP (a-sAPP) An alternative metabolic pathway 
involves at least two proteolytic activities known as P- and y-secretase that collectively 
generate Ap PO has been implicated in this latter pathway (Ishiura et a l , 1990) and is 
believed to act as a y-secretase cleaving the Ala42-Thr43 bond of APi 43
For this reason, the cleavage of APi 43 by PO and ZIP was investigated by RP HPLC 
analysis Fragments APi 28 and AP25 35 were also examined since studies have shown 
these to exhibit identical antigenic, structural, neurotrophic and neurotoxic effects as the 
Ap peptide (Kang et a l , 1987, Yanker et a l , 1990) The presence of alanine residues 
(marked in i t a l ic  in t a b l e  4 4 )  on these peptides serve as potential cleavage sites for PO, 
which also has the ability to hydrolyse alanyl bonds (Walter and Yoshimoto, 1978) 
HPLC chromatograms obtained reveal that neither PO nor ZIP appeared to hydrolyse any 
of the Ap peptides This was disappointing, though not that surprising for a number of 
reasons Firstly, the molar concentration of the peptides tested was very low (TABLE 
2 16) and the level o f enzyme activity may not have been sufficient to induce a 
detectable cleavage product Although prolyl ohgopeptidase does have an affinity for 
alanyl bonds, the rate of hydrolysis is orders of magnitude lower than that for prolyl 
bonds (Walter and Yoshimoto, 1978) Finally, PO and ZIP may be incapable of cleaving 
a 43 amino acid peptide ( A p i .43)  based on their classification as ohgopeptidases
Despite the identification of PO as a y-secretase, the ability of PO to cleave the Ala7 i4- 
Thr7i5 of APP to produce Api 42, is impossible due to the length of the APP peptide (742 
residues) However, if the P-secretase cleavage was to occur first, PO may then be able 
to act as a y-secretase on the remaining 27 residue peptide (FIGURE 4 7 )  This hypothesis 
has been proposed by Yamaguchi et a l , (1988) yet the ability of PO or ZIP to hydrolyse 
a 27 ammo acid residue peptide remains highly debatable Despite the controversy, PO 
has also been implicated in AD due to its ability to cleave neuropeptides such as arginine-
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vasopressin, substance P, angiotensin II and TRH, which have suggested roles in memory 
and learning (Schlesinger et a l , 1983, Griffiths, 1987) In view of the various potent 
biological effects elicited by neuropeptides, an inhibitor of the enzyme that regulates their 
metabolism may have the potential to be a therapeutic agent for AD (see section 4 8 11 
for discussion on prohne-specific inhibitors)
As previously discussed, the substrate specificity of PO favours hydrolysis of tetra- or N- 
blocked tn-peptides and there have been no reports of dipeptide cleavage HPLC 
analysis indicated similar specificities between ZIP and PO and the cadmium ninhydnn 
assay was performed to investigate the substrate specificity of ZIP with respect to 
dipeptides The method employed was a modification of that of Doi et a l  (1981) and 
T able  3 17 highlights that ZIP did not cleave any of the dipeptides tested The 
colorimetric cadmium ninhydnn assay is based on the interaction of ninhydnn with an 
ammo group as outlined in FIGURE 4 8 , producing a purple complex which absorbs at 
570nm in the absence of cadmium and at 505nm in its presence This coupled to the 
HPLC data suggests that the substrate specificity of PO and ZIP are extremely alike, both 
requiring at least four amino acid residues and a Pro in the Pi position for hydrolysis
°ll ^  li
i'TV 'V 4'II | /CC + h 2n c h r c o 2h  -------- ► II I / \  + n h 3 + c o 2 + RCHO
°n  ° H
o O
Ninhydrin Protein Hydrmdantin
F igure 4 8 Basis of the  Cadmium  Ninhydrin C olorim etric  Assay
Michaelis constants (Km) were determined for punfied ZIP and PO activities as described 
in section 2 9 113 1 using Z-Gly-Pro-MCA Four kinetic models were applied to the 
data, namely the Michaehs-Menten, Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf 
models Section 6 3 details how each model utilised the data to produce a Km value for 
the two enzymes Table 3 17 presents the calculated constants for ZIP and PO It is 
obvious that both enzymes had a high affinity for Z-Gly-Pro-MCA, since constants in the 
jiM region were obtained However, PO appeared to have a lower affinity for the N- 
blocked substrate showing an average Km of 99pM in comparison to 54jiM for ZIP This 
Km determined for PO is higher than that originally reported (20/iM) by Yoshimoto el al 
(1979) Yet, it is comparable to that of Cunningham and O’Connor (1998) for bovine 
serum PO and for membrane-bound brain PO (O’Leary et a l, 1996)
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Peptide AA Sequence and Proposed cleavage site
Aßi 28 28 Asp-^ /a-G/w-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-^ /a-G/w'Asp-Val-
Gly-Ser-Asn-Lys
Aß M3 43 Asp-^ /a-G/w-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-v4/a-G7w-Asp-Vai-
Gly-Ser-Asn-Lys-Gly-^ /a-//e-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-^ /a-777r
Aß25 35 11 Gly-Ser-Asn-Lys-Gly-^ /a-7/e-Ile-Gly-Leu-Met
Angiotensin I 11 Asp-Arg-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
Angiotensin II 8 Asp-Arg-V al-Tyr-He-His-Pro-Phe
Angiotensin III 7 Arg-Val-Tyr-Ile-His-Pro-Phe
Arg8 Vasopressin 9 Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Bradykinin 9 Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
(G1u2)-TRH 3 Pyr-Glu-Pro-NH2
LHRH 10 Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
Neurotensin 13 Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu
(Phe2)-TRH 3 Pyr-Phe-Pro-NH2
Substance P 11 Arg-Pro-Lys-Pro-Gln-GIn-Phe-Phe-Gly-Leu-Met
TRH 3 Pyr-His-Pro-NH2
TRH-Gly 4 Pyr-His-Pro-Gly
Table 4.4. Sequence of Bioactive Peptides Employed for Substrate Specificity Studies 
Scissile cleavage sites are marked in bold font, while italic residues indicate possible cleavage sites
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The effect of a range of prolme-containing peptides on the Km values determined for ZIP 
and PO using Z-Gly-Pro-MCA was examined as outlined in section 2 9 113 2 
Angiotensin I was found to be a competitive inhibitor of ZIP with a K, of 90j^ M as 
determined by the Michaelis-Menten plot (see TABLE 3 19 for results and section 6 4 2 
for calculations) Values obtained from the Michaelis-Menten plot were taken as the 
most accurate representation of K, values since the model does not involve reciprocals 
which can conceal a poor fit (Henderson, 1992) ZIP was uncompetitively inhibited by 
LHRH with a K, of IOOjjM These results suggest that ZIP has a greater specificity for Z- 
Gly-Pro-MCA than for either of these two bioactive peptides K, values for the other 
prolme-containing peptides could not be determined since the exact type of inhibition 
could not be identified (see section 6 3 3 ) PO was competitively inhibited by 
angiotensin I and II, bradykmin and Z-Gly-Pro-Ala with Michaelis-Menten K, values of 
75, 150, 275 and 476|aM respectively These results agree with those of Monyama et al 
(1988) who also found angiotensin I and II to be the most potent competitive inhibitors of 
PO among a number of bioactive peptides Previous reports in the literature though have 
claimed PO to be competitively inhibited by TRH, LHRH and bradykmin (Cunningham 
and O’Connor, 1998) although in this experiment, the exact mode of inhibition could not 
be determined for these peptides The poor specificity of PO towards Z-Gly-Pro-Ala 
(476 M^) is surprising considering a Km value of 99juM was observed for Z-Gly-Pro- 
MCA This may be due to a preference for a large hydrophobic group such as MCA in 
the Pi’ subsite
In summary, these studies verify the broad prohne-specific substrate specificity of prolyl 
oligopeptidase and suggest a similar specificity pattern for ZIP
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4 8.11 Inhibitor Studies
The specificity of PO described by Polgar (1992a) in relation to its exclusion of 
negatively charged peptides from the active site, has also been observed with PO specific 
inhibitors (Kolosko et a l , 1994) Therefore, the design of PO specific inhibitors has 
centred on mimicking the structure of short positively charged peptides (e g Z-Pro- 
Prolinal) A number of proline specific peptidase inhibitors were incubated with purified 
ZIP to determine its sensitivity towards them, purified PO was also assayed for 
comparison purposes TABLE 2 19 lists the inhibitors studied, most of which were kindly 
donated due to commercial unavailability Fmoc-Pro-Pro-CN, JTP-4819, S-17092-1, S- 
19825, Z-Phe-Pro-Methylketone and Z-Pro-Prolinal had little or no inhibitory effect on 
purified ZIP activity Conversely, PO was extremely sensitive to these inhibitors with 
IC50 values listed in ta b le  3 21 This specific inhibition of PO has been previously 
reported in the literature for these inhibitors (TABLE 4 5) The insensitivity of ZIP 
towards Z-Pro-Prolinal has been previously reported (Cunningham and O ’Connor, 
1997a), however this investigation highlights a number of alternative inhibitors 
exhibiting a similar profile Fmoc-Pro-Pro-CN (Li et a l, 1996) and Z-Phe-Pro- 
Methylketone (Steinmetzer et a l , 1993) are Z-Pro-Prolinal derivatives which may 
explain the similarity of the PO IC50 values obtained for these inhibitors in comparison to 
that for Z-Pro-Prolinal (TABLE 3 21) Fmoc-Ala-Pro-CN (Li et a l, 1996), was the most 
potent PO inhibitor tested with an IC50 of 1x10 12M, however ZIP was 60% inhibited at 
lxlO-^
JTP-4819 (FIGURE 4 9 ) is a potent inhibitor of PO activity exhibiting a high specificity 
for the target enzyme, with no effect on other prohne-related enzymes (Toide et a l, 
1995) The inhibitor is currently being considered as a potential agent for the treatment 
of AD The pharmacological actions of JTP-4819 include its inhibitory effects on PO 
activity which in turn may prevent neuropeptide degradation in the brain, and its 
enhancement of memory impairment in rats (Shinoda et a l, 1996, Toide et a l, 1998) 
JTP-4819 proved to be a relatively potent PO inhibitor yielding an IC50 value of 2 5x10 
6M, yet more importantly ZIP remained completely resistant to inhibition This result is 
in parallel to those discussed in section 46 6 where JTP-4819 was selected as the
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optimum inhibitor for the detection of ZIP alone in crude samples Using JTP-4819, 
Shinoda et al (1997) have implicated PO in the production of the APP fragment Api 42 
believed to be the hallmark of AD as previously discussed (section 4 8 10) The 
relevance of this is that if PO and ZIP possess a common substrate specificity as results 
of the HPLC analyses suggested, it is highly probable that if PO is responsible for Ap 
production then so too is ZIP However, it should be considered that ZIP is not inhibited 
by JTP-4819, and so the total Z-Gly-Pro-MCA degrading activity is not being inactivated 
by this novel inhibitor Therefore, use of JTP-4819 to minimise neuropeptide cleavage 
and eliminate Ap production would prove futile This is of particular relevance in light 
of the findings outlined in section 4 7 in which ZIP activity was detected in the brain
Figure 4.9 Structure of JTP-4819
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S-17902-1 and S-19825 were donated by Dr F Checler The perhydroindol carboxylic 
derivatives proved to be excellent PO inhibitors yielding IC50 values of 1x10' M  and 
1x10 9M  respectively (tab le  3 21) These inhibitors also proved to be PO-specific and 
did not affect the activity of ZIP (FIGURES 3 8 12 8 and 3 8 12 9) A similar specificity 
of S-17092-1 has been reported by Barelli et al (1999), who noted a resistance by 
aminopeptidases B and M, DPP IV and angiotensin-converting enzyme, among others, 
towards the inhibitor Like JTP-4819, S-17092-1 is also being investigated as a potential 
tool in the determination of the contribution of PO to AD (Barelli et a l, 1999) and so the 
observed insensitivity of ZIP to it, should not be overlooked
Commercially available Z-Pro-Prolmal dimethylacetate and Boc-Glu-(NHOB2)-Pyr, 
yielded the poorest IC50 values (1x 10‘5M  each) for PO, and also inhibited ZIP activity 
(FIGURES 3 8 12 1 and 3 8 12 13 ) Goossens et al (1997) reported an IC50 of 0 13j^ M
7 5(1 3x10 M) for Z-Pro-Prolmal dimethylacetate, however a value of 1x10 M  was 
obtained in this study Boc-Glu-(NHOB2)-Pyr was synthesised by Demuth et al (1993) 
as the most potent proline specific peptidase inhibitor from a range of aminodicarboxylic 
acid pyrrohdides (TABLE 4 5) An interesting profile was that of Z-Phe-Ala- 
Chloromethlyketone which appeared to exert a greater inhibitory effect on ZIP than on 
PO (figure 3 8 12 10) Postatin, an inhibitor of bacterial origin was adequate in its 
inhibition of PO (IC50 5xl0"7M) in comparison to 3 5xl0'8M  observed for PO from the 
same source by Cunningham and O’Connor (1998) Ile-Thiazohdide and Ile-Pyrrolidide 
were designed as DPP IV specific inhibitors (Pederson et a l, 1998, Pauly et a l, 1999) 
with reported K, values of 130nM and 250nM respectively However in this study, it is 
clear that Ile-Thiazohdide was also a potent inhibitor of PO activity yielding an improved 
IC50 value (1x10 8M) in comparison to DPP IV (1 3x10 7M) This observed inhibitory 
action of Ile-Thiazohdide for both PO and DPP IV is likely to be due the specificity of 
both peptidases for a proline residue at the scissile bond (Cunningham and O’Connor, 
1997b)
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Inhibitor
Boc-Glu-(NHOB2)-Pyr
Fmoc-Ala-Pro-CN
Fmoc-Pro-Pro-CN
JTP-4819
Po statin
S-17092-1
Z-Phe-Ala-Chloromethlyketone
Z-Phe-Pro-Methylketone
Z-Pro-Prolmal
Z-Pro-Prolinal dimethylacetate
Kx IC50
0 03fiM ND
5nM ND
5nm ND
ND 0 83nM
ND 0 03jug/mL
lnm ND
ND ND
1 8nM ND
ND 0 74nM
ND 0 13|iM
Table 4.5. Specific Inhibitors of PO
ND means not determined
Reference 
Demuth et a l, 1993 
Li et a l, 1996 
Li et a l, 1996 
Tolde eia/, 1995 
Aoyagi et a l, 1991
Barelli et a l, 1999 
Stone et a l, 1991 
Steinmetzer e/ a l , 1993 
Tsuru e/a/, 1988 
Goossens £/ a/, 1997
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6.0. A p p e n d ic e s
6 0 Appendices
6 1 Er r or Bars
Error bars on all graphs represent the standard error of the mean of triplicate fluorescence 
or absorbance values The standard error (SE) of mean is defined as
SE = of 4n
Where
o is the standard deviation i e -/variance (variance is (a2 + b2+ c2)/3, where a, b and c are 
the triplicate values)
n is the number of repeat values measured (three in these studies)
6 2 En z y m e Q uantitation
One unit of enzyme activity is defined as the amount of enzyme which releases lpicomole 
MCA per minute at 37°C
Derivation
Let MCA released = AjiM
= Ajimoles/Litre
(assay uses 400|liL MCA, lOO^ L enzyme)
- X x  104x 0 4  |imoles/min/100|iL 
60
= Arxl04x04xl0+6 picomoles/min/lQO^ L 
60
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= X x  40 picomoles/minute/100(iL 
60
= X x 400 picomoles/minute/lOOOuL 
60
= Xx 400 picomoles/minute/mL 
60
= X  picomoles/min/mL 
0 15
But.
lunit of activity is defined as amount of enzyme which releases lpicomole MCA/min, 
Therefore
- X  umts/ml 
0 15
And
MCA released (X) is also defined as fluorescent intensity observed/slope of the
appropnate MCA standard curve, so
Umt/mL = Fluorescent Intensity
Slope of filtered standard curve x 0 15
Therefore
Unit of activity = Flourescent Intensity
Slope of filtered standard curve x 0.15
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Total activity (unit). Units of enzyme activity, calculated from fluorescent intensity as 
described in section 6 2
Total protein (mg) mg/mL protein estimated from appropriate BSA standard curve 
(using Biuret or BCA assays) x volume of sample in mL
Specific Activity (unit/mg) Total activity/total protein
Purification factor* Specific activity of sample/specific activity of starting sample 
(serum)
Yield (%) (Total activity of sample/total activity of starting sample (serum)) x 100
6 3. Purification Table Calculations
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6 4. K inetic Analysis
6 4 1 K m Determinations
The Michaehs constant (KM) is defined as the dissociation equilibrium constant for the 
enzyme-substrate complex It may be measured by the analysis of initial velocities at a 
series of substrate concentrations and one concentration of enzyme The data points can 
then be fitted to a number of models as outlined below
Michaelis-Menten - Plot of fluorescent intensity versus substrate concentration 
Km is  the substrate concentration at half the maximum fluorescent intensity
Lineweaver-Burk - Plot of 1/fluorescent intensity versus 1/substrate concentration 
The intercept of the line at the x-axis is given as -1/KM
Eadie-Hofstee - Plot of fluorescent intensity versus fluorescent intensity/substrate
concentration
The slope is given as -KM
Hanes-Woolf - Plot of substrate concentration/fluorescent intensity versus substrate 
concentration
The intercept at the x-axis is given as -KM
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6 4 2 K, Determinations
Ki, the inhibition constant, is defined as the constant of dissociation of inhibitor from a 
reversibly bound enzyme-inhibitor complex
K, = K m x I 
K app- K m
Where
K, is the inhibition constant
Km is  the Michaehs constant with no inhibitor present 
I is the inhibitor concentration
K app is the apparent Michaehs constant and is taken to be the ‘new KM’ observed when a 
reversible inhibitor is incorporated into the assay Kapp is measured as for KM (described in 
section 6 4 1)
6 4 3 Types of Reversible Inhibition
Reversible inhibition involves noncovalent forces that bind inhibitors to enzymes The
following are the common forms of reversible inhibition
E- enzyme
I-inhibitor
S-substrate
P-product
Competitive inhibition involves binding of the enzyme to the inhibitor forming an 
enzyme-inhibitor complex The inhibitor competes with the substrate for the enzyme active 
site
E + S <-> ES E + P 
+
I
1 K,
El
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With competitive inhibition, the slope of the Lineweaver-Burk plot increases as does the 
Km Competitive inhibition is recognisable when plots intersect at a common point of 
intersection on the positive y-axis
Uncompetitive inhibition occurs when the inhibitor binds to the enzyme-substrate 
complex, binding to a site other than the substrate binding site
E + S < - >  ES -> E + P
+
I
tKt
ESI
This type of inhibition is identified by the presence of parallel lines in the Lineweaver-Burk 
plot Km decreases but slope values remain the same
Non-competitive inhibition involves the random binding of inhibitor to either enzyme or 
enzyme-substrate complex
E + S < - >  ES E + P
+ +
I I
I*, t*.
El + S <-► ESI
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Non-competitive inhibition may be identified by lines intersecting on the negative portion 
of the y-axis Km remains the same but Vmax decreases
Mixed inhibition occurs when inhibitor binds unequally to enzyme or enzyme-substrate 
complex Vmax decreases and Km may increase or decrease Non-competitive- 
uncompetitive mixed inhibition is evident when the type of inhibition lies between the two 
types and is identified by lines intersecting below the negative portion of the y-axis 
Competitive-non-competitive inhibition is recognisable by lines intersecting above the 
negative portion of the y-axis
6.5 IC50 Determinations
The IC50 is defined as the concentration at which an enzyme is half inhibited It can be 
calculated graphically from a plot of enzyme activity versus inhibitor concentration, by 
locating 50% activity on the y-axis and calculating the corresponding concentration on the 
x-axis
Inhibitor Concentration (M)
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